Compounds and methods for therapy and diagnosis of lung cancer

Abstract

Compounds and methods for the treatment and diagnosis of lung cancer are provided. The inventive compounds include polypeptides containing at least a portion of a lung tumor protein. Vaccines and pharmaceutical compositions for immunotherapy of lung cancer comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided, together with DNA molecules for preparing the inventive polypeptides.

Description

TECHNICAL FIELD

The present invention relates generally to compositions and methods for the treatment and diagnosis of lung cancer. The invention is more specifically related to nucleotide sequences that are preferentially expressed in lung tumor tissue, together with polypeptides encoded by such nucleotide sequences. The inventive nucleotide sequences and polypeptides may be used in vaccines and pharmaceutical compositions for the treatment and diagnosis of lung cancer.

BACKGROUND OF THE INVENTION

Lung cancer is the primary cause of cancer death among both men and women in the U.S., with an estimated 172,000 new cases being reported in 1994. The five-year survival rate among all lung cancer patients, regardless of the stage of disease at diagnosis, is only 13%. This contrasts with a five-year survival rate of 46% among cases detected while the disease is still localized. However, only 16% of lung cancers are discovered before the disease has spread.

Early detection is difficult since clinical symptoms are often not seen until the disease has reached an advanced stage. Currently, diagnosis is aided by the use of chest x-rays, analysis of the type of cells contained in sputum and fiberoptic examination of the bronchial passages. Treatment regimens are determined by the type and stage of the cancer, and include surgery, radiation therapy and/or chemotherapy. In spite of considerable research into therapies for the disease, lung cancer remains difficult to treat.

Accordingly, there remains a need in the art for improved vaccines, treatment methods and diagnostic techniques for lung cancer.

SUMMARY OF THE INVENTION

Briefly stated, the present invention provides compounds and methods for the therapy of lung cancer. In a first aspect isolated polynucleotide molecules encoding lung tumor polypeptides are provided, such polynucleotide molecules comprising a nucleotide sequence selected from the group consisting of: (a) sequences provided in SEQ ID NO: 1-3, 6-8, 10-13, 15-27, 29, 30, 32, 34-49, 51, 52, 54, 55, 57-59, 61-69, 71, 73, 74, 77, 78, 80-82, 84, 86-96, 107-109, 111, 113, 125, 127, 128, 129, 131-133, 142, 144, 148-151, 153, 154, 157, 158, 160, 167, 168 and 171; (b) sequences complementary to a sequence provided in SEQ ID NO: 1-3, 6-8, 10-13, 15-27, 29, 30, 32, 34-49, 51, 52, 54, 55, 57-59, 61-69, 71, 73, 74, 77, 78, 80-82, 84, 86-96, 107-109, 111, 113, 125, 127, 128, 129, 131-133, 142, 144, 148-151, 153, 154, 157, 158, 160, 167, 168 and 171; and (b) sequences that hybridize to a sequence of (a) or (b) under moderately stringent conditions.

In a second aspect, isolated polypeptides are provided that comprise at least an immunogenic portion of a lung tumor protein or a variant thereof. In specific embodiments, such polypeptides comprise an amino acid sequence encoded by a polynucleotide molecule comprising a nucleotide sequence selected from the group consisting of (a) sequences recited in SEQ ID NO: 1-3, 6-8, 10-13, 15-27, 29, 30, 32, 34-49, 51, 52, 54, 55, 57-59, 61-69, 71, 73, 74, 77, 78, 80-82, 84, 86-96, 107-109, 111, 113, 125, 127, 128, 129, 131-133, 142, 144, 148-151, 153, 154, 157, 158, 160, 167, 168 and 171; (b) sequences complementary to a sequence provided in SEQ ID NO: 1-3, 6-8, 10-13, 15-27, 29, 30, 32, 34-49, 51, 52, 54, 55, 57-59, 61-69, 71, 73, 74, 77, 78, 80-82, 84, 86-96, 107-109, 111, 113, 125, 127, 128, 129, 131-133, 142, 144, 148-151, 153, 154, 157, 158, 160, 167, 168 and 171; and (c) sequences that hybridize to a sequence of (a) or (b) under moderately stringent conditions.

In related aspects, expression vectors comprising the inventive polynucleotide molecules, together with host cells transformed or transfected with such expression vectors are provided. In preferred embodiments, the host cells are selected from the group consisting of E. coli , yeast and mammalian cells.

In another aspect, fusion proteins comprising a first and a second inventive polypeptide or, alternatively, an inventive polypeptide and a known lung tumor antigen, are provided.

The present invention further provides pharmaceutical compositions comprising one or more of the above polypeptides, fusion proteins or polynucleotide molecules and a physiologically acceptable carrier, together with vaccines comprising one or more such polypeptides, fusion proteins or polynucleotide molecules in combination with an immune response enhancer.

In related aspects, the present invention provides methods for inhibiting the development of lung cancer in a patient, comprising administering to a patient an effective amount of at least one of the above pharmaceutical compositions and/or vaccines.

Additionally, the present invention provides methods for immunodiagnosis of lung cancer, together with kits for use in such methods. Polypeptides are disclosed which comprise at least an immunogenic portion of a lung tumor protein or a variant of said protein that differs only in conservative substitutions and/or modifications, wherein the lung tumor protein comprises an amino acid sequence encoded by a polynucleotide molecule having a sequence selected from the group consisting of nucleotide sequences recited in SEQ ID NO: 1-109, 111, 113, 115-151, 153, 154, 157, 158, 160, 162-164, 167, 168 and 171, and variants thereof. Such polypeptides may be usefully employed in the diagnosis and monitoring of lung cancer.

In one specific aspect of the present invention, methods are provided for detecting lung cancer in a patient, comprising: (a) contacting a biological sample obtained from a patient with a binding agent that is capable of binding to one of the above polypeptides; and (b) detecting in the sample a protein or polypeptide that binds to the binding agent. In preferred embodiments, the binding agent is an antibody, most preferably a monoclonal antibody.

In related aspects, methods are provided for monitoring the progression of lung cancer in a patient, comprising: (a) contacting a biological sample obtained from a patient with a binding agent that is capable of binding to one of the above polypeptides; (b) determining in the sample an amount of a protein or polypeptide that binds to the binding agent; (c) repeating steps (a) and (b); and comparing the amounts of polypeptide detected in steps (b) and (c).

Within related aspects, the present invention provides antibodies, preferably monoclonal antibodies, that bind to the inventive polypeptides, as well as diagnostic kits comprising such antibodies, and methods of using such antibodies to inhibit the development of lung cancer.

The present invention further provides methods for detecting lung cancer comprising: (a) obtaining a biological sample from a patient; (b) contacting the sample with a first and a second oligonucleotide primer in a polymerase chain reaction, at least one of the oligonucleotide primers being specific for a polynucleotide molecule that encodes one of the above polypeptides; and (c) detecting in the sample a polynucleotide sequence that amplifies in the presence of the first and second oligonucleotide primers. In a preferred embodiment, at least one of the oligonucleotide primers comprises at least about 10 contiguous nucleotides of a polynucleotide molecule including a sequence selected from the group consisting of SEQ ID NO: 1-109, 111, 113, 115-151, 153, 154, 157, 158, 160, 162-164, 167, 168 and 171.

In a further aspect, the present invention provides a method for detecting lung cancer in a patient comprising: (a) obtaining a biological sample from the patient; (b) contacting the sample with an oligonucleotide probe specific for a polynucleotide molecule that encodes one of the above polypeptides; and (c) detecting in the sample a polynucleotide sequence that hybridizes to the oligonucleotide probe. Preferably, the oligonucleotide probe comprises at least about 15 contiguous nucleotides of a polynucleotide molecule having a partial sequence selected from the group consisting of SEQ ID NO: 1-109, 111, 113, 115-151, 153, 154,157, 158, 160, 162-164, 167, 168 and 171.

In related aspects, diagnostic kits comprising the above oligonucleotide probes or primers are provided.

In yet a further aspect, methods for the treatment of lung cancer in a patient are provided, the methods comprising obtaining PBMC from the patient, incubating the PBMC with a polypeptide of the present invention (or a polynucleotide that encodes such a polypeptide) to provide incubated T cells and administering the incubated T cells to the patient. The present invention additionally provides methods for the treatment of lung cancer that comprise incubating antigen presenting cells with a polypeptide of the present invention (or a polynucleotide that encodes such a polypeptide) to provide incubated antigen presenting cells and administering the incubated antigen presenting cells to the patient. In certain embodiments, the antigen presenting cells are selected from the group consisting of dendritic cells and macrophages. Compositions for the treatment of lung cancer comprising T cells or antigen presenting cells that have been incubated with a polypeptide or polynucleotide of the present invention are also provided. These and other aspects of the present invention will become apparent upon reference to the following detailed description. All references disclosed herein are hereby incorporated by reference in their entirety as if each was incorporated individually.

DETAILED DESCRIPTION OF THE INVENTION

As noted above, the present invention is generally directed to compositions and methods for the therapy and diagnosis of lung cancer. The compositions described herein include polypeptides, fusion proteins and polynucleotide molecules. Also included within the present invention are molecules (such as an antibody or fragment thereof) that bind to the inventive polypeptides. Such molecules are referred to herein as “binding agents.”

In one aspect, the subject invention discloses polypeptides comprising an immunogenic portion of a human lung tumor protein, wherein the lung tumor protein includes an amino acid sequence encoded by a polynucleotide molecule including a sequence selected from the group consisting of (a) nucleotide sequences recited in SEQ ID NO: 1-109, 111, 113 115-151, 153, 154,157, 158, 160, 162-164, 167, 168 and 171, (b) the complements of said nucleotide sequences, and (c) variants of such sequences. As used herein, the term “polypeptide” encompasses amino acid chains of any length, including full length proteins, wherein the amino acid residues are linked by covalent peptide bonds. Thus, a polypeptide comprising a portion of one of the above lung tumor proteins may consist entirely of the portion, or the portion may be present within a larger polypeptide that contains additional sequences. The additional sequences may be derived from the native protein or may be heterologous, and such sequences may (but need not) be immunoreactive and/or antigenic. As detailed below, such polypeptides may be isolated from lung tumor tissue or prepared by synthetic or recombinant means.

As used herein, an “immunogenic portion” of a lung tumor protein is a portion that is capable of eliciting an immune response in a patient inflicted with lung cancer and as such binds to antibodies present within sera from a lung cancer patient. Such immunogenic portions generally comprise at least about 5 amino acid residues, more preferably at least about 10, and most preferably at least about 20 amino acid residues. Immunogenic portions of the proteins described herein may be identified in antibody binding assays. Such assays may generally be performed using any of a variety of means known to those of ordinary skill in the art, as described, for example, in Harlow and Lane, Antibodies: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1988. For example, a polypeptide may be immobilized on a solid support (as described below) and contacted with patient sera to allow binding of antibodies within the sera to the immobilized polypeptide. Unbound sera may then be removed and bound antibodies detected using, for example, 125 I-labeled Protein A. Alternatively, a polypeptide may be used to generate monoclonal and polyclonal antibodies for use in detection of the polypeptide in blood or other fluids of lung cancer patients. Methods for preparing and identifying immunogenic portions of antigens of known sequence are well known in the art and include those summarized in Paul, Fundamental Immunology, 3 rd ed., Raven Press, 1993, pp. 243-247.

The term “polynucleotide(s),” as used herein, means a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases and includes DNA and corresponding RNA molecules, including HnRNA and mRNA molecules, both sense and anti-sense strands, and comprehends cDNA, genomic DNA and recombinant DNA, as well as wholly or partially synthesized polynucleotides. An HnRNA molecule contains introns and corresponds to a DNA molecule in a generally one-to-one manner. An mRNA molecule corresponds to an HnRNA and DNA molecule from which the introns have been excised. A polynucleotide may consist of an entire gene, or any portion thereof. Operable anti-sense polynucleotides may comprise a fragment of the corresponding polynucleotide, and the definition of “polynucleotide” therefore includes all such operable anti-sense fragments.

The compositions and methods of the present invention also encompass variants of the above polypeptides and polynucleotides. A polypeptide “variant,” as used herein, is a polypeptide that differs from the recited polypeptide only in conservative substitutions and/or modifications, such that the therapeutic, antigenic and/or immunogenic properties of the polypeptide are retained. In a preferred embodiment, variant polypeptides differ from an identified sequence by substitution, deletion or addition of five amino acids or fewer. Such variants may generally be identified by modifying one of the above polypeptide sequences, and evaluating the antigenic properties of the modified polypeptide using, for example, the representative procedures described herein. Polypeptide variants preferably exhibit at least about 70%, more preferably at least about 90% and most preferably at least about 95% identity (determined as describe below) to the identified polypeptides.

As used herein, a “conservative substitution” is one in which an amino acid is substituted for another amino acid that has similar properties, such that one skilled in the art of peptide chemistry would expect the secondary structure and hydropathic nature of the polypeptide to be substantially unchanged. In general, the following groups of amino acids represent conservative changes: (1) ala, pro, gly, glu, asp, gln, asn, ser, thr; (2) cys, ser, tyr, thr; (3) val, ile, leu, met, ala, phe; (4) lys, arg, his; and (5) phe, tyr, trp, his.

Variants may also, or alternatively, contain other modifications, including the deletion or addition of amino acids that have minimal influence on the antigenic properties, secondary structure and hydropathic nature of the polypeptide. For example, a polypeptide may be conjugated to a signal (or leader) sequence at the N-terminal end of the protein which co-translationally or post-translationally directs transfer of the protein. The polypeptide may also be conjugated to a linker or other sequence for ease of synthesis, purification or identification of the polypeptide (e.g., poly-His), or to enhance binding of the-polypeptide to a solid support. For example, a polypeptide may be conjugated to an immunoglobulin Fc region.

A nucleotide “variant” is a sequence that differs from the recited nucleotide sequence in having one or more nucleotide deletions, substitutions or additions. Such modifications may be readily introduced using standard mutagenesis techniques, such as oligonucleotide-directed site-specific mutagenesis as taught, for example, by Adelman et al. ( DNA, 2:183, 1983). Nucleotide variants may be naturally occurring allelic variants, or non-naturally occurring variants. Variant nucleotide sequences preferably exhibit at least about 70%, more preferably at least about 80% and most preferably at least about 90% identity (determined as described below) to the recited sequence.

The antigens provided by the present invention include variants that are encoded by polynucleotide sequences which are substantially homologous to one or more of the polynucleotide sequences specifically recited herein. “Substantial homology,” as used herein, refers to polynucleotide sequences that are capable of hybridizing under moderately stringent conditions. Suitable moderately stringent conditions include prewashing in a solution of 5×SSC, 0.5% SDS, 1.0 mM EDTA (pH 8.0); hybridizing at 50° C.-65° C., 5×SSC, overnight or, in the event of cross-species homology, at 45° C. with 0.5×SSC; followed by washing twice at 65° C. for 20 minutes with each of 2×, 0.5× and 0.2×SSC containing 0.1% SDS. Such hybridizing polynucleotide sequences are also within the scope of this invention, as are nucleotide sequences that, due to code degeneracy, encode an immunogenic polypeptide that is encoded by a hybridizing polynucleotide sequence.

Two nucleotide or polypeptide sequences are said to be “identical” if the sequence of nucleotides or amino acid residues in the two sequences is the same when aligned for maximum correspondence as described below. Comparisons between two sequences are typically performed by comparing the sequences over a comparison window to identify and compare local regions of sequence similarity. A “comparison window” as used herein, refers to a segment of at least about 20 contiguous positions, usually 30 to about 75, 40 to about 50, in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned.

Optimal alignment of sequences for comparison may be conducted using the Megalign program in the Lasergene suite of bioinformatics software (DNASTAR, Inc., Madison, Wis.), using default parameters. This program embodies several alignment schemes described in the following references: Dayhoff, M. O. (1978) A model of evolutionary change in proteins—Matrices for detecting distant relationships. In Dayhoff, M. O. (ed.) Atlas of Protein Sequence and Structure, National Biomedical Resarch Foundaiton, Washington D.C. Vol. 5, Suppl. 3, pp. 345-358; Hein J. (1990) Unified Approach to Alignment and Phylogenes pp. 626-645 Methods in Enzymology vol. 183, Academic Press, Inc., San Diego, Calif.; Higgins, D. G. and Sharp, P. M. (1989) Fast and sensitive multiple sequence alignments on a microcomputer CABIOS 5:151-153; Myers, E. W. and Muller W. (1988) Optimal alignments in linear space CABIOS 4:11-17; Robinson, E. D. (1971) Comb. Theor 11:105; Santou, N. Nes, M. (1987) The neighbor joining method. A new method for reconstructing phylogenetic trees Mol. Biol. Evol. 4:406-425; Sneath, P. H. A. and Sokal, R. R. (1 973) Numerical Taxonomy—the Principles and Practice of Numerical Taxonomy , Freeman Press, San Francisco, Calif.; Wilbur, W. J. and Lipman, D. J. (1983) Rapid similarity searches of nucleic acid and protein data banks Proc. Natl. Acad, Sci. USA 80:726-730.

Preferably, the “percentage of sequence identity” is determined by comparing two optimally aligned sequences over a window of comparison of at least 20 positions, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e. gaps) of 20 percent or less, usually 5 to 15 percent, or 10 to 12 percent, as compared to the reference sequences (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid bases or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the reference sequence (i.e. the window size) and multiplying the results by 100 to yield the percentage of sequence identity.

Also included in the scope of the present invention are alleles of the genes encoding the nucleotide sequences recited in herein. As used herein, an “allele” or “allellic sequence” is an alternative form of the gene which may result from at least one mutation in the nucleic acid sequence. Alleles may result in altered mRNAs or polypeptides whose structure or function may or may not be altered. Any given gene may have none, one, or many allelic forms. Common mutational changes which give rise to alleles are generally ascribed to natural deletions, additions, or substitutions of nucleotides. Each of these types of changes may occur alone or in combination with the others, one or more times in a given sequence.

For lung tumor polypeptides with immunoreactive properties, variants may, alternatively, be identified by modifying the amino acid sequence of one of the above polypeptides, and evaluating the immunoreactivity of the modified polypeptide. For lung tumor polypeptides useful for the generation of diagnostic binding agents, a variant may be identified by evaluating a modified polypeptide for the ability to generate antibodies that detect the presence or absence of lung cancer. Such modified sequences may be prepared and tested using, for example, the representative procedures described herein.

The lung tumor polypeptides of the present invention, and polynucleotide molecules encoding such polypeptides, may be isolated from lung tumor tissue using any of a variety of methods well known in the art. Polynucleotide sequences corresponding to a gene (or a portion thereof) encoding one of the inventive lung tumor proteins may be isolated from a lung tumor cDNA library using a subtraction technique as described in detail below. Examples of such polynucleotide sequences are provided in SEQ ID NO: 1-109,111,113 115-151, 153, 154, 157, 158, 160, 162-164, 167, 168 and 171. Partial polynucleotide sequences thus obtained may be used to design oligonucleotide primers for the amplification of full-length polynucleotide sequences from a human genomic DNA library or from a lung tumor cDNA library in a polymerase chain reaction (PCR), using techniques well known in the art (see, for example, Mullis et al., Cold Spring Harbor Symp. Quant. Biol. 51:263, 1987; Erlich ed., PCR Technology , Stockton Press, NY, 1989). For this approach, sequence-specific primers may be designed based on the nucleotide sequences provided herein and may be purchased or synthesized.

An amplified portion may be used to isolate a full length gene from a suitable library (e.g., a lung tumor cDNA library) using well known techniques: Within such techniques, a library (cDNA or genomic) is screened using one or more polynucleotide probes or primers suitable for amplification. Preferably, a library is size-selected to include larger molecules. Random primed libraries may also be preferred for identifying 5′ and upstream regions of genes. Genomic libraries are preferred for obtaining introns and extending 5′ sequences.

For hybridization techniques, a partial sequence may be labeled (e.g., by nick-translation or end-labeling with 32 P) using well known techniques. A bacterial or bacteriophage library is then screened by hybridizing filters containing denatured bacterial colonies (or lawns containing phage plaques) with the labeled probe (see Sambrook et al., Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratories, Cold Spring Harbor, N.Y., 1989). Hybridizing colonies or plaques are selected and expanded, and the DNA is isolated for further analysis. cDNA clones may be analyzed to determine the amount of additional sequence by, for example, PCR using a primer from the partial sequence and a primer from the vector. Restriction maps and partial sequences may be generated to identify one or more overlapping clones. The complete sequence may then be determined using standard techniques, which may involve generating a series of deletion clones. The resulting overlapping sequences are then assembled into a single contiguous sequence. A full length cDNA molecule can be generated by ligating suitable fragments, using well known techniques.

Alternatively, there are numerous amplification techniques for obtaining a full length coding sequence from a partial cDNA sequence. Within such techniques, amplification is generally performed via PCR. Any of a variety of commercially available kits may be used to perform the amplification step. Primers may be designed using techniques well known in the art (see, for example, Mullis et al., Cold Spring Harbor Symp. Quant. Biol. 51:263, 1987; Erlich ed., PCR Technology , Stockton Press, NY, 1989), and software well known in the art may also be employed. Primers are preferably 22-30 nucleotides in length, have a GC content of at least 50% and anneal to the target sequence at temperatures of about 68° C. to 72° C. The amplified region may be sequenced as described above, and overlapping sequences assembled into a contiguous sequence.

One such amplification technique is inverse PCR (see Triglia et al., Nucl. Acids Res. 16:8186, 1988), which uses restriction enzymes to generate a fragment in the known region of the gene. The fragment is then circularized by intramolecular ligation and used as a template for PCR with divergent primers derived from the known region. Within an alternative approach, sequences adjacent to a partial sequence may be retrieved by amplification with a primer to a linker sequence and a primer specific to a known region. The amplified sequences are typically subjected to a second round of amplification with the same linker primer and a second primer specific to the known region. A variation on this procedure, which employs two primers that initiate extension in opposite directions from the known sequence, is described in WO 96/38591. Additional techniques include capture PCR (Lagerstrom et al., PCR Methods Applic. 1:111-19, 1991) and walking PCR (Parker et al., Nucl. Acids. Res. 19:3055-60, 1991). Transcription-Mediated Amplification, or TMA is another method that may be utilized for the amplification of DNA, rRNA, or mRNA, as described in Patent No. PCT/US91/03184. This autocatalytic and isothermic non-PCR based method utilizes two primers and two enzymes: RNA polymerase and reverse transcriptase. One primer contains a promoter sequence for RNA polymerase. In the first amplification, the promoter-primer hybridizes to the target rRNA at a defined site. Reverse transcriptase creates a DNA copy of the target rRNA by extension from the 3′ end of the promoter-primer. The RNA in the resulting complex is degraded and a second primer binds to the DNA copy. A new strand of DNA is synthesized from the end of the primer by reverse transcriptase creating double stranded DNA. RNA polymerase recognizes the promoter sequence in the DNA template and initiates transcription. Each of the newly synthesized RNA amplicons re-enters the TMA process and serves as a template for a new round of replication leading to the expotential expansion of the RNA amplicon. Other methods employing amplification may also be employed to obtain a full length cDNA sequence.

In certain instances, it is possible to obtain a full length cDNA sequence by analysis of sequences provided in an expressed sequence tag (EST) database, such as that available from GenBank. Searches for overlapping ESTs may generally be performed using well known programs (e.g., NCBI BLAST searches), and such ESTs may be used to generate a contiguous full length sequence.

Once a polynucleotide sequence encoding a polypeptide is obtained, the polypeptide may be produced recombinantly by inserting the polynucleotide sequence into an expression vector and expressing the polypeptide in an appropriate host. Any of a variety of expression vectors known to those of ordinary skill in the art may be employed to express recombinant polypeptides of this invention. Expression may be achieved in any appropriate host cell that has been transformed or transfected with an expression vector containing a polynucleotide molecule that encodes the recombinant polypeptide. Suitable host cells include prokaryotes, yeast, insect and higher eukaryotic cells. Preferably, the host cells employed are E. coli , yeast or a mammalian cell line, such as COS or CHO cells. The polynucleotide sequences expressed in this manner may encode naturally occurring polypeptides, portions of naturally occurring polypeptides, or other variants thereof. Supernatants from suitable host/vector systems which secrete the recombinant polypeptide may first be concentrated using a commercially available filter. The concentrate may then be applied to a suitable purification matrix, such as an affinity matrix or ion exchange resin. Finally, one or more reverse phase HPLC steps can be employed to further purify the recombinant polypeptide.

The lung tumor polypeptides disclosed herein may also be generated by synthetic means. In particular, synthetic polypeptides having fewer than about 100 amino acids, and generally fewer than about 50 amino acids, may be generated using techniques well known to those of ordinary skill in the art. For example, such polypeptides may be synthesized using any of the commercially available solid-phase techniques, such as the Merrifield solid-phase synthesis method, where amino acids are sequentially added to a growing amino acid chain (see, for example, Merrifield, J. Am. Chem. Soc. 85:2149-2146, 1963). Equipment for automated synthesis of polypeptides is commercially available from suppliers such as Perkin Elmer/Applied BioSystems Division (Foster City, Calif.), and may be operated according to the manufacturer's instructions.

In addition, lung tumor antigens may be identified by T cell expression cloning. One source of tumor specific T cells is from surgically excised tumors from human patients. In one method for isolating and characterizing tumor specific T cells, the excised tumor is minced and enzymatically digested for several hours to release tumor cells and infiltrating lymphocytes (tumor infiltrating T cells, or TILs). The cells are washed in HBSS buffer and passed over a Ficoll (100%/75%/HBSS) discontinuous gradient to separate tumor cells and lymphocytes from non-viable cells. Two bands are harvested from the interfaces; the upper band at the 75%/HBSS interface contains predominantly tumor cells, while the lower band at the 100%/75%/HBSS interface contains a majority of lymphocytes. The TILs are expanded in culture by techniques well known in the art, but preferably in culture media supplemented with 10 ng/ml IL-7 and 100 U/ml IL-2, or alternatively, cultured and expanded in tissue culture plates that have been pre-adsorbed with anti-CD3 monoclonal antibody (OKT3). The resulting TIL cultures are analyzed by FACS to confirm that the vast majority are CD8+ T cells (>90% of gated population).

In addition, the tumor cells are also expanded in culture using standard techniques well known in the art to establish a tumor cell line, which is later confirmed to be lung carcinoma cells by immunohistochemical analysis. The tumor cell line is transduced with a retroviral vector to express human CD80. The tumor cell line is further characterized by FACS analysis to confirm the strong expression levels of CD80, class I and II MHC molecules.

The specificity of the TIL lines to lung tumor is confirmed by INF-γ and/or TNF-α cytokine release assays. For example, TIL cells from day 21 cultures are co-cultured with either autologous or allogeneic tumor cells, EBV-immortalized LCL, or control cell lines Daudi and K562 and the culture supernatant monitored by ELISA for the presence of cytokines. The expression of these specific cytokines in the presence of tumor or negative control cells indicates whether the TIL lines are tumor specific and potentially recognizing tumor antigen presented by the autologous MHC molecules.

The characterized tumor-specific TIL lines can be expanded and cloned by methods well known in the art. For example, the TIL lines may be expanded to suitable numbers for T cell expression cloning by using soluble anti-CD3 antibody in culture with irradiated EBV transformed LCLs and PBL feeder cells in the presence of 20 U/ml IL-2. Clones from the expanded TIL lines can be generated by standard limiting dilution techniques. In particular, TIL cells are seeded at 0.5 cells/well in a 96-well U bottom plate and stimulated with CD-80-transduced autologous tumor cells, EBV transformed LCL, and PBL feeder cells in the presence of 50 U/ml IL-2. These clones may be further analyzed for tumor specificity by 51 Cr microcytotoxicity and IFN-γ bioassays. Additionally, the MHC restriction element recognized by the TIL clones may be determined by antibody blocking studies well known in the art.

The CTL lines or clones described above may be employed to identify tumor specific antigens. For example, autologous fibroblasts or LCL from a patient may be transfected or transduced with polynucleotide fragments derived from a lung tumor cDNA library to generate target cells expressing tumor polypeptides. The target cells expressing tumor polypeptides in the context of MHC will be recognized by the CTL line or clone resulting in T-cell activation, which can be monitored by cytokine detection assays. The tumor gene being expressed by the target cell and recognized by the tumor-specific CTL is then isolated by techniques described above. In general, regardless of the method of preparation, the polypeptides disclosed herein are prepared in an isolated, substantially pure form (i.e., the polypeptides, are homogenous as determined by amino acid composition and primary sequence analysis). Preferably, the polypeptides are at least about 90% pure, more preferably at least about 95% pure and most preferably at least about 99% pure. In certain preferred embodiments, described in more detail below, the substantially pure polypeptides are incorporated into pharmaceutical compositions or vaccines for use in one or more of the methods disclosed herein.

In a related aspect, the present invention provides fusion proteins comprising a first and a second inventive polypeptide or, alternatively, a polypeptide of the present invention and a known lung tumor antigen, together with variants of such fusion proteins. The fusion proteins of the present invention may (but need not) include a linker peptide between the first and second polypeptides.

A polynucleotide sequence encoding a fusion protein of the present invention is constructed using known recombinant DNA techniques to assemble separate polynucleotide sequences encoding the first and second polypeptides into an appropriate expression vector. The 3′ end of a DNA sequence encoding the first polypeptide is ligated, with or without a peptide linker, to the 5′ end of a DNA sequence encoding the second polypeptide so that the reading frames of the sequences are in phase to permit mRNA translation of the two DNA sequences into a single fusion protein that retains the biological activity of both the first and the second polypeptides.

A peptide linker sequence may be employed to separate the first and the second polypeptides by a distance sufficient to ensure that each polypeptide folds into its secondary and tertiary structures. Such a peptide linker sequence is incorporated into the fusion protein using standard techniques well known in the art. Suitable peptide linker sequences may be chosen based on the following factors: (1) their ability to adopt a flexible extended conformation; (2) their inability to adopt a secondary structure that could interact with functional epitopes on the first and second polypeptides; and (3) the lack of hydrophobic or charged residues that might react with the polypeptide functional epitopes. Preferred peptide linker sequences contain Gly, Asn and Ser residues. Other near neutral amino acids, such as Thr and Ala may also be used in the linker sequence. Amino acid sequences which may be usefully employed as linkers include those disclosed in Maratea et al., Gene 40:39-46, 1985; Murphy et al., Proc. Natl. Acad. Sci. USA 83:8258-8262, 1986; U.S. Pat. Nos. 4,935,233 and 4,751,180. The linker sequence may be from 1 to about 50 amino acids in length. Peptide sequences are not required when the first and second polypeptides have non-essential N-terminal amino acid regions that can be used to separate the functional domains and prevent steric interference.

The ligated polynucleotide sequences are operably linked to suitable transcriptional or translational regulatory elements. The regulatory elements responsible for expression of polynucleotide are located only 5′ to the DNA sequence encoding the first polypeptides. Similarly, stop codons require to end translation and transcription termination signals are only present 3′ to the DNA sequence encoding the second polypeptide.

Fusion proteins are also provided that comprise a polypeptide of the present invention together with an unrelated immunogenic protein. Preferably the immunogenic protein is capable of eliciting a recall response. Examples of such proteins include tetanus, tuberculosis and hepatitis proteins (see, for example, Stoute et al. New Engl. J. Med., 336:86-91 (1997)).

Polypeptides of the present invention that comprise an immunogenic portion of a lung tumor protein may generally be used for therapy of lung cancer, wherein the polypeptide stimulates the patient's own immune response to lung tumor cells. The present invention thus provides methods for using one or more of the compounds described herein (which may be polypeptides, polynucleotide molecules or fusion proteins) for immunotherapy of lung cancer in a patient. As used herein, a “patient” refers to any warm-blooded animal, preferably a human. A patient may be afflicted with disease, or may be free of detectable disease. Accordingly, the compounds disclosed herein may be used to treat lung cancer or to inhibit the development of lung cancer. The compounds are preferably administered either prior to or following surgical removal of primary tumors and/or treatment by administration of radiotherapy and conventional chemotherapeutic drugs.

In these aspects, the inventive polypeptide is generally present within a pharmaceutical composition or a vaccine. Pharmaceutical compositions may comprise one or more polypeptides, each of which may contain one or more of the above sequences (or variants thereof), and a physiologically acceptable carrier. The vaccines may comprise one or more such polypeptides and a non-specific immune-response enhancer, wherein the non-specific immune response enhancer is capable of eliciting or enhancing an immune response to an exogenous antigen. Examples of non-specific-immune response enhancers include adjuvants, biodegradable microspheres (e.g., polylactic galactide) and liposomes (into which the polypeptide is incorporated). Pharmaceutical compositions and vaccines may also contain other epitopes of lung tumor antigens, either incorporated into a fusion protein as described above (i.e., a single polypeptide that contains multiple epitopes) or present within a separate polypeptide.

Alternatively, a pharmaceutical composition or vaccine may contain polynucleotide encoding one or more of the above polypeptides and/or fusion proteins, such that the polypeptide is generated in situ. In such pharmaceutical compositions and vaccines, the polynucleotide may be present within any of a variety of delivery systems known to those of ordinary skill in the art, including nucleic acid expression systems, bacteria and viral expression systems. Appropriate nucleic acid expression systems contain the necessary polynucleotide sequences for expression in the patient (such as a suitable promoter). Bacterial delivery systems involve the administration of a bacterium (such as Bacillus-Calmette-Guerrin) that expresses an epitope of a lung cell antigen on its cell surface. In a preferred embodiment, the polynucleotides may be introduced using a viral expression system (e.g., vaccinia or other pox virus, retrovirus, or adenovirus), which may involve the use of a non-pathogenic (defective), replication competent virus. Suitable systems are disclosed, for example, in Fisher-Hoch et al., PNAS 86:317-321, 1989; Flexner et al., Ann. N.Y. Acad. Sci. 569:86-103, 1989; Flexner et al., Vaccine 8:17-21, 1990; U.S. Pat. Nos. 4,603,112, 4,769,330, and 5,017,487; WO 89/01973; U.S. Pat. No. 4,777,127; GB 2,200,651; EP 0,345,242; WO 91/02805; Berkner, Biotechniques 6:616-627, 1988; Rosenfeld et al., Science 252:431-434, 1991; Kolls et al., PNAS 91:215-219, 1994; Kass-Eisler et al., PNAS 90:11498-11502, 1993; Guzman et al., Circulation 88:2838-2848, 1993; and Guzman et al., Cir. Res. 73:1202-1207, 1993. Techniques for incorporating polynucleotide into such expression systems are well known to those of ordinary skill in the art. The polynucleotides may also be “naked,” as described, for example, in published PCT application WO 90/11092, and Ulmer et al., Science 259:1745-1749, 1993, reviewed by Cohen, Science 259:1691-1692, 1993. The uptake of naked polynucleotides may be increased by coating the polynucleotides onto biodegradable beads which are efficiently transported into the cells.

Routes and frequency of administration, as well as dosage, will vary from individual to individual and may parallel those currently being used in immunotherapy of other diseases. In general, the pharmaceutical compositions and vaccines may be administered by injection (e.g., intracutaneous, intramuscular, intravenous or subcutaneous), intranasally (e.g., by aspiration) or orally. Between 1 and 10 doses may be administered over a 3-24 week period. Preferably, 4 doses are administered, at an interval of 3 months, and booster administrations may be given periodically thereafter. Alternate protocols may be appropriate for individual patients. A suitable dose is an amount of polypeptide or polynucleotide that is effective to raise an immune response (cellular and/or humoral) against lung tumor cells in a treated patient. A suitable immune response is at least 10-50% above the basal (i.e., untreated) level. In general, the amount of polypeptide present in a dose (or produced in situ by the polynucleotide molecule(s) in a dose) ranges from about 1 pg to about 100 mg per kg of host, typically from about 10 pg to about 1 mg, and preferably from about 100 pg to about 1 μg. Suitable dose sizes will vary with the size of the patient, but will typically range from about 0.01 mL to about 5 mL.

While any suitable carrier known to those of ordinary skill in the art may be employed in the pharmaceutical compositions of this invention, the type of carrier will vary depending on the mode of administration. For parenteral administration, such as subcutaneous injection, the carrier preferably comprises water, saline, alcohol, a lipid, a wax and/or a buffer. For oral administration, any of the above carriers or a solid carrier, such as mannitol, lactose, starch, magnesium stearate, sodium saccharine, talcuim, cellulose, glucose, sucrose, and/or magnesium carbonate, may be employed. Biodegradable microspheres (e.g., polylactic glycolide) may also be employed as carriers for the pharmaceutical compositions of this invention. Suitable biodegradable microspheres are disclosed, for example, in U.S. Pat. Nos. 4,897,268 and 5,075,109.

Any of a variety of immune-response enhancers may be employed in the vaccines of this invention. For example, an adjuvant may be included. Most adjuvants contain a substance designed to protect the antigen from rapid catabolism, such as aluminum hydroxide or mineral oil, and a nonspecific stimulator of immune response, such as lipid A, Bordella pertussis or Mycobacterium tuberculosis . Such adjuvants are commercially available as, for example, Freund's Incomplete Adjuvant and Complete Adjuvant (Difco Laboratories, Detroit, Mich.) and Merck Adjuvant 65 (Merck and Company, Inc., Rahway, N.J.). Polypeptides and polynucleotides disclosed herein may also be employed in adoptive immunotherapy for the treatment of cancer. Adoptive immunotherapy may be broadly classified into either active or passive immunotherapy. In active immunotherapy, treatment relies on the in vivo stimulation of the endogenous host immune system to react against tumors with the administration of immune response-modifying agents (for example, tumor vaccines, bacterial adjuvants, and/or cytokines).

In passive immunotherapy, treatment involves the delivery of biologic reagents with established tumor-immune reactivity (such as effector cells or antibodies) that can directly or indirectly mediate antitumor effects and does not necessarily depend on an intact host immune system. Examples of effector cells include T lymphocytes (for example, CD8+ cytotoxic T-lymphocyte, CD4+ T-helper, gamma/delta T lymphocytes, tumor-infiltrating lymphocytes), killer cells (such as Natural Killer cells, lymphokine-activated killer cells), B cells, or antigen presenting cells (such as dendritic cells and macrophages) expressing the disclosed antigens. The polypeptides disclosed herein may also be used to generate antibodies or anti-idiotypic antibodies (as in U.S. Pat. No. 4,918,164), for passive immunotherapy.

The predominant method of procuring adequate numbers of T-cells for adoptive immunotherapy is to grow immune T-cells in vitro. Culture conditions for expanding single antigen-specific T-cells to several billion in number with retention of antigen recognition in vivo are well known in the art. These in vitro culture conditions typically utilize intermittent stimulation with antigen, often in the presence of cytokines, such as IL-2, and non-dividing feeder cells. As noted above, the immunoreactive polypeptides described herein may be used to rapidly expand antigen-specific T cell cultures in order to generate sufficient number of cells for immunotherapy. In particular, antigen-presenting cells, such as dendritic, macrophage, monocyte, fibroblast, or B-cells, may be pulsed with immunoreactive polypeptides, or polynucleotide sequence(s) may be introduced into antigen presenting cells, using a variety of standard techniques well known in the art. For example, antigen presenting cells may be transfected or transduced with a polynucleotide sequence, wherein said sequence contains a promoter region appropriate for increasing expression, and can be expressed as part of a recombinant virus or other expression system. Several viral vectors may be used to transduce an antigen presenting cell, including pox virus, vaccinia virus, and adenovirus; also, antigen presenting cells may be transfected with polynucleotide sequences disclosed herein by a variety of means, including gene-gun technology, lipid-mediated delivery, electroporation, osmotic shock, and particlate delivery mechanisms, resulting in efficient and acceptable expression levels as determined by one of ordinary skill in the art. For cultured T-cells to be effective in therapy, the cultured T-cells must be able to grow and distribute widely and to survive long term in vivo. Studies have demonstrated that cultured T-cells can be induced to grow in vivo and to survive long term in substantial numbers by repeated stimulation with antigen supplemented with IL-2 (see, for example, Cheever, M., et al, “Therapy With Cultured T Cells: Principles Revisited,” Immunological Reviews, 157:177, 1997).

The polypeptides disclosed herein may also be employed to generate and/or isolate tumor-reactive T-cells, which can then be administered to the patient. In one technique, antigen-specific T-cell lines may be generated by in vivo immunization with short peptides corresponding to immunogenic portions of the disclosed polypeptides. The resulting antigen specific CD8+ CTL clones may be isolated from the patient, expanded using standard tissue culture techniques, and returned to the patient.

Alternatively, peptides corresponding to immunogenic portions of the polypeptides may be employed to generate tumor reactive T cell subsets by selective in vitro stimulation and expansion of autologous T cells to provide antigen-specific T cells which may be subsequently transferred to the patient as described, for example, by Chang et al, ( Crit. Rev. Oncol. Hematol., 22(3), 213, 1996). Cells of the immune system, such as T cells, may be isolated from, the peripheral blood of a patient, using a commercially available cell separation system, such as CellPro Incorporated's (Bothell, Wash.) CEPRATE™ system (see U.S. Pat. Nos. 5,240,856; 5,215,926; WO 89/06280; WO 91/16116 and WO 92/07243). The separated cells are stimulated with one or more of the immunoreactive polypeptides contained within a delivery vehicle, such as a microsphere, to provide antigen-specific T cells. The population of tumor antigen-specific T cells is then expanded using standard techniques and the cells are administered back to the patient.

In other embodiments, T-cell and/or antibody receptors specific for the polypeptides disclosed herein can be cloned, expanded, and transferred into other vectors or effector cells for use in adoptive immunotherapy. In particular, T cells may be transfected with the appropriate genes to express the variable domains from tumor specific monoclonal antibodies as the extracellular recognition elements and joined to the T cell receptor signaling chains, resulting in T cell activation, specific lysis, and cytokine release. This enables the T cell to redirect its specificity in an MHC-independent manner. See for example, Eshhar, Z., Cancer Immunol Immunother, 45(3-4):131-6, 1997 and Hwu, P., et al, Cancer Res, 55(15):3369-73, 1995. Another embodiment may include the transfection of tumor antigen specific alpha and beta T cell receptor chains into alternate T cells, as in Cole, D J, et al, Cancer Res, 55(4):748-52, 1995.

In a further embodiment, syngeneic or autologous dendritic cells may be pulsed with peptides corresponding to at least an immunogenic portion of a polypeptide disclosed herein. The resulting antigen-specific dendritic cells may either be transferred into a patient, or employed to stimulate T cells to provide antigen-specific T cells which may, in turn, be administered to a patient. The use of peptide-pulsed dendritic cells to generate antigen-specific T cells and the subsequent use of such antigen-specific T cells to eradicate tumors in a murine model has been demonstrated by Cheever et al, Immunological Reviews, 157:177, 1997).

Furthermore, vectors expressing the disclosed polynucleotides may be introduced into stem cells taken from the patient and clonally propagated in vitro for autologous transplant back into the same patient.

Additionally, vectors expressing the disclosed polynucleotides may be introduced into stem cells taken from the patient and clonally propagated in vitro for autologous transplant back into the same patient. Polypeptides and fusion proteins of the present invention may also, or alternatively, be used to generate binding agents, such as antibodies or fragments thereof, that are capable of detecting metastatic human lung tumors. Binding agents of the present invention may generally be prepared using methods known to those of ordinary skill in the art, including the representative procedures described herein. Binding agents are capable of differentiating between patients with and without lung cancer, using the representative assays described herein. In other words, antibodies or other binding agents raised against a lung tumor protein, or a suitable portion thereof, will generate a signal indicating the presence of primary or metastatic lung cancer in at least about 20% of patients afflicted with the disease, and will generate a negative signal indicating the absence of the disease in at least about 90% of individuals without primary or metastatic lung cancer. Suitable portions of such lung tumor proteins are portions that are able to generate a binding agent that indicates the presence of primary or metastatic lung cancer in substantially all (i.e., at least about 80%, and preferably at least about 90%) of the patients for which lung cancer would be indicated using the full length protein, and that indicate the absence of lung cancer in substantially all of those samples that would be negative when tested with full length protein. The representative assays described below, such as the two-antibody sandwich assay, may generally be employed for evaluating the ability of a binding agent to detect metastatic human lung tumors.

The ability of a polypeptide prepared as described herein to generate antibodies capable of detecting primary or metastatic human lung tumors may generally be evaluated by raising one or more antibodies against the polypeptide (using, for example, a representative method described herein) and determining the ability of such antibodies to detect such tumors in patients. This determination may be made by assaying biological samples from patients with and without primary or metastatic lung cancer for the presence of a polypeptide that binds to the generated antibodies. Such test assays may be performed, for example, using a representative procedure described below. Polypeptides that generate antibodies capable of detecting at least 20% of primary or metastatic lung tumors by such procedures are considered to be useful in assays for detecting primary or metastatic human lung tumors. Polypeptide specific antibodies may be used alone or in combination to improve sensitivity.

Polypeptides capable of detecting primary or metastatic human lung tumors may be used as markers for diagnosing lung cancer or for monitoring disease progression in patients. In one embodiment, lung cancer in a patient may be diagnosed by evaluating a biological sample obtained from the patient for the level of one or more of the above polypeptides, relative to a predetermined cut-off value. As used herein, suitable “biological samples” include blood, sera, urine and/or lung secretions.

The level of one or more of the above polypeptides may be evaluated using any binding agent specific for the polypeptide(s). A “binding agent,” in the context of this invention, is any agent (such as a compound or a cell) that binds to a polypeptide as described above. As used herein, “binding” refers to a noncovalent association between two separate molecules (each of which may be free (i.e., in solution) or present on the surface of a cell or a solid support), such that a “complex” is formed. Such a complex may be free or immobilized (either covalently or noncovalently) on a support material. The ability to bind may generally be evaluated by determining a binding constant for the formation of the complex. The binding constant is the value obtained when the concentration of the complex is divided by the product of the component concentrations. In general, two compounds are said to “bind” in the context of the present invention when the binding constant for complex formation exceeds about 10 3 L/mol. The binding constant may be determined using methods well known to those of ordinary skill in the art.

Any agent that satisfies the above requirements may be a binding agent. For example, a binding agent may be a ribosome with or without a peptide component, an RNA molecule or a peptide. In a preferred embodiment, the binding partner is an antibody, or a fragment thereof. Such antibodies may be polyclonal, or monoclonal. In addition, the antibodies may be single chain, chimeric, CDR-grafted or humanized. Antibodies may be prepared by the methods described herein and by other methods well known to those of skill in the art.

There are a variety of assay formats known to those of ordinary skill in the art for using a binding partner to detect polypeptide markers in a sample. See, e.g., Harlow and Lane, Antibodies: A Laboratory Manual , Cold Spring Harbor Laboratory, 1988. In a preferred embodiment, the assay involves the use of binding partner immobilized on a solid support to bind to and remove the polypeptide from the remainder of the sample. The bound polypeptide may then be detected using a second binding partner that contains a reporter group. Suitable second binding partners include antibodies that bind to the binding partner/polypeptide complex. Alternatively, a competitive assay may be utilized, in which a polypeptide is labeled with a reporter group and allowed to bind to the immobilized binding partner after incubation of the binding partner with the sample. The extent to which components of the sample inhibit the binding of the labeled polypeptide to the binding partner is indicative of the reactivity of the sample with the immobilized binding partner.

The solid support may be any material known to those of ordinary skill in the art to which the antigen may be attached. For example, the solid support may be a test well in a microtiter plate or a nitrocellulose or other suitable membrane. Alternatively, the support may be a bead or disc, such as glass, fiberglass, latex or a plastic material such as polystyrene or polyvinylchloride. The support may also be a magnetic particle or a fiber optic sensor, such as those disclosed, for example, in U.S. Pat. No. 5,359,681. The binding agent may be immobilized on the solid support using a variety of techniques known to those of skill in the art, which are amply described in the patent and scientific literature. In the context of the present invention, the term “immobilization” refers to both noncovalent association, such as adsorption, and covalent attachment (which may be a direct linkage between the antigen and functional groups on the support or may be a linkage by way of a cross-linking agent). Immobilization by adsorption to a well in a microtiter plate or to a membrane is preferred. In such cases, adsorption may be achieved by contacting the binding agent, in a suitable buffer, with the solid support for a suitable amount of time. The contact time varies with temperature, but is typically between about 1 hour and about 1 day. In general, contacting a well of a plastic microtiter plate (such as polystyrene or polyvinylchloride) with an amount of binding agent ranging from about 10 ng to about 10 μg, and preferably about 100 ng to about 1 μg, is sufficient to immobilize an adequate amount of binding agent.

Covalent attachment of binding agent to a solid support may generally be achieved by first reacting the support with a bifunctional reagent that will react with both the support and a functional group, such as a hydroxyl or amino group, on the binding agent. For example, the binding agent may be covalently attached to supports having an appropriate polymer coating using benzoquinone or by condensation of an aldehyde group on the support with an amine and an active hydrogen on the binding partner (see, e.g., Pierce Immunotechnology Catalog and Handbook, 1991, at A12-A13).

In certain embodiments, the assay is a two-antibody sandwich assay. This assay may be performed by first contacting an antibody that has been immobilized on a solid support, commonly the well of a microtiter plate, with the sample, such that polypeptides within the sample are allowed to bind to the immobilized antibody. Unbound sample is then removed from the immobilized polypeptide-antibody complexes and a second antibody (containing a reporter group) capable of binding to a different site on the polypeptide is added. The amount of second antibody that remains bound to the solid support is then determined using a method appropriate for the specific reporter group.

More specifically, once the antibody is immobilized on the support as described above, the remaining protein binding sites on the support are typically blocked. Any suitable blocking agent known to those of ordinary skill in the art, such as bovine serum albumin or Tween 20™ (Sigma Chemical Co., St. Louis, Mo.). The immobilized antibody is then incubated with the sample, and polypeptide is allowed to bind to the antibody. The sample may be diluted with a suitable diluent, such as phosphate-buffered saline (PBS) prior to incubation. In general, an appropriate contact time (i.e., incubation time) is that period of time that is sufficient to detect the presence of polypeptide within a sample obtained from an individual with lung cancer. Preferably, the contact time is sufficient to achieve a level of binding that is at least about 95% of that achieved at equilibrium between bound and unbound polypeptide. Those of ordinary skill in the art will recognize that the time necessary to achieve equilibrium may be readily determined by assaying the level of binding that occurs over a period of time. At room temperature, an incubation time of about 30 minutes is generally sufficient.

Unbound sample may then be removed by washing the solid support with an appropriate buffer, such as PBS containing 0.1% Tween 20™. The second antibody, which contains a reporter group, may then be added to the solid support. Preferred reporter groups include enzymes (such as horseradish peroxidase), substrates, cofactors, inhibitors, dyes, radionuclides, luminescent groups, fluorescent groups and biotin. The conjugation of antibody to reporter group may be achieved using standard methods known to those of ordinary skill in the art.

The second antibody is then incubated with the immobilized antibody-polypeptide complex for an amount of time sufficient to detect the bound polypeptide. An appropriate amount of time may generally be determined by assaying the level of binding that occurs over a period of time. Unbound second antibody is then removed and bound second antibody is detected using the reporter group. The method employed for detecting the reporter group depends upon the nature of the reporter group. For radioactive groups, scintillation counting or autoradiographic methods are generally appropriate. Spectroscopic methods may be used to detect dyes, luminescent groups and fluorescent groups. Biotin may be detected using avidin, coupled to a different reporter group (commonly a radioactive or fluorescent group or an enzyme). Enzyme reporter groups may generally be detected by the addition of substrate (generally for a specific period of time), followed by spectroscopic or other analysis of the reaction products.

To determine the presence or absence of lung cancer, the signal detected from the reporter group that remains bound to the solid support is generally compared to a signal that corresponds to a predetermined cut-off value. In one preferred embodiment, the cut-off value is the average mean signal obtained when the immobilized antibody is incubated with samples from patients without lung cancer. In general, a sample generating a signal that is three standard deviations above the predetermined cut-off value is considered positive for lung cancer. In an alternate preferred embodiment, the cut-off value is determined using a Receiver Operator Curve, according to the method of Sackett et al., Clinical Epidemiology: A Basic Science for Clinical Medicine , Little Brown and Co., 1985, p. 106-7. Briefly, in this embodiment, the cut-off value may be determined from a plot of pairs of true positive rates (i.e., sensitivity) and false positive rates (100%-specificity) that correspond to each possible cut-off value for the diagnostic test result. The cut-off value on the plot that is the closest to the upper left-hand corner (i.e., the value that encloses the largest area) is the most accurate cut-off value, and a sample generating a signal that is higher than the cut-off value determined by this method may be considered positive. Alternatively, the cut-off value may be shifted to the left along the plot, to minimize the false positive rate, or to the right, to minimize the false negative rate. In general, a sample generating a signal that is higher than the cut-off value determined by this method is considered positive for lung cancer.

In a related embodiment, the assay is performed in a flow-through or strip test format, wherein the antibody is immobilized on a membrane, such as nitrocellulose. In the flow-through test, polypeptides within the sample bind to the immobilized antibody as the sample passes through the membrane. A second, labeled antibody then binds to the antibody-polypeptide complex as a solution containing the second antibody flows through the membrane. The detection of bound second antibody may then be performed as described above. In the strip test format, one end of the membrane to which antibody is bound is immersed in a solution containing the sample. The sample migrates along the membrane through a region containing second antibody and to the area of immobilized antibody. Concentration of second antibody at the area of immobilized antibody indicates the presence of lung cancer. Typically, the concentration of second antibody at that site generates a pattern, such as a line, that can be read visually. The absence of such a pattern indicates a negative result. In general, the amount of antibody immobilized on the membrane is selected to generate a visually discernible pattern when the biological sample contains a level of polypeptide that would be sufficient to generate a positive signal in the two-antibody sandwich assay, in the format discussed above. Preferably, the amount of antibody immobilized on the membrane ranges from about 25 ng to about 1 μg and more preferably from about 50 ng to about 500 ng. Such tests can typically be performed with a very small amount of biological sample.

Of course, numerous other assay protocols exist that are suitable for use with the antigens or antibodies of the present invention. The above descriptions are intended to be exemplary only.

In another embodiment, the above polypeptides may be used as markers for the progression of lung cancer. In this embodiment, assays as described above for the diagnosis of lung cancer may be performed over time, and the change in the level of reactive polypeptide(s) evaluated. For example, the assays may be performed every 24-72 hours for a period of 6 months to 1 year, and thereafter performed as needed. In general, lung cancer is progressing in those patients in whom the level of polypeptide detected by the binding agent increases over time. In contrast, lung cancer is not progressing when the level of reactive polypeptide either remains constant or decreases with time.

Antibodies for use in the above methods may be prepared by any of a variety of techniques known to those of ordinary skill in the art. See, e.g., Harlow and Lane, Antibodies: A Laboratory Manual , Cold Spring Harbor Laboratory, 1988. In one such technique, an immunogen comprising the antigenic polypeptide is initially injected into any of a wide variety of mammals (e.g., mice, rats, rabbits, sheep and goats). In this step, the polypeptides of this invention may serve as the immunogen without modification. Alternatively, particularly for relatively short polypeptides, a superior immune response may be elicited if the polypeptide is joined to a carrier protein, such as bovine serum albumin or keyhole limpet hemocyanin. The immunogen is injected into the animal host, preferably according to a predetermined schedule incorporating one or more booster immunizations, and the animals are bled periodically. Polyclonal antibodies specific for the polypeptide may then be purified from such antisera by, for example, affinity chromatography using the polypeptide coupled to a suitable solid support.

Monoclonal antibodies specific for the antigenic polypeptide of interest may be prepared, for example, using the technique of Kohler and Milstein, Eur. J Immunol. 6:511-519, 1976, and improvements thereto. Briefly, these methods involve the preparation of immortal cell lines capable of producing antibodies having the desired specificity (i.e., reactivity with the polypeptide of interest). Such cell lines may be produced, for example, from spleen cells obtained from an animal immunized as described above. The spleen cells are then immortalized by, for example, fusion with a myeloma cell fusion partner, preferably one that is syngeneic with the immunized animal. A variety of fusion techniques may be employed. For example, the spleen cells and myeloma cells may be combined with a nonionic detergent for a few minutes and then plated at low density on a selective medium that supports the growth of hybrid cells but not myeloma cells. A preferred selection technique uses HAT (hypoxanthine, aminopterin, thymidine) selection. After a sufficient time, usually about 1 to 2 weeks, colonies of hybrids are observed. Single colonies are selected and tested for binding activity against the polypeptide. Hybridomas having high reactivity and specificity are preferred.

Monoclonal antibodies may be isolated from the supernatants of growing hybridoma colonies. In addition, various techniques may be employed to enhance the yield, such as injection of the hybridoma cell line into the peritoneal cavity of a suitable vertebrate host, such as a mouse. Monoclonal antibodies may then be harvested from the ascites fluid or the blood. Contaminants may be removed from the antibodies by conventional techniques, such as chromatography, gel filtration, precipitation, and extraction. The polypeptides of this invention may be used in the purification process in, for example, an affinity chromatography step.

Monoclonal antibodies of the present invention may also be used as therapeutic reagents, to diminish or eliminate lung tumors. The antibodies may be used on their own (for instance, to inhibit metastases) or coupled to one or more therapeutic agents. Suitable agents in this regard include radionuclides, differentiation inducers, drugs, toxins, and derivatives thereof. Preferred radionuclides include 90 Y, 123 I, 125 I, 131 I, 186 Re, 188 Re, 211 At, and 212 Bi. Preferred drugs include methotrexate, and pyrimidine and purine analogs. Preferred differentiation inducers include phorbol esters and butyric acid. Preferred toxins include ricin, abrin, diptheria toxin, cholera toxin, gelonin, Pseudomonas exotoxin, Shigella toxin , and pokeweed antiviral protein.

A therapeutic agent may be coupled (e.g., covalently bonded) to a suitable monoclonal antibody either directly or indirectly (e.g., via a linker group). A direct reaction between an agent and an antibody is possible when each possesses a substituent capable of reacting with the other. For example, a nucleophilic group, such as an amino or sulfhydryl group, on one may be capable of reacting with a carbonyl-containing group, such as an anhydride or an acid halide, or with an alkyl group containing a good leaving group (e.g., a halide) on the other.

Alternatively, it may be desirable to couple a therapeutic agent and an antibody via a linker group. A linker group can function as a spacer to distance an antibody from an agent in order to avoid interference with binding capabilities. A linker group can also serve to increase the chemical reactivity of a substituent on an agent or an antibody, and thus increase the coupling efficiency. An increase in chemical reactivity may also facilitate the use of agents, or functional groups on agents, which otherwise would not be possible.

It will be evident to those skilled in the art that a variety of bifunctional or polyfunctional reagents, both homo- and hetero-functional (such as those described in the catalog of the Pierce Chemical Co., Rockford, Ill.), may be employed as the linker group. Coupling may be effected, for example, through amino groups, carboxyl groups, sulfhydryl groups or oxidized carbohydrate residues. There are numerous references describing such methodology, e.g., U.S. Pat. No. 4,671,958, to Rodwell et al.

Where a therapeutic agent is more potent when free from the antibody portion of the immunoconjugates of the present invention, it may be desirable to use a linker group which is cleavable during or upon internalization into a cell. A number of different cleavable linker groups have been described. The mechanisms for the intracellular release of an agent from these linker groups include cleavage by reduction of a disulfide bond (e.g., U.S. Pat. No. 4,489,710, to Spitler), by irradiation of a photolabile bond (e.g., U.S. Pat. No. 4,625,014, to Senter et al.), by hydrolysis of derivatized amino acid side chains (e.g., U.S. Pat. No. 4,638,045, to Kohn et al.), by serum complement-mediated hydrolysis (e.g., U.S. Pat. No. 4,671,958, to Rodwell et al.), and acid-catalyzed hydrolysis (e.g., U.S. Pat. No. 4,569,789, to Blattler et al.).

It may be desirable to couple more than one agent to an antibody. In one embodiment, multiple molecules of an agent are coupled to one antibody molecule. In another embodiment, more than one type of agent may be coupled to one antibody. Regardless of the particular embodiment, immunoconjugates with more than one agent may be prepared in a variety of ways. For example, more than one agent may be coupled directly to an antibody molecule, or linkers which provide multiple sites for attachment can be used. Alternatively, a carrier can be used.

A carrier may bear the agents in a variety of ways, including covalent bonding either directly or via a linker group. Suitable carriers include proteins such as albumins (e.g., U.S. Pat. No. 4,507,234, to Kato et al.), peptides and polysaccharides such as aminodextran (e.g., U.S. Pat. No. 4,699,784, to Shih et al.). A carrier may also bear an agent by noncovalent bonding or by encapsulation, such as within a liposome vesicle (e.g., U.S. Pat. Nos. 4,429,008 and 4,873,088). Carriers specific for radionuclide agents include radiohalogenated small molecules and chelating compounds. For example, U.S. Pat. No. 4,735,792 discloses representative radiohalogenated small molecules and their synthesis. A radionuclide chelate may be formed from chelating compounds that include those containing nitrogen and sulfur atoms as the donor atoms for binding the metal, or metal oxide, radionuclide. For example, U.S. Pat. No. 4,673,562, to Davison et al. discloses representative chelating compounds and their synthesis.

A variety of routes of administration for the antibodies and immunoconjugates may be used. Typically, administration will be intravenous, intramuscular, subcutaneous or in the bed of a resected tumor. It will be evident that the precise dose of the antibody/immunoconjugate will vary depending upon the antibody used, the antigen density on the tumor, and the rate of clearance of the antibody.

Diagnostic reagents of the present invention may also comprise polynucleotide sequences encoding one or more of the above polypeptides, or one or more portions thereof. For example, at least two oligonucleotide primers may be employed in a polymerase chain reaction (PCR) based assay to amplify lung tumor-specific cDNA derived from a biological sample, wherein at least one of the oligonucleotide primers is specific for a polynucleotide molecule encoding a lung tumor protein of the present invention. The presence of the amplified cDNA is then detected using techniques well known in the art, such as gel electrophoresis. Similarly, oligonucleotide probes specific for a polynucleotide molecule encoding a lung tumor protein of the present invention may be used in a hybridization assay to detect the presence of an inventive polypeptide in a biological sample.

As used herein, the term “oligonucleotide primer/probe specific for a polynucleotide molecule” means an oligonucleotide sequence that has at least about 60%, preferably at least about 75% and more preferably at least about 90%, identity to the polynucleotide molecule in question. Oligonucleotide primers and/or probes which may be usefully employed in the inventive diagnostic methods preferably have at least about 10-40 nucleotides. In a preferred embodiment, the oligonucleotide primers comprise at least about 10 contiguous nucleotides of a polynucleotide molecule comprising sequence selected from SEQ ID NO: 1-109, 111, 113 115-151, 153, 154, 157, 158, 160, 162-164, 167, 168 and 171. Preferably, oligonucleotide probes for use in the inventive diagnostic methods comprise at least about 15 contiguous oligonucleotides of a polynucleotide molecule comprising a sequence provided in SEQ ID NO: 1-109,111, 113 115-151, 153, 154, 157, 158, 160, 162-164, 167, 168 and 171. Techniques for both PCR based assays and hybridization assays are well known in the art (see, for example, Mullis et al. Ibid; Ehrlich, Ibid). Primers or probes may thus be used to detect lung tumor-specific sequences in biological samples, including blood, semen, lung tissue and/or lung tumor tissue.

The following Examples are offered by way of illustration and not by way of limitation.

EXAMPLES

Example 1

Isolation and Characterization of cDNA Sequences Encoding Lung Tumor Polypeptides

This example illustrates the isolation of cDNA molecules encoding lung tumor-specific polypeptides from lung tumor cDNA libraries.

A. Isolation of cDNA Sequences from a Lung Squamous Cell Carcinoma Library

A human lung squamous cell carcinoma cDNA expression library was constructed from poly A + RNA from a pool of two patient tissues using a Superscript Plasmid System for cDNA Synthesis and Plasmid Cloning kit (BRL Life Technologies, Gaithersburg, Md.) following the manufacturer's protocol. Specifically, lung carcinoma tissues were homogenized with polytron (Kinematica, Switzerland) and total RNA was extracted using Trizol reagent (BRL Life Technologies) as directed by the manufacturer. The poly A + RNA was then purified using an oligo dT cellulose column as described in Sambrook et al., Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratories, Cold Spring Harbor, N.Y., 1989. First-strand cDNA was synthesized using the NotI/Oligo-dT18 primer. Double-stranded cDNA was synthesized, ligated with BstXI/EcoRI adaptors (Invitrogen, San Diego, Calif.) and digested with NotI. Following size fractionation with cDNA size fractionation columns (BRL Life Technologies), the cDNA was ligated into the BstXI/NotI site of pcDNA3.1 (Invitrogen) and transformed into ElectroMax E. coli DH10B cells (BRL Life Technologies) by electroporation.

Using the same procedure, a normal human lung cDNA expression library was prepared from a pool of four tissue specimens. The cDNA libraries were characterized by determining the number of independent colonies, the percentage of clones that carried insert, the average insert size and by sequence analysis. The lung squamous cell carcinoma library contained 2.7×10 6 independent colonies, with 100% of clones having an insert and the average insert size being 2100 base pairs. The normal lung cDNA library contained 1.4×10 6 independent colonies, with 90% of clones having inserts and the average insert size being 1800 base pairs. For both libraries, sequence analysis showed that the majority of clones had a full length cDNA sequence and were synthesized from mRNA.

cDNA library subtraction was performed using the above lung squamous cell carcinoma and normal lung cDNA libraries, as described by Hara et al. ( Blood, 84:189-199, 1994) with some modifications. Specifically, a lung squamous cell carcinoma-specific subtracted cDNA library was generated as follows. Normal tissue CDNA library (80 μg) was digested with BamHI and XhoI, followed by a filling-in reaction with DNA polymerase Klenow fragment. After phenol-chloroform extraction and ethanol precipitation, the DNA was dissolved in 133 μl of H 2 O, heat-denatured and mixed with 133 μl (133 μg) of Photoprobe biotin (Vector Laboratories, Burlingame, Calif.). As recommended by the manufacturer, the resulting mixture was irradiated with a 270 W sunlamp on ice for 20 minutes. Additional Photoprobe biotin (67 μl) was added and the biotinylation reaction was repeated. After extraction with butanol five times, the DNA was ethanol-precipitated and dissolved in 23 μl H 2 O to form the driver DNA.

To form the tracer DNA, 10 μg lung squamous cell carcinoma cDNA library was digested with NotI and SpeI, phenol chloroform extracted and passed through Chroma spin-400 columns (Clontech, Palo Alto, Calif.). Typically, 5 μg of cDNA was recovered after the sizing column. Following ethanol precipitation, the tracer DNA was dissolved in 5 μl H 2 O. Tracer DNA was mixed with 15 μl driver DNA and 20 μl of 2×hybridization buffer (1.5 M NaCl/10 mM EDTA/50 mM HEPES pH 7.5/0.2% sodium dodecyl sulfate), overlaid with mineral oil, and heat-denatured completely. The sample was immediately transferred into a 68° C. water bath and incubated for 20 hours (long hybridization [LH]). The reaction mixture was then subjected to a streptavidin treatment followed by phenol/chloroform extraction. This process was repeated three more times. Subtracted DNA was precipitated, dissolved in 12 μl H 2 O, mixed with 8 μl driver DNA and 20 μl of 2×hybridization buffer, and subjected to a hybridization at 68° C. for 2 hours (short hybridization [SH]). After removal of biotinylated double-stranded DNA, subtracted cDNA was ligated into NotI/SpeI site of chloramphenicol resistant pBCSK + (Stratagene, La Jolla, Calif.) and transformed into ElectroMax E. coli DH10B cells by electroporation to generate a lung squamous cell carcinoma specific subtracted cDNA library (herein after referred to as “lung subtraction I”).

A second lung squamous cell carcinoma specific subtracted cDNA library (referred to as “lung subtraction II”) was generated in a similar way to the lung subtraction library I, except that eight frequently recovered genes from lung subtraction I were included in the driver DNA, and 24,000 independent clones were recovered.

To analyze the subtracted cDNA libraries, plasmid DNA was prepared from 320 independent clones, randomly picked from the subtracted lung squamous cell carcinoma specific libraries. Representative cDNA clones were further characterized by DNA sequencing with a Perkin Elmer/Applied Biosystems Division Automated Sequencer Model 373A and/or Model 377 (Foster City, Calif.). The cDNA sequences for sixty isolated clones are provided in SEQ ID NO: 1-60. These sequences were compared to known sequences in the gene bank using the EMBL and GenBank databases (release 96). No significant homologies were found to the sequences provided in SEQ ID NO: 2, 3, 19, 38 and 46. The sequences of SEQ ID NO: 1, 6-8, 10-13, 15, 17, 18, 20-27, 29, 30, 32, 34-37, 39-45, 47-49, 51, 52, 54, 55 and 57-59 were found to show some homology to previously identified expressed sequence tags (ESTs). The sequences of SEQ ID NO: 9, 28, 31 and 33 were found to show some homology to previously identified non-human gene sequences and the sequences of SEQ ID NO: 4, 5, 14, 50, 53, 56 and 60 were found to show some homology to gene sequences previously identified in humans.

The subtraction procedure described above was repeated using the above lung squamous cell carcinoma cDNA library as the tracer DNA, and the above normal lung tissue cDNA library and a cDNA library from normal liver and heart (constructed from a pool of one sample of each tissue as described above), plus twenty other cDNA clones that were frequently recovered in lung subtractions I and II, as the driver DNA (lung subtraction III). The normal liver and heart cDNA library contained 1.76×10 6 independent colonies, with 100% of clones having inserts and the average insert size being 1600 base pairs. Ten additional clones were isolated (SEQ ID NO: 61-70). Comparison of these cDNA sequences with those in the gene bank as described above, revealed no significant homologies to the sequences provided in SEQ ID NO: 62 and 67. The sequences of SEQ ID NO: 61, 63-66, 68 and 69 were found to show some homology to previously isolated ESTs and the sequence provided in SEQ ID NO: 70 was found to show some homology to a previously identified rat gene.

B. Isolation of cDNA Sequences from a Lung Adenocarcinoma Library

A human lung adenocarcinoma cDNA expression library was constructed as described above. The library contained 3.2×10 6 independent colonies, with 100% of clones having an insert and the average insert size being 1500 base pairs. Library subtraction was performed as described above using the normal lung and normal liver and heart cDNA expression libraries described above as the driver DNA. Twenty-six hundred independent clones were recovered.

Initial cDNA sequence analysis from 100 independent clones revealed many ribosomal protein genes. The cDNA sequences for fifteen clones isolated in this subtraction are provided in SEQ ID NO: 71-86. Comparison of these sequences with those in the gene bank as described above revealed no significant homologies to the sequence provided in SEQ ID NO: 84. The sequences of SEQ ID NO: 71, 73, 74, 77, 78 and 80-82 were found to show some homology to previously isolated ESTs, and the sequences of SEQ ID NO: 72, 75, 76, 79, 83 and 85 were found to show some homology to previously identified human genes.

Example 2

Determination of Tissue Specificity of Lung Tumor Polypeptides

Using gene specific primers, mRNA expression levels for seven representative lung tumor polypeptides described in Example 1 were examined in a variety of normal and tumor tissues using RT-PCR.

Briefly, total RNA was extracted from a variety of normal and tumor tissues using Trizol reagent as described above. First strand synthesis was carried out using 2 μg of total RNA with SuperScript II reverse transcriptase (BRL Life Technologies) at 42° C. for one hour. The cDNA was then amplified by PCR with gene-specific primers. To ensure the semi-quantitative nature of the RT-PCR, β-actin was used as an internal control for each of the tissues examined. 1 μl of 1:30 dilution of cDNA was employed to enable the linear range amplification of the β-actin template and was sensitive enough to reflect the differences in the initial copy numbers. Using these conditions, the β-actin levels were determined for each reverse transcription reaction from each tissue. DNA contamination was minimized by DNase treatment and by assuring a negative PCR result when using first strand cDNA that was prepared without adding reverse transcriptase.

mRNA Expression levels were examined in five different types of tumor tissue (lung squamous cell carcinoma from 3 patients, lung adenocarcinoma, colon tumor from 2 patients, breast tumor and prostate tumor), and thirteen different normal tissues (lung from 4 donors, prostate, brain, kidney, liver, ovary, skeletal muscle, skin, small intestine, stomach, myocardium, retina and testes). Using a 10-fold amount of cDNA, the antigen LST-S1-90 (SEQ ID NO: 3) was found to be expressed at high levels in lung squamous cell carcinoma and in breast tumor, and at low to undetectable levels in the other tissues examined.

The antigen LST-S2-68 (SEQ ID NO: 15) appears to be specific to lung and breast tumor, however, expression was also detected in normal kidney. Antigens LST-S1-169 (SEQ ID NO: 6) and LST-S1-133 (SEQ ID NO: 5) appear to be very abundant in lung tissues (both normal and tumor), with the expression of these two genes being decreased in most of the normal tissues tested. Both LST-S1-169 and LST-S1-133 were also expressed in breast and colon tumors. Antigens LST-S1-6 (SEQ ID NO: 7) and LST-S2-I2-5F (SEQ ID NO: 47) did not show tumor or tissue specific expression, with the expression of LST-S1-28 being rare and only detectable in a few tissues. The antigen LST-S3-7 (SEQ ID NO: 63) showed lung and breast tumor specific expression, with its message only being detected in normal testes when the PCR was performed for 30 cycles. Lower level expression was detected in some normal tissues when the cycle number was increased to 35. Antigen LST-S3-13 (SEQ ID NO: 66) was found to be expressed in 3 out of 4 lung tumors, one breast tumor and both colon tumor samples. Its expression in normal tissues was lower compared to tumors, and was only detected in 1 out of 4 normal lung tissues and in normal tissues from kidney, ovary and retina. Expression of antigens LST-S3-4 (SEQ ID NO: 62) and LST-S3-14 (SEQ ID NO: 67) was rare and did not show any tissue or tumor specificity. Consistent with Northern blot analyses, the RT-PCT results on antigen LAT-S1-A-10A (SEQ ID NO: 78) suggested that its expression is high in lung, colon, stomach and small intestine tissues, including lung and colon tumors, whereas its expression was low or undetectable in other tissues.

A total of 2002 cDNA fragments isolated in lung subtractions I, II and III, described above, were colony PCR amplified and their mRNA expression levels in lung tumor, normal lung, and various other normal and tumor tissues were determined using microarray technology (Synteni, Palo Alto, Calif.). Briefly, the PCR amplification products were dotted onto slides in an array format, with each product occupying a unique location in the array. mRNA was extracted from the tissue sample to be tested, reverse transcribed, and fluorescent-labeled cDNA probes were generated. The microarrays were probed with the labeled cDNA probes, the slides scanned and fluorescence intensity was measured. This intensity correlates with the hybridization intensity. Seventeen non-redundant cDNA clones showed over-expression in lung squamous tumors, with expression in normal tissues tested (lung, skin, lymph node, colon, liver, pancreas, breast, heart, bone marrow, large intestine, kidney, stomach, brain, small intestine, bladder and salivary gland) being either undetectable, or 10-fold less compared to lung squamous tumors. The determined partial cDNA sequences for the clone L513S are provided in SEQ ID NO: 87 and 88; those for L514S are provided in SEQ ID NO: 89 and 90; those for L516S in SEQ ID NO: 91 and 92; that for L517S in SEQ ID NO: 93; that for L519S in SEQ ID NO: 94; those for L520S in SEQ ID NO: 95 and 96; those for L521S in SEQ ID NO: 97 and 98; that for L522S in SEQ ID NO: 99; that for L523S in SEQ ID NO: 100; that for L524S in SEQ ID NO: 101; that for L525S in SEQ ID NO: 102; that for L526S in SEQ ID NO: 103; that for L527S in SEQ ID NO: 104; that for L528S in SEQ ID NO: 105; that for L529S in SEQ ID NO: 106; and those for L530S in SEQ ID NO: 107 and 108. Additionally, the full-length cDNA sequences for L503S and L514S (variants 1 and 2), are provided in SEQ ID NO: 151, 153 and 154, respectively, with the corresponding predicted amino acid sequence being provided in SEQ ID NO: 152, 155 and 156. Due to polymorphisms, the clone L531 S appears to have two forms. A first determined full-length cDNA sequence for L531 S is provided in SEQ ID NO: 109, with the corresponding predicted amino acid sequence being provided in SEQ ID NO: 110. A second determined full-length cDNA sequence for L531S is provided in SEQ ID NO: 111, with the corresponding predicted amino acid sequence being provided in SEQ ID NO: 112. The sequence of SEQ ID NO: 111 is identical to that of SEQ ID NO: 109, except that it contains a 27 bp insertion. Similarly, L514S also has two alternatively spliced forms; the first variant cDNA is listed as SEQ ID NO: 153, with the corresponding amino acid sequence as SEQ ID NO: 155. The second variant form of L514S full-length cDNA is referred to as SEQ ID NO: 154, with its corresponding amino acid sequence as SEQ ID NO: 156.

Full length cloning for L524S (SEQ ID NO: 101) yielded two variants (SEQ ID NO: 163 and 164) with the corresponding predicted amino acid sequences (SEQ ID NO: 165 and 166), respectively. Both variants have been shown to encode parathyroid hormone-related peptide.

Comparison of the sequences of L514S and L531S (SEQ ID NO: 87 and 88, 89 and 90, and 109, respectively) with those in the gene bank, as described above, revealed no significant homologies to known sequences. The sequences of L513S, L516S, L517S, L519S, L520S and L530S (SEQ ID NO: 87 and 88, 91 and 92, 93, 94, 95 and 96, 107 and 108, respectively) were found to show some homology to previously identified ESTs. The sequences of L521S, L522S, L523S, L524S, L525S, L526S, L527S, L528S and L529S (SEQ ID NO: 97 and 98, 99, 99, 101, 102, 103, 104, 105, and 106, respectively) were found to represent known genes. The determined full-length cDNA sequences for L520S is provided in SEQ ID NO: 113, with the corresponding predicted amino acid sequence being provided in SEQ ID NO: 114. Subsequent microarray analysis has shown L520S to be overexpressed in breast tumors in addition to lung squamous tumors.

Further analysis has demonstrated L529S (SEQ ID NO: 106 and 115), L525S (SEQ ID NO: 102 and 120) and L527S (SEQ ID NO: 104) are cytosleletal components and potentially squamous cell specific proteins. L529S is connexin 26, a gap junction protein. It is highly expressed in lung squamous tumor 9688T, and moderately over-expressed in two others. However, lower level expression of connexin 26 is also detectable in normal skin, colon, liver and stomach. The over-expression of connexin 26 in some breast tumors has been reported and a mutated form of L529S may result in over-expression in lung tumors. L525S is plakophilin 1, a desmosomal protein found in plaque-bearing adhering junctions of the skin. Expression levels for L525S mRNA is highly elevated in three out of four lung squamous tumors tested, and in normal skin. L527S has been identified as keratin 6 isoform, type II 58 Kd keratin, and cytokeratin 13 and shows over-expression in squamous tumors and low expression in normal skin, breast and colon tissues. Notably, keratin and keratin-related genes have been extensively documented as potential markers for lung cancer including CYFRA2.1 (Pastor, A., et al, Eur. Respir. J., 10:603-609, 1997). L513S (SEQ ID NO: 87 and 88) shows moderate over-expression in several tumor tissues tested, and encodes a protein that was first isolated as a pemphigus vulgaris antigen.

L520S (SEQ ID NO: 95 and 96) and L521S (SEQ ID NO: 97 and 98) are highly expressed in lung squamous tumors, and L520S is up-regulated in normal salivary gland and L521 S is over-expressed in normal skin. Both belong to a family of small proline rich proteins and represent markers for fully differentiated squamous cells. L521S has been described as a specific marker for lung squamous tumor (Hu, R., et al, Lung Cancer, 20:25-30, 1998). L515S (SEQ ID NO: 162) encodes IGF-β2 and L516S is an aldose reductase homologue and both are moderately expressed in lung squamous tumors and in normal colon. Notably, L516S (SEQ ID NO: 91 and 92) is up-regulated in metastatic tumors but not primary lung adenocarcinoma, an indication of its potential role in metatasis and a potential prognostic marker. L522S (SEQ ID NO: 99) is moderately over-expressed in lung squamous tumors with minimum expression in normal tissues. L522S has been shown to belong to a class IV alcohol dehydrogenase, ADH7, and its expression profile suggests it is a squamous cell specific antigen. L523S (SEQ ID NO: 100) is moderately over-expressed in lung squamous tumor, human pancreatic cancer cell lines and pancreatic cancer tissues, suggesting this gene may be a shared antigen between pancreatic and lung squamous cell cancer.

L524S (SEQ ID NO: 101) is over-expressed in the majority of squamous tumors tested and is homolgous with parathyroid hormone-related peptide (PTHrP), which is best known to cause humoral hypercalcaemia associated with malignant tumors such as leukemia, prostate and breast cancer. It is also believed that PTHrP is most commonly associated with squamous carcinoma of lung and rarely with lung adenocarcinoma (Davidson, L. A., et al, J. Pathol., 178: 398-401, 1996). L528S (SEQ ID NO: 105) is highly over-expressed in two lung squamous tumors with moderate expression in two other squamous tumors, one lung adenocarcinoma and some normal tissues, including skin, lymph nodes, heart, stomach and lung. It encodes the NMB gene that is similar to the precursor of melanocyte specific gene Pmel17, wfhich is reported to be preferentially expressed in low-metastatic potential melanoma cell lines. This suggests that L528S may be a shared antigen in both melanoma and lung aquamous cell carcinoma. L526S (SEQ ID NO: 103) is overexpressed in all lung squamous cell tumor tissues tested and has been shown to share homology with a gene (ATM) in which a mutation causes ataxia telangiectasia, a genetic disorder in humans causing a predisposition to cancer, among other symptoms. ATM encodes a protein that activates p53 mediated cell-cycle checkpoint through direct binding and phosphorylation of the p53 molecule. Approximately 40% of lung cancer is associated with p53 mutations, and it is speculated that over-expression of ATM is a result of compensation for loss of p53 function, but it is unknown whether over-expression is the cause of result of lung squamous cell carcinoma. Additionally, expression of L526S (ATM) is also detected in a metastatic but not lung adenocarcinoma, suggesting a role in metastasis.

Example 3

Isolation and Characterization of Lung Tumor Polypeptides by PCR-Based Subtraction

Eight hundred and fifty seven clones from a cDNA subtraction library, containing cDNA from a pool of two human lung squamous tumors subtracted against eight normal human tissue cDNAs including lung, PBMC, brain, heart, kidney, liver, pancreas, and skin, (Clontech, Palo Alto, Calif.) were derived and submitted to a first round of PCR amplification. This library was subjected to a second round of PCR amplification, following the manufacturer's protocol. The resulting cDNA fragments were subcloned into the vector P7-Adv vector (Clontech, Palo Alto, Calif.) and transformed into DH5α E. coli (Gibco, BRL). DNA was isolated from independent clones and sequenced using a Perkin Elmer/Applied Biosystems Division Automated Sequencer Model 373A.

One hundred and sixty two positive clones were sequenced. Comparison of the DNA sequences of these clones with those in the gene bank using the EMBL and GenBank databases, as described above, revealed no significant homologies to 13 of these clones, hereinafter referred to as Contig 13, 16, 17, 19, 22, 24, 29, 47, 49, 56-59 . The determined cDNA sequences for these clones are provided in SEQ ID NO: 125, 127-129, 131-133, 142, 144, 148-150, and 157, respectively. Contigs 1, 3-5, 7-10, 12, 11, 15, 20, 31, 33, 38, 39, 41, 43, 44, 45, 48, 50, 53, 54 (SEQ ID NO: 115-124, 126, 130, 134-141, 143, 145-147, respectively) were found to show some degree of homology to previously identified DNA sequences. Contig 57 (SEQ ID NO: 149) was found to represent the clone L519S (SEQ ID NO: 94) disclosed in U.S. patent application Ser. No. 09/123,912, filed Jul. 27, 1998. To the best of the inventors' knowledge, none of these sequences have been previously shown to be differentially over-expressed in lung tumors.

mRNA expression levels for representative clones in lung tumor tissues, normal lung tissues (n=4), resting PBMC, salivary gland, heart, stomach, lymph nodes, skeletal muscle, soft palate, small intestine, large intestine, bronchial, bladder, tonsil, kidney, esophagus, bone marrow, colon, adrenal gland, pancreas, and skin, (all derived from human) were determined by RT-PCR as described above. Expression levels using microarray technology, as described above, were examined in one sample of each tissue type unless otherwise indicated.

Contig 3 (SEQ ID NO: 116) was found to be highly expressed in all head and neck squamous cell tumors tested (17/17), and expressed in the majority (8/12) of lung squamous tumors, (high expression in 7/12, moderate in 2/12, and low in 2/12), while showing negative expression for 2/4 normal lung tissues and low expression in the remaining two samples. Contig 3 showed moderate expression in skin and soft palate, and lowered expression levels in resting PBMC, large intestine, salivary gland, tonsil, pancreas, esophagus, and colon. Contig 11 (SEQ ID NO: 124) was found to be expressed in all head and neck squamous cell tumors tested (17/17): highly expressed in 14/17, and moderately expressed in 3/17. Additionally, expression in lung squamous tumors showed high expression in 3/12 and moderate in 4/12. Contig 11 was negative for 3/4 normal lung samples, with the remaining sample having only low expression. Contig 11 showed low to moderate reactivity to salivary gland, soft palate, bladder, tonsil, skin, esophagus, and large intestine. Contig 13 (SEQ ID NO: 125) was found to be expressed in all head and neck squamous cell tumors tested (17/17): highly expressed in 12/17, and moderately expressed in 5/17. Contig 13 was expressed in 7/12 lung squamous tumors, with high expression in 4/12 and moderate expression in three samples. Analysis of normal lung samples showed negative expression for 2/4 and low to moderate expression in the remaining two samples. Contig 13 did show low to moderate reactivity to resting PBMC, salivary gland, bladder, pancreas, tonsil, skin, esophagus, and large intestine, as well as high expression in soft palate. Contig 16 (SEQ ID NO: 127) was found to be moderately expressed in some head and neck squamous cell tumors (6/17) and one lung squamous tumor; while showing no expression in any normal lung samples tested. Contig 16 did show low reactivity to resting PBMC, large intestine, skin, salivary gland, and soft palate. Contig 17 (SEQ ID NO: 128) was shown to be expressed in all head and neck squamous cell tumors tested (17/17): highly expressed in 5/17, and moderately expressed in 12/17. Expression levels in lung squamous tumors showed one tumor sample with high expression and 3/12 with moderate levels. Contig 17 was negative for 2/4 normal lung samples, with the remaining samples having only low expression. Additionally, low level expression was found in esophagus and soft palate. Contig 19 (SEQ ID NO: 129) was found to be expressed in most head and neck squamous cell tumors tested (11/17): with two samples having high levels, 6/17 showing moderate expression, and low expression being found in 3/17. Testing in lung squamous tumors revealed only moderate expression in 3/12 samples. Expression levels in 2/4 of normal lung samples were negative, the two other samples having only low expression. Contig 19 did show low expression levels in esophagus, resting PBMC, salivary gland, bladder, soft palate and pancreas.

Contig 22, (SEQ ID NO: 131) was shown to be expressed in most head and neck squamous cell tumors tested (13/17) with high expression in four of these samples, moderate expression in 6/17, and low expression in 3/17. Expression levels in lung squamous tumors were found to be moderate to high for 3/12 tissues tested, with negative expression in two normal lung samples and low expression in two other samples (n=4). Contig 22 did show low expression in skin, salivary gland and soft palate. Similarly, Contig 24 (SEQ ID NO: 132) was found to be expressed in most head and neck squamous cell tumors tested (13/17) with high expression in three of these samples, moderate expression in 6/17, and low expression in 4/17. Expression levels in lung squamous tumors were found to be moderate to high for 3/12 tissues tested, with negative expression for three normal lung samples and low expression in one sample (n=4). Contig 24 did show low expression in skin, salivary gland and soft palate. Contig 29 (SEQ ID NO: 133) was expressed in nearly all head and neck squamous cell tumors tested (16/17): highly expressed in 4/17, moderately expressed in 11/17, with low expression in one sample. Also, it was moderately expressed in 3/12 lung squamous tumors, while being negative for 2/4 normal lung samples. Contig 29 showed low to moderate expression in large intestine, skin, salivary gland, pancreas, tonsil, heart and soft palate. Contig 47 (SEQ ID NO: 142) was expressed in most head and neck squamous cell tumors tested (12/17): moderate expression in 10/17, and low expression in two samples. In lung squamous tumors, it was highly expressed in one sample and moderately expressed in two others (n=13). Contig 47 was negative for 2/4 normal lung samples, with the remaining two samples having moderate expression. Also, Contig 47 showed moderate expression in large intestine, and pancreas, and low expression in skin, salivary gland, soft palate, stomach, bladder, resting PBMC, and tonsil.

Contig 48 (SEQ ID NO: 143) was expressed in all head and neck squamous cell tumors tested (17/17): highly expressed in 8/17 and moderately expressed in 7/17, with low expression in two samples. Expression levels in lung squamous tumors were high to moderate in three samples (n=13). Contig 48 was negative for one out of four normal lung samples, the remaining showing low or moderate expression. Contig 48 showed moderate expression in soft palate, large intestine, pancreas, and bladder, and low expression in esophagus, salivary gland, resting PBMC, and heart. Contig 49 (SEQ ID NO: 144) was expressed at low to moderate levels in 6/17 head and neck squamous cell tumors tested. Expression levels in lung squamous tumors were moderate in three samples (n=13). Contig 49 was negative for 2/4 normal lung samples, the remaining samples showing low expression. Moderate expression levels in skin, salivary gland, large intestine, pancreas, bladder and resting PBMC were shown, as well as low expression in soft palate, lymph nodes, and tonsil. Contig 56 (SEQ ID NO: 148) was expressed in low to moderate levels in 3/17 head and neck squamous cell tumors tested, and in lung squamous tumors, showing low to moderate levels in three out of thirteen samples. Notably, low expression levels were detected in one adenocarcinoma lung tumor sample (n=2). Contig 56 was negative for 3/4 normal lung samples, and showed moderate expression levels in only large intestine, and low expression in salivary gland, soft palate, pancreas, bladder, and resting PBMC. Contig 58, also known as L769P, (SEQ ID NO: 150) was expressed at moderate levels in 11/17 head and neck squamous cell tumors tested and low expression in one additional sample. Expression in lung squamous tumors showed low to moderate levels in three out of thirteen samples. Contig 58 was negative for 3/4 normal lung samples, with one sample having low expression. Moderate expression levels in skin, large intestine, and resting PBMC were demonstrated, as well as low expression in salivary gland, soft palate, pancreas, and bladder. Contig 59 (SEQ ID NO: 157) was expressed in some head, neck, and lung squamous tumors. Low level expression of Contig 59 was also detected in salivary gland and large intestine.

Additionally, the full-length cDNA sequence for Contigs 22, referred to as L763P, is provided in SEQ ID NO: 158, with the corresponding predicted amino acid sequence being provided in SEQ ID NO: 159. Also, the full-length cDNA sequence incorporating Contigs 17, 19, and 24, referred to as L762P, is provided in SEQ ID NO: 160, with the corresponding predicted amino acid sequence being provided in SEQ ID NO: 161. Further analysis of L762P has determined it to be a type I membrane protein and two additional variants have been sequenced. Variant 1 (SEQ ID NO: 167 and the corresponding amino acid sequence in SEQ ID NO: 169) is an alternatively spliced form of SEQ ID NO: 160 resulting in deletion of 503 nucleotides, as well as deletion of a short segment of the expressed protein. Variant 2 (SEQ ID NO: 168 and the corresponding amino acid sequence in SEQ ID NO: 170) has a two nucleotide deletion at the 3′ coding region in comparison to SEQ ID NO: 160, resulting in a secreted form of the expressed protein.

The full-length cDNA sequence for contig 56 (SEQ ID NO: 148), referred to as L773P, is provided in SEQ ID NO: 171, with the predicted amino acid sequence in SEQ ID NO: 172. Subsequent Northern blot analysis of L773P demonstrates this transcript is differentially over-expressed in squamous tumors and detected at approximately 1.6 Kb in primary lung tumor tissue and approximately 1.3 Kb in primary head and neck tumor tissue.

Subsequent microarray analysis has shown Contig 58, also referred to as L769S (SEQ ID NO: 150), to be overexpressed in breast tumors in addition to lung squamous tumors.

Example 4

Synthesis of Polypeptides

Polypeptides may be synthesized on a Perkin Elmer/Applied Biosystems Division 430A peptide synthesizer using FMOC chemistry with HPTU (O-Benzotriazole-N,N,N′,N′-tetramethyluronium hexafluorophosphate) activation. A Gly-Cys-Gly sequence may be attached to the amino terminus of the peptide to provide a method of conjugation, binding to an immobilized surface, or labeling of the peptide. Cleavage of the peptides from the solid support may be carried out using the following cleavage mixture: trifluoroacetic acid:ethanedithiol:thioanisole:water:phenol (40:1:2:2:3). After cleaving for 2 hours, the peptides may be precipitated in cold methyl-t-butyl-ether. The peptide pellets may then be dissolved in water containing 0.1% trifluoroacetic acid (TFA) and lyophilized prior to purification by C18 reverse phase HPLC. A gradient of 0%-60% acetonitrile (containing 0.1% TFA) in water (containing 0.1% TFA) may be used to elute the peptides. Following lyophilization of the pure fractions, the peptides may be characterized using electrospray or other types of mass spectrometry and by amino acid analysis.

From the foregoing, it will be appreciated that, although specific embodiments of the invention have been described herein for the purposes of illustration, various modifications may be made without deviating from the spirit and scope of the invention.

172 1 315 DNA Homo sapien misc_feature (1)...(315) n = A,T,C or G 1gcagagacag actggtggtt gaacctggag gtgccaaaaa agccagctgc gggcccagga 60cagctgccgt gagactcccg atgtcacagg cagtctgtgt ggttacagcg cccctcagtg 120ttcatctcca gcagagacaa cggaggaggc tcccaccagg acggttctca ttatttatat 180gttaatatgt ttgtaaactc atgtacagtt ttttttgggg gggaagcaat gggaanggta 240naaattacaa atagaatcat ttgctgtaat ccttaaatgg caaacggtca ggccacgtga 300aaaaaaaaaa aaaaa 315 2 380 DNA Homo sapien 2atttaggctt aagattttgt ttacccttgt tactaaggag caaattagta ttaaagtata 60atatatataa acaaatacaa aaagttttga gtggttcagc ttttttattt tttttaatgg 120cataactttt aacaacactg ctctgtaatg ggttgaactg tggtactcag actgagataa 180ctgaaatgag tggatgtata gtgttattgc ataattatcc cactatgaag caaagggact 240ggataaattc ccagtctaga ttattagcct ttgttaacca tcaagcacct agaagaagaa 300ttattggaaa ttttgtcctc tgtaactggc actttggggt gtgacttatc ttttgccttt 360gtaaaaaaaa aaaaaaaaaa 380 3 346 DNA Homo sapien misc_feature (1)...(346) n = A,T,C or G 3ttgtaagtat acaattttag aaaggattaa atgttattga tcattttact gaatactgca 60catcctcacc atacaccatc cactttccaa taacatttaa tcctttctaa aattgtaagt 120atacaattgt actttctttg gattttcata acaaatatac catagactgt taattttatt 180gaagtttcct taatggaatg agtcattttt gtcttgtgct tttgaggtta cctttgcttt 240gacttccaac aatttgatca tatagtgttg agctgtggaa atctttaagt ttattctata 300gcaataattt ctattnnnag annccnggnn naaaannann annaaa 346 4 372 DNA Homo sapien misc_feature (1)...(372) n = A,T,C or G 4actagtctca ttactccaga attatgctct tgtacctgtg tggctgggtt tcttagtcgt 60tggtttggtt tggttttttg aactggtatg tagggtggtt cacagttcta atgtaagcac 120tctcttctcc aagttgtgct ttgtggggac aatcattctt tgaacattag agaggaaggc 180agttcaagct gttgaaaaga ctattgctta tttttgtttt taaagaccta cttgacgtca 240tgtggacagt gcacgtgcct tacgctacat cttgttttct aggaagaagg ggatgcnggg 300aaggantggg tgctttgtga tggataaaac gnctaaataa cacaccttta cattttgaaa 360aaaacaaaac aa 372 5 698 DNA Homo sapien misc_feature (1)...(698) n = A,T,C or G 5actagtanga tagaaacact gtgtcccgag agtaaggaga gaagctacta ttgattagag 60cctaacccag gttaactgca agaagaggcg ggatactttc agctttccat gtaactgtat 120gcataaagcc aatgtagtcc agtttctaag atcatgttcc aagctaactg aatcccactt 180caatacacac tcatgaactc ctgatggaac aataacaggc ccaagcctgt ggtatgatgt 240gcacacttgc tagactcaga aaaaatacta ctctcataaa tgggtgggag tattttgggt 300gacaacctac tttgcttggc tgagtgaagg aatgatattc atatnttcat ttattccatg 360gacatttagt tagtgctttt tatataccag gcatgatgct gagtgacact cttgtgtata 420tntccaaatn ttngtncngt cgctgcacat atctgaaatc ctatattaag antttcccaa 480natgangtcc ctggtttttc cacgccactt gatcngtcaa ngatctcacc tctgtntgtc 540ctaaaaccnt ctnctnnang gttagacngg acctctcttc tcccttcccg aanaatnaag 600tgtgngaaga nanccncncn cccccctncn tncnncctng ccngctnnnc cncntgtngg 660gggngccgcc cccgcggggg gacccccccn ttttcccc 698 6 740 DNA Homo sapien misc_feature (1)...(740) n = A,T,C or G 6actagtcaaa aatgctaaaa taatttggga gaaaatattt tttaagtagt gttatagttt 60catgtttatc ttttattatg tnttgtgaag ttgtgtcttt tcactaatta cctatactat 120gccaatattt ccttatatct atccataaca tttatactac atttgtaaga gaatatgcac 180gtgaaactta acactttata aggtaaaaat gaggtttcca agatttaata atctgatcaa 240gttcttgtta tttccaaata gaatggactt ggtctgttaa ggggctaagg gagaagaaga 300agataaggtt aaaagttgtt aatgaccaaa cattctaaaa gaaatgcaaa aaaaaattta 360ttttcaagcc ttcgaactat ttaaggaaag caaaatcatt tcctanatgc atatcatttg 420tgagantttc tcantaatat cctgaatcat tcatttcagc tnaggcttca tgttgactcg 480atatgtcatc tagggaaagt ctatttcatg gtccaaacct gttgccatag ttggtnaggc 540tttcctttaa ntgtgaanta ttnacangaa attttctctt tnanagttct tnatagggtt 600aggggtgtgg gaaaagcttc taacaatctg tagtgttncg tgttatctgt ncagaaccan 660aatnacggat cgnangaagg actgggtcta tttacangaa cgaatnatct ngttnnntgt 720gtnnncaact ccngggagcc 740 7 670 DNA Homo sapien misc_feature (1)...(670) n = A,T,C or G 7gctggggagc tcggcatggc ggtccccgct gcagccatgg ggccctcggc gttgggccag 60agcggccccg gctcgatggc cccgtggtgc tcagtgagca gcggcccgtc gcgctacgtg 120cttgggatgc aggagctgtt ccggggccac agcaagaccg cgagttcctg gcgcacagcg 180ccaaggtgca ctcggtggcc tggagttgcg acgggcgtcg cctacctcgg ggtcttcgac 240aagacgccac gtcttcttgc tgganaanga ccgttggtca aagaaaacaa ttatcgggga 300catggggata gtgtggacca ctttgttggc atccaagtaa tcctgaccta tttgttacgg 360cgtctggaga taaaaccatt cgcatctggg atgtgaggac tacaaaatgc attgccactg 420tgaacactaa aggggagaac attaatatct gctggantcc tgatgggcan accattgctg 480tagcnacaag gatgatgtgg tgactttatt gatgccaaga aaccccgttc caaagcaaaa 540aaacanttcc aanttcgaag tcaccnaaat ctcctggaac aatgaacatn aatatnttct 600tcctgacaat ggnccttggg tgtntcacat cctcagctnc cccaaaactg aancctgtnc 660natccacccc 670 8 689 DNA Homo sapien misc_feature (1)...(689) n = A,T,C or G 8actagtatct aggaatgaac agtaaaagag gagcagttgg ctacttgatt acaacagagt 60aaatgaagta ctggatttgg gaaaacctgg ttttattaga acatatggaa tgaaagccta 120cacctagcat tgcctactta gccccctgaa ttaacagagc ccaattgaga caaacccctg 180gcaacaggaa attcaaggga gaaaaagtaa gcaacttggg ctaggatgag ctgactccct 240tagagcaaag ganagacagc ccccattacc aaataccatt tttgcctggg gcttgtgcag 300ctggcagtgt tcctgcccca gcatggcacc ttatngtttt gatagcaact tcgttgaatt 360ttcaccaact tattacttga aattataata tagcctgtcc gtttgctgtn tccaggctgt 420gatatatntt cctagtggtt tgactttnaa aataaatnag gtttantttt ctccccccnn 480cnntnctncc nntcnctcnn cnntcccccc cnctcngtcc tccnnnnttn gggggggccn 540cccccncggn ggacccccct ttggtccctt agtggaggtt natggcccct ggnnttatcc 600nggccntann tttccccgtn nnaaatgntt ccccctccca ntcccnccac ctcaanccgg 660aagcctaagt ttntaccctg ggggtcccc 689 9 674 DNA Homo sapien misc_feature (1)...(674) n = A,T,C or G 9gtccactctc ctttgagtgt actgtcttac tgtgcactct gtttttcaac tttctagata 60taaaaaatgc ttgttctata gtggagtaag agctcacaca cccaaggcag caagataact 120gaaaaaagcg aggctttttt gccaccttgg taaaggccag ttcactgcta tagaactgct 180ataagcctga agggaagtag ctatgagact ttccattttt cttagttctc ccaataggct 240ccttcatgga aaaaggcttc ctgtaataat tttcacctaa tgaattagca gtgtgattat 300ttctgaaata agagacaaat tgggccgcag agtcttcctg tgatttaaaa taaacaaccc 360aaagttttgt ttggtcttca ccaaaggaca tactctaggg ggtatgttgt tgaagacatt 420caaaaacatt agctgttctg tctttcaatt tcaagttatt ttggagactg cctccatgtg 480agttaattac tttgctctgg aactagcatt attgtcatta tcatcacatt ctgtcatcat 540catctgaata atattgtgga tttccccctc tgcttgcatc ttcttttgac tcctctggga 600anaaatgtca aaaaaaaagg tcgatctact cngcaaggnc catctaatca ctgcgctgga 660aggacccnct gccc 674 10 346 DNA Homo sapien misc_feature (1)...(346) n = A,T,C or G 10actagtctgc tgatagaaag cactatacat cctattgttt ctttctttcc aaaatcagcc 60ttctgtctgt aacaaaaatg tactttatag agatggagga aaaggtctaa tactacatag 120ccttaagtgt ttctgtcatt gttcaagtgt attttctgta acagaaacat atttggaatg 180tttttctttt ccccttataa attgtaattc ctgaaatact gctgctttaa aaagtcccac 240tgtcagatta tattatctaa caattgaata ttgtaaatat acttgtctta cctctcaata 300aaagggtact tttctattan nnagnngnnn gnnnnataaa anaaaa 346 11 602 DNA Homo sapien 11actagtaaaa agcagcattg ccaaataatc cctaattttc cactaaaaat ataatgaaat 60gatgttaagc tttttgaaaa gtttaggtta aacctactgt tgttagatta atgtatttgt 120tgcttccctt tatctggaat gtggcattag cttttttatt ttaaccctct ttaattctta 180ttcaattcca tgacttaagg ttggagagct aaacactggg atttttggat aacagactga 240cagttttgca taattataat cggcattgta catagaaagg atatggctac cttttgttaa 300atctgcactt tctaaatatc aaaaaaggga aatgaagtta taaatcaatt tttgtataat 360ctgtttgaaa catgagtttt atttgcttaa tattagggct ttgccccttt tctgtaagtc 420tcttgggatc ctgtgtagaa ctgttctcat taaacaccaa acagttaagt ccattctctg 480gtactagcta caaattcggt ttcatattct acttaacaat ttaaataaac tgaaatattt 540ctagatggtc tacttctgtt catataaaaa caaaacttga tttccaaaaa aaaaaaaaaa 600aa 602 12 685 DNA Homo sapien misc_feature (1)...(685) n = A,T,C or G 12actagtcctg tgaaagtaca actgaaggca gaaagtgtta ggattttgca tctaatgttc 60attatcatgg tattgatgga cctaagaaaa taaaaattag actaagcccc caaataagct 120gcatgcattt gtaacatgat tagtagattt gaatatatag atgtagtatn ttgggtatct 180aggtgtttta tcattatgta aaggaattaa agtaaaggac tttgtagttg tttttattaa 240atatgcatat agtagagtgc aaaaatatag caaaaatana aactaaaggt agaaaagcat 300tttagatatg ccttaatnta nnaactgtgc caggtggccc tcggaataga tgccaggcag 360agaccagtgc ctgggtggtg cctccccttg tctgcccccc tgaagaactt ccctcacgtg 420angtagtgcc ctcgtaggtg tcacgtggan tantggganc aggccgnncn gtnanaagaa 480ancanngtga nagtttcncc gtngangcng aactgtccct gngccnnnac gctcccanaa 540cntntccaat ngacaatcga gtttccnnnc tccngnaacc tngccgnnnn cnngcccnnc 600cantntgnta accccgcgcc cggatcgctc tcnnntcgtt ctcncncnaa ngggntttcn 660cnnccgccgt cncnnccccg cnncc 685 13 694 DNA Homo sapien misc_feature (1)...(694) n = A,T,C or G 13cactagtcac tcattagcgt tttcaatagg gctcttaagt ccagtagatt acgggtagtc 60agttgacgaa gatctggttt acaagaacta attaaatgtt tcattgcatt tttgtaagaa 120cagaataatt ttataaaatg tttgtagttt ataattgccg aaaataattt aaagacactt 180tttctctgtg tgtgcaaatg tgtgtttgtg atccattttt tttttttttt taggacacct 240gtttactagc tagctttaca atatgccaaa aaaggatttc tccctgaccc catccgtggt 300tcaccctctt ttccccccat gctttttgcc ctagtttata acaaaggaat gatgatgatt 360taaaaagtag ttctgtatct tcagtatctt ggtcttccag aaccctctgg ttgggaaggg 420gatcattttt tactggtcat ttccctttgg agtgtactac tttaacagat ggaaagaact 480cattggccat ggaaacagcc gangtgttgg gagccagcag tgcatggcac cgtccggcat 540ctggcntgat tggtctggct gccgtcattg tcagcacagt gccatgggac atggggaana 600ctgactgcac ngccaatggt tttcatgaag aatacngcat ncncngtgat cacgtnancc 660angacgctat gggggncana gggccanttg cttc 694 14 679 DNA Homo sapien misc_feature (1)...(679) n = A,T,C or G 14cagccgcctg catctgtatc cagcgccang tcccgccagt cccagctgcg cgcgcccccc 60agtcccgnac ccgttcggcc cangctnagt tagncctcac catnccggtc aaaggangca 120ccaagtgcat caaatacctg cngtncggat ntaaattcat cttctggctt gccgggattg 180ctgtccntgc cattggacta nggctccgat ncgactctca gaccanganc atcttcganc 240naganactaa tnatnattnt tccagcttct acacaggagt ctatattctg atcggatccg 300gcnccctcnt gatgctggtg ggcttcctga gctgctgcgg ggctgtgcaa gagtcccant 360gcatgctggg actgttcttc ggcttcntct tggtgatatn cgccattgaa atacctgcgg 420ccatctgggg atattccact ncgatnatgt gattaaggaa ntccacggag ttttacaagg 480acacgtacaa cnacctgaaa accnnggatg anccccaccg ggaancnctg aangccatcc 540actatgcgtt gaactgcaat ggtttggctg gggnccttga acaatttaat cncatacatc 600tggccccann aaaggacntn ctcganncct tcnccgtgna attcngttct gatnccatca 660cagaagtctc gaacaatcc 679 15 695 DNA Homo sapien misc_feature (1)...(695) n = A,T,C or G 15actagtggat aaaggccagg gatgctgctc aacctcctac catgtacagg gacgtctccc 60cattacaact acccaatccg aagtgtcaac tgtgtcagga ctaanaaacc ctggttttga 120ttaaaaaagg gcctgaaaaa aggggagcca caaatctgtc tgcttcctca cnttantcnt 180tggcaaatna gcattctgtc tcnttggctg cngcctcanc ncaaaaaanc ngaactcnat 240cnggcccagg aatacatctc ncaatnaacn aaattganca aggcnntggg aaatgccnga 300tgggattatc ntccgcttgt tgancttcta agtttcnttc ccttcattcn accctgccag 360ccnagttctg ttagaaaaat gccngaattc naacnccggt tttcntactc ngaatttaga 420tctncanaaa cttcctggcc acnattcnaa ttnanggnca cgnacanatn ccttccatna 480ancncacccc acntttgana gccangacaa tgactgcntn aantgaaggc ntgaaggaan 540aactttgaaa ggaaaaaaaa ctttgtttcc ggccccttcc aacncttctg tgttnancac 600tgccttctng naaccctgga agcccngnga cagtgttaca tgttgttcta nnaaacngac 660ncttnaatnt cnatcttccc nanaacgatt ncncc 695 16 669 DNA Homo sapien misc_feature (1)...(669) n = A,T,C or G 16cgccgaagca gcagcgcagg ttgtccccgt ttcccctccc ccttcccttc tccggttgcc 60ttcccgggcc ccttacactc cacagtcccg gtcccgccat gtcccagaaa caagaagaag 120agaaccctgc ggaggagacc ggcgaggaga agcaggacac gcaggagaaa gaaggtattc 180tgcctgagag agctgaagag gcaaagctaa aggccaaata cccaagccta ggacaaaagc 240ctggaggctc cgacttcctc atgaagagac tccagaaagg gcaaaagtac tttgactcng 300gagactacaa catggccaaa gccaacatga agaataagca gctgccaagt gcangaccag 360acaagaacct ggtgactggt gatcacatcc ccaccccaca ggatctgccc agagaaagtc 420ctcgctcgtc accagcaagc ttgcgggtgg ccaagttgaa tgatgctgcc ggggctctgc 480canatctgag acgcttccct ccctgcccca cccgggtcct gtgctggctc ctgcccttcc 540tgcttttgca gccangggtc aggaagtggc ncnggtngtg gctggaaagc aaaacccttt 600cctgttggtg tcccacccat ggagcccctg gggcgagccc angaacttga ncctttttgt 660tntcttncc 669 17 697 DNA Homo sapien misc_feature (1)...(697) n = A,T,C or G 17gcaagatatg gacaactaag tgagaaggta atnctctact gctctagntn ctccnggcnn 60gacgcgctga ggagannnac gctggcccan ctgccggcca cacacgggga tcntggtnat 120gcctgcccan gggancccca ncnctcggan cccatntcac acccgnnccn tncgcccacn 180ncctggctcn cncngcccng nccagctcnc gnccccctcc gccnnnctcn ttnncntctc 240cncnccctcc ncnacnacct cctacccncg gctccctccc cagccccccc ccgcaancct 300ccacnacncc ntcnncncga ancnccnctc gcnctcngcc ccngccccct gccccccgcc 360cncnacnncg cgntcccccg cgcncgcngc ctcnccccct cccacnacag ncncacccgc 420agncacgcnc tccgcccnct gacgccccnn cccgccgcgc tcaccttcat ggnccnacng 480ccccgctcnc nccnctgcnc gccgncnngg cgccccgccc cnnccgngtn ccncncgnng 540ccccngcngn angcngtgcg cnncangncc gngccgnncn ncaccctccg nccnccgccc 600cgcccgctgg gggctcccgc cncgcggntc antccccncc cntncgccca ctntccgntc 660cnncnctcnc gctcngcgcn cgcccnccnc ccccccc 697 18 670 DNA Homo sapien misc_feature (1)...(670) n = A,T,C or G 18ctcgtgtgaa gggtgcagta cctaagccgg agcggggtag aggcgggccg gcaccccctt 60ctgacctcca gtgccgccgg cctcaagatc agacatggcc cagaacttga acgacttggc 120gggacggctg cccgccgggc cccggggcat gggcacggcc ctgaagctgt tgctgggggc 180cggcgccgtg gcctacggtg tgcgcgaatc tgtgttcacc gtggaaggcg ggcncagagc 240catcttcttc aatcggatcg gtggagtgca caggacacta tcctgggccg anggccttca 300cttcaggatc cttggttcca gtaccccanc atctatgaca ttcgggccag acctcgaaaa 360aatctcctcc ctacaggctc caaagaccta cagatggtga atatctccct gcgagtgttg 420tctcgaccaa tgctcangaa cttcctaaca tgttccancg cctaagggct ggactacnaa 480gaacgantgt tgccgtccat tgtcacgaag tgctcaagaa tttnggtggc caagttcaat 540gncctcacnn ctgatcnccc agcggggcca agttanccct ggttgatccc cgggganctg 600acnnaaaagg gccaaggact tcccctcatc ctggataatg tggccntcac aaagctcaac 660tttanccacc 670 19 606 DNA Homo sapien misc_feature (1)...(606) n = A,T,C or G 19actagtgcca acctcagctc ccaggccagt tctctgaatg tcgaggagtt ccaggatctc 60tggcctcagt tgtccttggt tattgatggg ggacaaattg gggatggcca gagccccgag 120tgtcgccttg gctcaactgt ggttgatttg tctgtgcccg gaaagtttgg catcattcgt 180ccaggctgtg ccctggaaag tactacagcc atcctccaac agaagtacgg actgctcccc 240tcacatgcgt cctacctgtg aaactctggg aagcaggaag gcccaagacc tggtgctgga 300tactatgtgt ctgtccactg acgactgtca aggcctcatt tgcagaggcc accggagcta 360gggcactagc ctgactttta aggcagtgtg tctttctgag cactgtagac caagcccttg 420gagctgctgg tttagccttg cacctgggga aaggatgtat ttatttgtat tttcatatat 480cagccaaaag ctgaatggaa aagttnagaa cattcctagg tggccttatt ctaataagtt 540tcttctgtct gttttgtttt tcaattgaaa agttattaaa taacagattt agaatctagt 600gagacc 606 20 449 DNA Homo sapien 20actagtaaac aacagcagca gaaacatcag tatcagcagc gtcgccagca ggagaatatg 60cagcgccaga gccgaggaga acccccgctc cctgaggagg acctgtccaa actcttcaaa 120ccaccacagc cgcctgccag gatggactcg ctgctcattg caggccagat aaacacttac 180tgccagaaca tcaaggagtt cactgcccaa aacttaggca agctcttcat ggcccaggct 240cttcaagaat acaacaacta agaaaaggaa gtttccagaa aagaagttaa catgaactct 300tgaagtcaca ccagggcaac tcttggaaga aatatatttg catattgaaa agcacagagg 360atttctttag tgtcattgcc gattttggct ataacagtgt ctttctagcc ataataaaat 420aaaacaaaat cttgactgct tgctcaaaa 449 21 409 DNA Homo sapien 21tatcaatcaa ctggtgaata attaaacaat gtgtggtgtg atcatacaaa gggtaccact 60caatgataaa aggaacaagc tgcctatatg tggaacaaca tggatgcatt tcagaaactt 120tatgttgagt gaaagaacaa acacggagaa catactatgt ggttctcttt atgtaacatt 180acagaaataa aaacagaggc aaccaccttt gaggcagtat ggagtgagat agactggaaa 240aaggaaggaa ggaaactcta cgctgatgga aatgtctgtg tcttcattgg gtggtagtta 300tgtggggata tacatttgtc aaaatttatt gaactatata ctaaagaact ctgcatttta 360ttgggatgta aataatacct caattaaaaa gacaaaaaaa aaaaaaaaa 409 22 649 DNA Homo sapien misc_feature (1)...(649) n = A,T,C or G 22acaattttca ttatcttaag cacattgtac atttctacag aacctgtgat tattctcgca 60tgataaggat ggtacttgca tatggtgaat tactactgtt gacagtttcc gcagaaatcc 120tatttcagtg gaccaacatt gtggcatggc agcaaatgcc aacattttgt ggaatagcag 180caaatctaca agagaccctg gttggttttt cgttttgttt tctttgtttt ttcccccttc 240tcctgaatca gcagggatgg aangagggta gggaagttat gaattactcc ttccagtagt 300agctctgaag tgtcacattt aatatcagtt ttttttaaac atgattctag ttnaatgtag 360aagagagaag aaagaggaag tgttcacttt tttaatacac tgatttagaa atttgatgtc 420ttatatcagt agttctgagg tattgatagc ttgctttatt tctgccttta cgttgacagt 480gttgaagcag ggtgaataac taggggcata tatatttttt ttttttgtaa gctgtttcat 540gatgttttct ttggaatttc cggataagtt caggaaaaca tctgcatgtt gttatctagt 600ctgaagttcn tatccatctc attacaacaa aaacncccag aacggnttg 649 23 669 DNA Homo sapien misc_feature (1)...(669) n = A,T,C or G 23actagtgccg tactggctga aatccctgca ggaccaggaa gagaaccagt tcagactttg 60tactctcagt caccagctct ggaattagat aaattccttg aagatgtcag gaatgggatc 120tatcctctga cagcctttgg gctgcctcgg ccccagcagc cacagcagga ggaggtgaca 180tcacctgtcg tgcccccctc tgtcaagact ccgacacctg aaccagctga ggtggagact 240cgcaaggtgg tgctgatgca gtgcaacatt gagtcggtgg aggagggagt caaacaccac 300ctgacacttc tgctgaagtt ggaggacaaa ctgaaccggc acctgagctg tgacctgatg 360ccaaatgaga atatccccga gttggcggct gagctggtgc agctgggctt cattagtgag 420gctgaccaga gccggttgac ttctctgcta gaagagactt gaacaagttc aattttgcca 480ggaacagtac cctcaactca gccgctgtca ccgtctcctc ttagagctca ctcgggccag 540gccctgatct gcgctgtggc tgtcctggac gtgctgcacc ctctgtcctt ccccccagtc 600agtattacct gtgaagccct tccctccttt attattcagg anggctgggg gggctccttg 660nttctaacc 669 24 442 DNA Homo sapien 24actagtacca tcttgacaga ggatacatgc tcccaaaacg tttgttacca cacttaaaaa 60tcactgccat cattaagcat cagtttcaaa attatagcca ttcatgattt actttttcca 120gatgactatc attattctag tcctttgaat ttgtaagggg aaaaaaaaca aaaacaaaaa 180cttacgatgc acttttctcc agcacatcag atttcaaatt gaaaattaaa gacatgctat 240ggtaatgcac ttgctagtac tacacacttt ggtacaacaa aaaacagagg caagaaacaa 300cggaaagaga aaagccttcc tttgttggcc cttaaactga gtcaagatct gaaatgtaga 360gatgatctct gacgatacct gtatgttctt attgtgtaaa taaaattgct ggtatgaaat 420gacctaaaaa aaaaaaaaga aa 442 25 656 DNA Homo sapien misc_feature (1)...(656) n = A,T,C or G 25tgcaagtacc acacactgtt tgaattttgc acaaaaagtg actgtaggat caggtgatag 60ccccggaatg tacagtgtct tggtgcacca agatgccttc taaaggctga cataccttgg 120accctaatgg ggcagagagt atagccctag cccagtggtg acatgaccac tccctttggg 180aggcctgagg tagaggggag tggtatgtgt tttctcagtg gaagcagcac atgagtgggt 240gacaggatgt tagataaagg ctctagttag ggtgtcattg tcatttgaga gactgacaca 300ctcctagcag ctggtaaagg ggtgctggan gccatggagg anctctagaa acattagcat 360gggctgatct gattacttcc tggcatcccg ctcactttta tgggaagtct tattagangg 420atgggacagt tttccatatc cttgctgtgg agctctggaa cactctctaa atttccctct 480attaaaaatc actgccctaa ctacacttcc tccttgaagg aatagaaatg gaactttctc 540tgacatantt cttggcatgg ggagccagcc acaaatgana atctgaacgt gtccaggttt 600ctcctganac tcatctacat agaattggtt aaaccctccc ttggaataag gaaaaa 656 26 434 DNA Homo sapien misc_feature (1)...(434) n = A,T,C or G 26actagttcag actgccacgc caaccccaga aaatacccca catgccagaa aagtgaagtc 60ctaggtgttt ccatctatgt ttcaatctgt ccatctacca ggcctcgcga taaaaacaaa 120acaaaaaaac gctgccaggt tttagaagca gttctggtct caaaaccatc aggatcctgc 180caccagggtt cttttgaaat agtaccacat gtaaaaggga atttggcttt cacttcatct 240aataactgaa ttgtcaggct ttgattgata attgtagaaa taagtagcct tctgttgtgg 300gaataagtta taatcagtat tcatctcttt gttttttgtc actcttttct ctctaattgt 360gtcatttgta ctgtttgaaa aatatttctt ctatnaaatt aaactaacct gccttaaaaa 420aaaaaaaaaa aaaa 434 27 654 DNA Homo sapien misc_feature (1)...(654) n = A,T,C or G 27actagtccaa cacagtcaga aacattgttt tgaatcctct gtaaaccaag gcattaatct 60taataaacca ggatccattt aggtaccact tgatataaaa aggatatcca taatgaatat 120tttatactgc atcctttaca ttagccacta aatacgttat tgcttgatga agacctttca 180cagaatccta tggattgcag catttcactt ggctacttca tacccatgcc ttaaagaggg 240gcagtttctc aaaagcagaa acatgccgcc agttctcaag ttttcctcct aactccattt 300gaatgtaagg gcagctggcc cccaatgtgg ggaggtccga acattttctg aattcccatt 360ttcttgttcg cggctaaatg acagtttctg tcattactta gattccgatc tttcccaaag 420gtgttgattt acaaagaggc cagctaatag cagaaatcat gaccctgaaa gagagatgaa 480attcaagctg tgagccaggc agganctcag tatggcaaag gtcttgagaa tcngccattt 540ggtacaaaaa aaattttaaa gcntttatgt tataccatgg aaccatagaa anggcaaggg 600aattgttaag aanaatttta agtgtccaga cccanaanga aaaaaaaaaa aaaa 654 28 670 DNA Homo sapien misc_feature (1)...(670) n = A,T,C or G 28cgtgtgcaca tactgggagg atttccacag ctgcacggtc acagccctta cggattgcca 60ggaaggggcg aaagatatgt gggataaact gagaaaagaa nccaaaaacc tcaacatcca 120aggcagctta ttcgaactct gcggcagcgg caacggggcg gcggggtccc tgctcccggc 180gttcccggtg ctcctggtgt ctctctcggc agctttagcg acctgncttt ccttctgagc 240gtggggccag ctccccccgc ggcgcccacc cacnctcact ccatgctccc ggaaatcgag 300aggaagatca ttagttcttt ggggacgttn gtgattctct gtgatgctga aaaacactca 360tatagggaat gtgggaaatc ctganctctt tnttatntcg tntgatttct tgtgttttat 420ttgccaaaat gttaccaatc agtgaccaac cnagcacagc caaaaatcgg acntcngctt 480tagtccgtct tcacacacag aataagaaaa cggcaaaccc accccacttt tnantttnat 540tattactaan ttttttctgt tgggcaaaag aatctcagga acngccctgg ggccnccgta 600ctanagttaa ccnagctagt tncatgaaaa atgatgggct ccncctcaat gggaaagcca 660agaaaaagnc 670 29 551 DNA Homo sapien misc_feature (1)...(551) n = A,T,C or G 29actagtcctc cacagcctgt gaatccccct agacctttca agcatagtga gcggagaaga 60agatctcagc gtttagccac cttacccatg cctgatgatt ctgtagaaaa ggtttcttct 120ccctctccag ccactgatgg gaaagtattc tccatcagtt ctcaaaatca gcaagaatct 180tcagtaccag aggtgcctga tgttgcacat ttgccacttg agaagctggg accctgtctc 240cctcttgact taagtcgtgg ttcagaagtt acagcaccgg tagcctcaga ttcctcttac 300cgtaatgaat gtcccagggc agaaaaagag gatacncaga tgcttccaaa tccttcttcc 360aaagcaatag ctgatgggaa gaggagctcc agcagcagca ggaatatcga aaacagaaaa 420aaaagtgaaa ttgggaagac aaaagctcaa cagcatttgg taaggagaaa aganaagatg 480aggaaggaag agagaagaga gacnaagatc nctacggacc gnnncggaag aagaagaagn 540aaaaaanaaa a 551 30 684 DNA Homo sapien misc_feature (1)...(684) n = A,T,C or G 30actagttcta tctggaaaaa gcccgggttg gaagaagctg tggagagtgc gtgtgcaatg 60cgagactcat ttcttggaag catccctggc aaaaatgcag ctgagtacaa ggttatcact 120gtgatagaac ctggactgct ttttgagata atagagatgc tgcagtctga agagacttcc 180agcacctctc agttgaatga attaatgatg gcttctgagt caactttact ggctcaggaa 240ccacgagaga tgactgcaga tgtaatcgag cttaaaggga aattcctcat caacttagaa 300ggtggtgata ttcgtgaaga gtcttcctat aaagtaattg tcatgccgac tacgaaagaa 360aaatgccccc gttgttggaa gtatacagcg ggagtcttca gatacactgt gtcctcgatg 420tgcagaagtt gtcagtggga aaatagtatt aacagctcac tcgagcaaga accctcctga 480cagtactggg ctagaagttt ggatggatta tttacaatat aggaaagaaa gccaagaatt 540aggtnatgag tggatgagta aatggtggan gatggggaat tcaaatcaga attatggaag 600aagttnttcc tgttactata gaaaggaatt atgtttattt acatgcagaa aatatanatg 660tgtggtgtgt accgtggatg gaan 684 31 654 DNA Homo sapien misc_feature (1)...(654) n = A,T,C or G 31gcgcagaaaa ggaaccaata tttcagaaac aagcttaata ggaacagctg cctgtacatc 60aacatcttct cagaatgacc cagaagttat catcgtggga gctggcgtgc ttggctctgc 120tttggcagct gtgctttcca gagatggaag aaaggtgaca gtcattgaga gagacttaaa 180agagcctgac agaatagttg gagaattcct gcagccgggt ggttatcatg ttctcaaaga 240ccttggtctt ggagatacag tggaaggtct tgatgcccag gttgtaaatg gttacatgat 300tcatgatcag ggaaagcaaa tcagangttc agattcctta ccctctgtca gaaaacaatc 360aagtgcagag tggaagagct ttccatcacg gaagattcat catgagtctc cggaaagcag 420ctatggcaga gcccaatgca aagtttattg aaggtgttgt gttacagtta ttagaggaag 480atgatgttgt gatgggagtt cagtacaagg ataaagagac tgggagatat caaggaactc 540catgctccac tgactgttgt tgcagatggg cttttctcca anttcaggaa aagcctggtc 600tcaataaagt ttctgtatca ctcatttggt tggcttctta tgaagaatgc nccc 654 32 673 DNA Homo sapien misc_feature (1)...(673) n = A,T,C or G 32actagtgaag aaaaagaaat tctgatacgg gacaaaaatg ctcttcaaaa catcattctt 60tatcacctga caccaggagt tttcattgga aaaggatttg aacctggtgt tactaacatt 120ttaaagacca cacaaggaag caaaatcttt ctgaaagaag taaatgatac acttctggtg 180aatgaattga aatcaaaaga atctgacatc atgacaacaa atggtgtaat tcatgttgta 240gataaactcc tctatccagc agacacacct gttggaaatg atcaactgct ggaaatactt 300aataaattaa tcaaatacat ccaaattaag tttgttcgtg gtagcacctt caaagaaatc 360cccgtgactg tctatnagcc aattattaaa aaatacacca aaatcattga tgggagtgcc 420tgtgggaaat aactgaaaaa gagaccgaga agaacgaatc attacaggtc ctgaaataaa 480atacctagga tttctactgg aggtggagaa acagaagaac tctgaagaaa ttgttacaag 540aagangtccc aaggtcacca aattcattga aggtggtgat ggtctttatt tgaagatgaa 600gaaattaaaa gacgcttcag ggagacnccc catgaaggaa ttgccagcca caaaaaaatt 660cagggattag aaa 673 33 673 DNA Homo sapien misc_feature (1)...(673) n = A,T,C or G 33actagttatt tactttcctc cgcttcagaa ggtttttcag actgagagcc taagcatact 60ggatctgttg tttcttttgg gtctcacctc atcagtgtgc atagtggcag aaattataaa 120gaaggttgaa aggagcaggg aaaagatcca gaagcatgtt agttcgacat catcatcttt 180tcttgaagta tgatgcatat tgcattattt tatttgcaaa ctaggaattg cagtctgagg 240atcatttaga agggcaagtt caagaggata tgaagatttg agaacttttt aactattcat 300tgactaaaaa tgaacattaa tgttnaagac ttaagacttt aacctgctgg cagtcccaaa 360tgaaattatg caactttgat atcatattcc ttgatttaaa ttgggctttt gtgattgant 420gaaactttat aaagcatatg gtcagttatt tnattaaaaa ggcaaaacct gaaccacctt 480ctgcacttaa agaagtctaa cagtacaaat acctatctat cttagatgga tntatttntt 540tntattttta aatattgtac tatttatggt nggtggggct ttcttactaa tacacaaatn 600aatttatcat ttcaanggca ttctatttgg gtttagaagt tgattccaag nantgcatat 660ttcgctactg tnt 673 34 684 DNA Homo sapien misc_feature (1)...(684) n = A,T,C or G 34actagtttat tcaagaaaag aacttactga ttcctctgtt cctaaagcaa gagtggcagg 60tgatcagggc tggtgtagca tccggttcct ttagtgcagc taactgcatt tgtcactgat 120gaccaaggag gaaatcacta agacatttga gaagcagtgg tatgaacgtt cttggacaag 180ccacagttct gagccttaac cctgtagttt gcacacaaga acgagctcca cctccccttc 240ttcaggagga atctgtgcgg atagattggc tggacttttc aatggttctg ggttgcaagt 300gggcactgtt atggctgggt atggagcgga cagccccagg aatcagagcc tcagcccggc 360tgcctggttg gaaggtacag gtgttcagca ccttcggaaa aagggcataa agtngtgggg 420gacaattctc agtccaagaa gaatgcattg accattgctg gctatttgct tncctagtan 480gaattggatn catttttgac cangatnntt ctnctatgct ttnttgcaat gaaatcaaat 540cccgcattat ctacaagtgg tatgaagtcc tgcnnccccc agagaggctg ttcaggcnat 600gtcttccaag ggcagggtgg gttacaccat tttacctccc ctctcccccc agattatgna 660cncagaagga atttntttcc tccc 684 35 614 DNA Homo sapien misc_feature (1)...(614) n = A,T,C or G 35actagtccaa cgcgttngcn aatattcccc tggtagccta cttccttacc cccgaatatt 60ggtaagatcg agcaatggct tcaggacatg ggttctcttc tcctgtgatc attcaagtgc 120tcactgcatg aagactggct tgtctcagtg tntcaacctc accagggctg tctcttggtc 180cacacctcgc tccctgttag tgccgtatga cagcccccat canatgacct tggccaagtc 240acggtttctc tgtggtcaat gttggtnggc tgattggtgg aaagtanggt ggaccaaagg 300aagncncgtg agcagncanc nccagttctg caccagcagc gcctccgtcc tactngggtg 360ttccngtttc tcctggccct gngtgggcta nggcctgatt cgggaanatg cctttgcang 420gaaggganga taantgggat ctaccaattg attctggcaa aacnatntct aagattnttn 480tgctttatgt ggganacana tctanctctc atttnntgct gnanatnaca ccctactcgt 540gntcgancnc gtcttcgatt ttcgganaca cnccantnaa tactggcgtt ctgttgttaa 600aaaaaaaaaa aaaa 614 36 686 DNA Homo sapien misc_feature (1)...(686) n = A,T,C or G 36gtggctggcc cggttctccg cttctcccca tcccctactt tcctccctcc ctccctttcc 60ctccctcgtc gactgttgct tgctggtcgc agactccctg acccctccct cacccctccc 120taacctcggt gccaccggat tgcccttctt ttcctgttgc ccagcccagc cctagtgtca 180gggcgggggc ctggagcagc ccgaggcact gcagcagaag ananaaaaga cacgacnaac 240ctcagctcgc cagtccggtc gctngcttcc cgccgcatgg caatnagaca gacgccgctc 300acctgctctg ggcacacgcg acccgtggtt gatttggcct tcagtggcat cacccttatg 360ggtatttctt aatcagcgct tgcaaagatg gttaacctat gctacgccag ggagatacag 420gagactggat tggaacattt ttggggtcta aaggtctgtt tggggtgcaa cactgaataa 480ggatgccacc aaagcagcta cagcagctgc agatttcaca gcccaagtgt gggatgctgt 540ctcagganat naattgataa cctggctcat aacacattgt caagaatgtg gatttcccca 600ggatattatt atttgtttac cggggganag gataactgtt tcncntattt taattgaaca 660aactnaaaca aaanctaagg aaatcc 686 37 681 DNA Homo sapien misc_feature (1)...(681) n = A,T,C or G 37gagacanacn naacgtcang agaanaaaag angcatggaa cacaanccag gcncgatggc 60caccttccca ccagcancca gcgcccccca gcngccccca ngnccggang accangactc 120cancctgnat caatctganc tctattcctg gcccatncct acctcggagg tggangccgn 180aaaggtcgca cnnncagaga agctgctgcc ancaccancc gccccnnccc tgncgggctn 240nataggaaac tggtgaccnn gctgcanaat tcatacagga gcacgcgang ggcacnnnct 300cacactgagt tnnngatgan gcctnaccan ggacctnccc cagcnnattg annacnggac 360tgcggaggaa ggaagacccc gnacnggatc ctggccggcn tgccaccccc ccacccctag 420gattatnccc cttgactgag tctctgaggg gctacccgaa cccgcctcca ttccctacca 480natnntgctc natcgggact gacangctgg ggatnggagg ggctatcccc cancatcccc 540tnanaccaac agcnacngan natnggggct ccccngggtc ggngcaacnc tcctncaccc 600cggcgcnggc cttcggtgnt gtcctccntc aacnaattcc naaanggcgg gccccccngt 660ggactcctcn ttgttccctc c 681 38 687 DNA Homo sapien misc_feature (1)...(687) n = A,T,C or G 38canaaaaaaa aaaacatggc cgaaaccagn aagctgcgcg atggcgccac ggcccctctt 60ctcccggcct gtgtccggaa ggtttccctc cgaggcgccc cggctcccgc aagcggagga 120gagggcggga cntgccgggg ccggagctca naggccctgg ggccgctctg ctctcccgcc 180atcgcaaggg cggcgctaac ctnaggcctc cccgcaaagg tccccnangc ggnggcggcg 240gggggctgtg anaaccgcaa aaanaacgct gggcgcgcng cgaacccgtc cacccccgcg 300aaggananac ttccacagan gcagcgtttc cacagcccan agccacnttt ctagggtgat 360gcaccccagt aagttcctgn cggggaagct caccgctgtc aaaaaanctc ttcgctccac 420cggcgcacna aggggangan ggcangangc tgccgcccgc acaggtcatc tgatcacgtc 480gcccgcccta ntctgctttt gtgaatctcc actttgttca accccacccg ccgttctctc 540ctccttgcgc cttcctctna ccttaanaac cagcttcctc tacccnatng tanttnctct 600gcncnngtng aaattaattc ggtccnccgg aacctcttnc ctgtggcaac tgctnaaaga 660aactgctgtt ctgnttactg cngtccc 687 39 695 DNA Homo sapien misc_feature (1)...(695) n = A,T,C or G 39actagtctgg cctacaatag tgtgattcat gtaggacttc tttcatcaat tcaaaacccc 60tagaaaaacg tatacagatt atataagtag ggataagatt tctaacattt ctgggctctc 120tgacccctgc gctagactgt ggaaagggag tattattata gtatacaaca ctgctgttgc 180cttattagtt ataacatgat aggtgctgaa ttgtgattca caatttaaaa acactgtaat 240ccaaactttt ttttttaact gtagatcatg catgtgaatg ttaatgttaa tttgttcaan 300gttgttatgg gtagaaaaaa ccacatgcct taaaatttta aaaagcaggg cccaaactta 360ttagtttaaa attaggggta tgtttccagt ttgttattaa ntggttatag ctctgtttag 420aanaaatcna ngaacangat ttngaaantt aagntgacat tatttnccag tgacttgtta 480atttgaaatc anacacggca ccttccgttt tggtnctatt ggnntttgaa tccaancngg 540ntccaaatct tnttggaaac ngtccnttta acttttttac nanatcttat ttttttattt 600tggaatggcc ctatttaang ttaaaagggg ggggnnccac naccattcnt gaataaaact 660naatatatat ccttggtccc ccaaaattta aggng 695 40 674 DNA Homo sapien misc_feature (1)...(674) n = A,T,C or G 40actagtagtc agttgggagt ggttgctata ccttgacttc atttatatga atttccactt 60tattaaataa tagaaaagaa aatcccggtg cttgcagtag agttatagga cattctatgc 120ttacagaaaa tatagccatg attgaaatca aatagtaaag gctgttctgg ctttttatct 180tcttagctca tcttaaataa gtagtacact tgggatgcag tgcgtctgaa gtgctaatca 240gttgtaacaa tagcacaaat cgaacttagg atgtgtttct tctcttctgt gtttcgattt 300tgatcaattc tttaattttg ggaacctata atacagtttt cctattcttg gagataaaaa 360ttaaatggat cactgatatt taagtcattc tgcttctcat ctnaatattc catattctgt 420attagganaa antacctccc agcacagccc cctctcaaac cccacccaaa accaagcatt 480tggaatgagt ctcctttatt tccgaantgt ggatggtata acccatatcn ctccaatttc 540tgnttgggtt gggtattaat ttgaactgtg catgaaaagn ggnaatcttt nctttgggtc 600aaantttncc ggttaatttg nctngncaaa tccaatttnc tttaagggtg tctttataaa 660atttgctatt cngg 674 41 657 DNA Homo sapien misc_feature (1)...(657) n = A,T,C or G 41gaaacatgca agtaccacac actgtttgaa ttttgcacaa aaagtgactg tagggatcag 60gtgatagccc cggaatgtac agtgtcttgg tgcaccaaga tgccttctaa aggctgacat 120accttgggac cctaatgggg cagagagtat agccctagcc cagtggtgac atgaccactc 180cctttgggag gctgaagtta aagggaatgg tatgtgtttt ctcatggaag cagcacatga 240atnggtnaca ngatgttaaa ntaaggntct antttgggtg tcttgtcatt tgaaaaantg 300acacactcct ancanctggt aaaggggtgc tggaagccat ggaagaactc taaaaacatt 360agcatgggct gatctgatta cttcctggca tcccgctcac ttttatggga agtcttatta 420naaggatggg ananttttcc atatccttgc tgttggaact ctggaacact ctctaaattt 480ccctctatta aaaatcactg nccttactac acttcctcct tganggaata gaaatggacc 540tttctctgac ttagttcttg gcatggganc cagcccaaat taaaatctga cttntccggt 600ttctccngaa ctcacctact tgaattggta aaacctcctt tggaattagn aaaaacc 657 42 389 DNA Homo sapien misc_feature (1)...(389) n = A,T,C or G 42actagtgctg aggaatgtaa acaagtttgc tgggccttgc gagacttcac caggttgttt 60cgatagctca cactcctgca ctgtgcctgt cacccaggaa tgtctttttt aattagaaga 120caggaagaaa acaaaaacca gactgtgtcc cacaatcaga aacctccgtt gtggcagang 180ggccttcacc gccaccaggg tgtcccgcca gacagggaga gactccagcc ttctgaggcc 240atcctgaaga attcctgttt gggggttgtg aaggaaaatc acccggattt aaaaagatgc 300tgttgcctgc ccgcgtngtn gggaagggac tggtttcctg gtgaatttct taaaagaaaa 360atattttaag ttaagaaaaa aaaaaaaaa 389 43 279 DNA Homo sapien 43actagtgaca agctcctggt cttgagatgt cttctcgtta aggagatggg ccttttggag 60gtaaaggata aaatgaatga gttctgtcat gattcactat tctagaactt gcatgacctt 120tactgtgtta gctctttgaa tgttcttgaa attttagact ttctttgtaa acaaataata 180tgtccttatc attgtataaa agctgttatg tgcaacagtg tggagatcct tgtctgattt 240aataaaatac ttaaacactg aaaaaaaaaa aaaaaaaaa 279 44 449 DNA Homo sapien misc_feature (1)...(449) n = A,T,C or G 44actagtagca tcttttctac aacgttaaaa ttgcagaagt agcttatcat taaaaaacaa 60caacaacaac aataacaata aatcctaagt gtaaatcagt tattctaccc cctaccaagg 120atatcagcct gttttttccc ttttttctcc tgggaataat tgtgggcttc ttcccaaatt 180tctacagcct ctttcctctt ctcatgcttg agcttccctg tttgcacgca tgcgttgtgc 240aagantgggc tgtttngctt ggantncggt ccnagtggaa ncatgctttc ccttgttact 300gttggaagaa actcaaacct tcnancccta ggtgttncca ttttgtcaag tcatcactgt 360atttttgtac tggcattaac aaaaaaagaa atnaaatatt gttccattaa actttaataa 420aactttaaaa gggaaaaaaa aaaaaaaaa 449 45 559 DNA Homo sapien misc_feature (1)...(559) n = A,T,C or G 45actagtgtgg gggaatcacg gacacttaaa gtcaatctgc gaaataattc ttttattaca 60cactcactga agtttttgag tcccagagag ccattctatg tcaaacattc caagtactct 120ttgagagccc agcattacat caacatgccc gtgcagttca aaccgaagtc cgcaggcaaa 180tttgaagctt tgcttgtcat tcaaacagat gaaggcaaga gtattgctat tcgactaatt 240ggtgaagctc ttggaaaaaa ttnactagaa tactttttgt gttaagttaa ttacataagt 300tgtattttgt taactttatc tttctacact acaattatgc ttttgtatat atattttgta 360tgatggatat ctataattgt agattttgtt tttacaagct aatactgaag actcgactga 420aatattatgt atctagccca tagtattgta cttaactttt acagggtgaa aaaaaaattc 480tgtgtttgca ttgattatga tattctgaat aaatatggga atatatttta atgtgggtaa 540aaaaaaaaaa aaaaaggaa 559 46 731 DNA Homo sapien misc_feature (1)...(731) n = A,T,C or G 46actagttcta gtaccatggc tgtcatagat gcaaccatta tattccattt agtttcttcc 60tcaggttccc taacaattgt ttgaaactga atatatatgt ttatgtatgt gtgtgtgttc 120actgtcatgt atatggtgta tatgggatgt gtgcagtttt cagttatata tatattcata 180tatacatatg catatatatg tataatatac atatatacat gcatacactt gtataatata 240catatatata cacatatatg cacacatatn atcactgagt tccaaagtga gtctttattt 300ggggcaattg tattctctcc ctctgtctgc tcactgggcc tttgcaagac atagcaattg 360cttgatttcc tttggataag agtcttatct tcggcactct tgactctagc cttaacttta 420gatttctatt ccagaatacc tctcatatct atcttaaaac ctaaganggg taaagangtc 480ataagattgt agtatgaaag antttgctta gttaaattat atctcaggaa actcattcat 540ctacaaatta aattgtaaaa tgatggtttg ttgtatctga aaaaatgttt agaacaagaa 600atgtaactgg gtacctgtta tatcaaagaa cctcnattta ttaagtctcc tcatagccan 660atccttatat ngccctctct gacctgantt aatananact tgaataatga atagttaatt 720taggnttggg c 731 47 640 DNA Homo sapien misc_feature (1)...(640) n = A,T,C or G 47tgcgngccgg tttggccctt ctttgtanga cactttcatc cgccctgaaa tcttcccgat 60cgttaataac tcctcaggtc cctgcctgca cagggttttt tcttantttg ttgcctaaca 120gtacaccaaa tgtgacatcc tttcaccaat atngattnct tcataccaca tcntcnatgg 180anacgactnc aacaattttt tgatnacccn aaanactggg ggctnnaana agtacantct 240ggagcagcat ggacctgtcn gcnactaang gaacaanagt nntgaacatt tacacaacct 300ttggtatgtc ttactgaaag anagaaacat gcttctnncc ctagaccacg aggncaaccg 360caganattgc caatgccaag tccgagcggt tagatcaggt aatacattcc atggatgcat 420tacatacntt gtccccgaaa nanaagatgc cctaanggct tcttcanact ggtccngaaa 480acanctacac ctggtgcttg ganaacanac tctttggaag atcatctggc acaagttccc 540cccagtgggt tttnccttgg cacctanctt accanatcna ttcggaancc attctttgcc 600ntggcnttnt nttgggacca ntcttctcac aactgnaccc 640 48 257 DNA Homo sapien 48actagtatat gaaaatgtaa atatcacttg tgtactcaaa caaaagttgg tcttaagctt 60ccaccttgag cagccttgga aacctaacct gcctctttta gcataatcac attttctaaa 120tgattttctt tgttcctgaa aaagtgattt gtattagttt tacatttgtt ttttggaaga 180ttatatttgt atatgtatca tcataaaata tttaaataaa aagtatcttt agagtgaaaa 240aaaaaaaaaa aaaaaaa 257 49 652 DNA Homo sapien misc_feature (1)...(652) n = A,T,C or G 49actagttcag atgagtggct gctgaagggg cccccttgtc attttcatta taacccaatt 60tccacttatt tgaactctta agtcataaat gtataatgac ttatgaatta gcacagttaa 120gttgacacta gaaactgccc atttctgtat tacactatca aataggaaac attggaaaga 180tggggaaaaa aatcttattt taaaatggct tagaaagttt tcagattact ttgaaaattc 240taaacttctt tctgtttcca aaacttgaaa atatgtagat ggactcatgc attaagactg 300ttttcaaagc tttcctcaca tttttaaagt gtgattttcc ttttaatata catatttatt 360ttctttaaag cagctatatc ccaacccatg actttggaga tatacctatn aaaccaatat 420aacagcangg ttattgaagc agctttctca aatgttgctt cagatgtgca agttgcaaat 480tttattgtat ttgtanaata caatttttgt tttaaactgt atttcaatct atttctccaa 540gatgcttttc atatagagtg aaatatccca ngataactgc ttctgtgtcg tcgcatttga 600cgcataactg cacaaatgaa cagtgtatac ctcttggttg tgcattnacc cc 652 50 650 DNA Homo sapien misc_feature (1)...(650) n = A,T,C or G 50ttgcgctttg atttttttag ggcttgtgcc ctgtttcact tatagggtct agaatgcttg 60tgttgagtaa aaaggagatg cccaatattc aaagctgcta aatgttctct ttgccataaa 120gactccgtgt aactgtgtga acacttggga tttttctcct ctgtcccgag gtcgtcgtct 180gctttctttt ttgggttctt tctagaagat tgagaaatgc atatgacagg ctgagancac 240ctccccaaac acacaagctc tcagccacan gcagcttctc cacagcccca gcttcgcaca 300ggctcctgga nggctgcctg ggggaggcag acatgggagt gccaaggtgg ccagatggtt 360ccaggactac aatgtcttta tttttaactg tttgccactg ctgccctcac ccctgcccgg 420ctctggagta ccgtctgccc canacaagtg ggantgaaat gggggtgggg gggaacactg 480attcccantt agggggtgcc taactgaaca gtagggatan aaggtgtgaa cctgngaant 540gcttttataa attatnttcc ttgttanatt tattttttaa tttaatctct gttnaactgc 600ccngggaaaa ggggaaaaaa aaaaaaaaat tctntttaaa cacatgaaca 650 51 545 DNA Homo sapien misc_feature (1)...(545) n = A,T,C or G 51tggcgtgcaa ccagggtagc tgaagtttgg gtctgggact ggagattggc cattaggcct 60cctganattc cagctccctt ccaccaagcc cagtcttgct acgtggcaca gggcaaacct 120gactcccttt gggcctcagt ttcccctccc cttcatgana tgaaaagaat actacttttt 180cttgttggtc taacnttgct ggacncaaag tgtngtcatt attgttgtat tgggtgatgt 240gtncaaaact gcagaagctc actgcctatg agaggaanta agagagatag tggatganag 300ggacanaagg agtcattatt tggtatagat ccacccntcc caacctttct ctcctcagtc 360cctgcncctc atgtntctgg tntggtgagt cctttgtgcc accanccatc atgctttgca 420ttgctgccat cctgggaagg gggtgnatcg tctcacaact tgttgtcatc gtttganatg 480catgctttct tnatnaaaca aanaaannaa tgtttgacag ngtttaaaat aaaaaanaaa 540caaaa 545 52 678 DNA Homo sapien misc_feature (1)...(678) n = A,T,C or G 52actagtagaa gaactttgcc gcttttgtgc ctctcacagg cgcctaaagt cattgccatg 60ggaggaagac gatttggggg gggagggggg gggggcangg tccgtggggc tttccctant 120ntatctccat ntccantgnn cnntgtcgcc tcttccctcg tcncattnga anttantccc 180tggnccccnn nccctctccn ncctncncct cccccctccg ncncctccnn ctttttntan 240ncttccccat ctccntcccc cctnanngtc ccaacnccgn cagcaatnnc ncacttnctc 300nctccncncc tccnnccgtt cttctnttct cnacntntnc ncnnntnccn tgccnntnaa 360annctctccc cnctgcaanc gattctctcc ctccncnnan ctntccactc cntncttctc 420ncncgctcct nttcntcnnc ccacctctcn ccttcgnccc cantacnctc nccncccttn 480cgnntcnttn nnntcctcnn accncccncc tcccttcncc cctcttctcc ccggtntntc 540tctctcccnc nncncnncct cnncccntcc nngcgnccnt ttccgccccn cnccnccntt 600ccttcntcnc cantccatcn cntntnccat nctncctncc nctcacnccc gctncccccn 660ntctctttca cacngtcc 678 53 502 DNA Homo sapien misc_feature (1)...(502) n = A,T,C or G 53tgaagatcct ggtgtcgcca tgggccgccg ccccgcccgt tgttaccggt attgtaagaa 60caagccgtac ccaaagtctc gcttctgccg aggtgtccct gatgccaaaa ttcgcatttt 120tgacctgggg cggaaaaang caaaantgga tgagtctccg ctttgtggcc acatggtgtc 180agatcaatat gagcagctgt cctctgaagc cctgnangct gcccgaattt gtgccaataa 240gtacatggta aaaagtngtg gcnaagatgc ttccatatcc gggtgcggnt ccaccccttc 300cacgtcatcc gcatcaacaa gatgttgtcc tgtgctgggg ctgacaggct cccaacaggc 360atgcgaagtg cctttggaaa acccanggca ctgtggccag ggttcacatt gggccaattn 420atcatgttca tccgcaccaa ctgcagaaca angaacntgt naattnaagc cctgcccagg 480gncaanttca aatttcccgg cc 502 54 494 DNA Homo sapien misc_feature (1)...(494) n = A,T,C or G 54actagtccaa gaaaaatatg cttaatgtat attacaaagg ctttgtatat gttaacctgt 60tttaatgcca aaagtttgct ttgtccacaa tttccttaag acctcttcag aaagggattt 120gtttgcctta atgaatactg ttgggaaaaa acacagtata atgagtgaaa agggcagaag 180caagaaattt ctacatctta gcgactccaa gaagaatgag tatccacatt tagatggcac 240attatgagga ctttaatctt tccttaaaca caataatgtt ttcttttttc ttttattcac 300atgatttcta agtatatttt tcatgcagga cagtttttca accttgatgt acagtgactg 360tgttaaattt ttctttcagt ggcaacctct ataatcttta aaatatggtg agcatcttgt 420ctgttttgaa ngggatatga cnatnaatct atcagatggg aaatcctgtt tccaagttag 480aaaaaaaaaa aaaa 494 55 606 DNA Homo sapien misc_feature (1)...(606) n = A,T,C or G 55actagtaaaa agcagcattg ccaaataatc cctaattttc cactaaaaat ataatgaaat 60gatgttaagc tttttgaaaa gtttaggtta aacctactgt tgttagatta atgtatttgt 120tgcttccctt tatctggaat gtggcattag cttttttatt ttaaccctct ttaattctta 180ttcaattcca tgacttaagg ttggagagct aaacactggg atttttggat aacagactga 240cagttttgca taattataat cggcattgta catagaaagg atatggctac cttttgttaa 300atctgcactt tctaaatatc aaaaaaggga aatgaagtat aaatcaattt ttgtataatc 360tgtttgaaac atgantttta tttgcttaat attanggctt tgcccttttc tgttagtctc 420ttgggatcct gtgtaaaact gttctcatta aacaccaaac agttaagtcc attctctggt 480actagctaca aattccgttt catattctac ntaacaattt aaattaactg aaatatttct 540anatggtcta cttctgtcnt ataaaaacna aacttgantt nccaaaaaaa aaaaaaaaaa 600aaaaaa 606 56 183 DNA Homo sapien 56actagtatat ttaaacttac aggcttattt gtaatgtaaa ccaccatttt aatgtactgt 60aattaacatg gttataatac gtacaatcct tccctcatcc catcacacaa ctttttttgt 120gtgtgataaa ctgattttgg tttgcaataa aaccttgaaa aataaaaaaa aaaaaaaaaa 180aaa 183 57 622 DNA Homo sapien misc_feature (1)...(622) n = A,T,C or G 57actagtcact actgtcttct ccttgtagct aatcaatcaa tattcttccc ttgcctgtgg 60gcagtggaga gtgctgctgg gtgtacgctg cacctgccca ctgagttggg gaaagaggat 120aatcagtgag cactgttctg ctcagagctc ctgatctacc ccacccccta ggatccagga 180ctgggtcaaa gctgcatgaa accaggccct ggcagcaacc tgggaatggc tggaggtggg 240agagaacctg acttctcttt ccctctccct cctccaacat tactggaact ctatcctgtt 300agggatcttc tgagcttgtt tccctgctgg gtgggacaga agacaaagga gaagggangg 360tctacaanaa gcagcccttc tttgtcctct ggggttaatg agcttgacct ananttcatg 420gaganaccan aagcctctga tttttaattt ccntnaaatg tttgaagtnt atatntacat 480atatatattt ctttnaatnt ttgagtcttt gatatgtctt aaaatccant ccctctgccn 540gaaacctgaa ttaaaaccat gaanaaaaat gtttncctta aagatgttan taattaattg 600aaacttgaaa aaaaaaaaaa aa 622 58 433 DNA Homo sapien 58gaacaaattc tgattggtta tgtaccgtca aaagacttga agaaatttca tgattttgca 60gtgtggaagc gttgaaaatt gaaagttact gcttttccac ttgctcatat agtaaaggga 120tcctttcagc tgccagtgtt gaataatgta tcatccagag tgatgttatc tgtgacagtc 180accagcttta agctgaacca ttttatgaat accaaataaa tagacctctt gtactgaaaa 240catatttgtg actttaatcg tgctgcttgg atagaaatat ttttactggt tcttctgaat 300tgacagtaaa cctgtccatt atgaatggcc tactgttcta ttatttgttt tgacttgaat 360ttatccacca aagacttcat ttgtgtatca tcaataaagt tgtatgtttc aactgaaaaa 420aaaaaaaaaa aaa 433 59 649 DNA Homo sapien misc_feature (1)...(649) n = A,T,C or G 59actagttatt atctgacttt cnggttataa tcattctaat gagtgtgaag tagcctctgg 60tgtcatttgg atttgcattt ctctgatgag tgatgctatc aagcaccttt gctggtgctg 120ttggccatat gtgtatgttc cctggagaag tgtctgtgct gagccttggc ccacttttta 180attaggcgtn tgtcttttta ttactgagtt gtaaganttc tttatatatt ctggattcta 240gacccttatc agatacatgg tttgcaaata ttttctccca ttctgtgggt tgtgttttca 300ctttatcgat aatgtcctta gacatataat aaatttgtat tttaaaagtg acttgatttg 360ggctgtgcaa ggtgggctca cgcttgtaat cccagcactt tgggagactg aggtgggtgg 420atcatatgan gangctagga gttcgaggtc agcctggcca gcatagcgaa aacttgtctc 480tacnaaaaat acaaaaatta gtcaggcatg gtggtgcacg tctgtaatac cagcttctca 540ggangctgan gcacaaggat cacttgaacc ccagaangaa gangttgcag tganctgaag 600atcatgccag ggcaacaaaa atgagaactt gtttaaaaaa aaaaaaaaa 649 60 423 DNA Homo sapien misc_feature (1)...(423) n = A,T,C or G 60actagttcag gccttccagt tcactgacaa acatggggaa gtgtgcccag ctggctggaa 60acctggcagt gataccatca agcctgatgt ccaaaagagc aaagaatatt tctccaagca 120gaagtgagcg ctgggctgtt ttagtgccag gctgcggtgg gcagccatga gaacaaaacc 180tcttctgtat tttttttttc cattagtana acacaagact cngattcagc cgaattgtgg 240tgtcttacaa ggcagggctt tcctacaggg ggtgganaaa acagcctttc ttcctttggt 300aggaatggcc tgagttggcg ttgtgggcag gctactggtt tgtatgatgt attagtagag 360caacccatta atcttttgta gtttgtatna aacttganct gagaccttaa acaaaaaaaa 420aaa 423 61 423 DNA Homo sapien misc_feature (1)...(423) n = A,T,C or G 61cgggactgga atgtaaagtg aagttcggag ctctgagcac gggctcttcc cgccgggtcc 60tccctcccca gaccccagag ggagaggccc accccgccca gccccgcccc agcccctgct 120caggtctgag tatggctggg agtcgggggc cacaggcctc tagctgtgct gctcaagaag 180actggatcag ggtanctaca agtggccggg ccttgccttt gggattctac cctgttccta 240atttggtgtt ggggtgcggg gtccctggcc cccttttcca cactncctcc ctccngacag 300caacctccct tggggcaatt gggcctggnt ctccncccgn tgttgcnacc ctttgttggt 360ttaaggnctt taaaaatgtt annttttccc ntgccngggt taaaaaagga aaaaactnaa 420aaa 423 62 683 DNA Homo sapien misc_feature (1)...(683) n = A,T,C or G 62gctggagagg ggtacggact ttcttggagt tgtcccaggt tggaatgaga ctgaactcaa 60gaagagaccc taagagactg gggaatggtt cctgccttca ggaaagtgaa agacgcttag 120gctgtcaaca cttaaaggaa gtccccttga agcccagagt ggacagacta gacccattga 180tggggccact ggccatggtc cgtggacaag acattccngt gggccatggc acaccggggg 240ggatcaaaat gtgtacttgt ggggtctcgc cccttgccaa aaccaaacca ntcccactcc 300tgtcnttgga ctttcttccc attccctcct ccccaaatgc acttcccctc ctccctctgc 360ccctcctgtg tttttggaat tctgtttccc tcaaaattgt taatttttta nttttngacc 420atgaacttat gtttggggtc nangttcccc ttnccaatgc atactaatat attaatggtt 480atttattttt gaaatatttt ttaatgaact tggaaaaaat tnntggaatt tccttncttc 540cnttttnttt ggggggggtg gggggntggg ttaaaatttt tttggaancc cnatnggaaa 600ttnttacttg gggcccccct naaaaaantn anttccaatt cttnnatngc ccctnttccn 660ctaaaaaaaa ananannaaa aan 683 63 731 DNA Homo sapien misc_feature (1)...(731) n = A,T,C or G 63actagtcata aagggtgtgc gcgtcttcga cgtggcggtc ttggcgccac tgctgcgaga 60cccggccctg gacctcaagg tcatccactt ggtgcgtgat ccccgcgcgg tggcgagttc 120acggatccgc tcgcgccacg gcctcatccg tgagagccta caggtggtgc gcagccgaga 180ccgcgagctc accgcatgcc cttcttggag gccgcgggcc acaagcttgg cgcccanaaa 240gaaggcgtng ggggcccgca aantaccacg ctctgggcgc tatggaangt cctcttgcaa 300taatattggt tnaaaanctg canaanagcc cctgcanccc cctgaactgg gntgcagggc 360cncttacctn gtttggntgc ggttacaaag aacctgtttn ggaaaaccct nccnaaaacc 420ttccgggaaa attntncaaa tttttnttgg ggaattnttg ggtaaacccc ccnaaaatgg 480gaaacntttt tgccctnnaa antaaaccat tnggttccgg gggccccccc ncaaaaccct 540tttttntttt tttntgcccc cantnncccc ccggggcccc tttttttngg ggaaaanccc 600cccccctncc nanantttta aaagggnggg anaatttttn nttncccccc gggncccccn 660ggngntaaaa nggtttcncc cccccgaggg gnggggnnnc ctcnnaaacc cntntcnnna 720ccncnttttn n 731 64 313 DNA Homo sapien misc_feature (1)...(313) n = A,T,C or G 64actagttgtg caaaccacga ctgaagaaag acgaaaagtg ggaaataact tgcaacgtct 60gttagagatg gttgctacac atgttgggtc tgtagagaaa catcttgagg agcagattgc 120taaagttgat agagaatatg aagaatgcat gtcagaagat ctctcggaaa atattaaaga 180gattagagat aagtatgaga agaaagctac tctaattaag tcttctgaag aatgaagatn 240aaatgttgat catgtatata tatccatagt gaataaaatt gtctcagtaa agttgtaaaa 300aaaaaaaaaa aaa 313 65 420 DNA Homo sapien misc_feature (1)...(420) n = A,T,C or G 65actagttccc tggcaggcaa gggcttccaa ctgaggcagt gcatgtgtgg cagagagagg 60caggaagctg gcagtggcag cttctgtgtc tagggagggg tgtggctccc tccttccctg 120tctgggaggt tggagggaag aatctaggcc ttagcttgcc ctcctgccac ccttcccctt 180gtagatactg ccttaacact ccctcctctc tcagctgtgg ctgccaccca agccaggttt 240ctccgtgctc actaatttat ttccaggaaa ggtgtgtgga agacatgagc cgtgtataat 300atttgtttta acattttcat tgcaagtatt gaccatcatc cttggttgtg tatcgttgta 360acacaaatta atgatattaa aaagcatcca aacaaagccn annnnnaana nnannngaaa 420 66 676 DNA Homo sapien misc_feature (1)...(676) n = A,T,C or G 66actagtttcc tatgatcatt aaactcattc tcagggttaa gaaaggaatg taaatttctg 60cctcaatttg tacttcatca ataagttttt gaagagtgca gatttttagt caggtcttaa 120aaataaactc acaaatctgg atgcatttct aaattctgca aatgtttcct ggggtgactt 180aacaaggaat aatcccacaa tatacctagc tacctaatac atggagctgg ggctcaaccc 240actgttttta aggatttgcg cttacttgtg gctgaggaaa aataagtagt tccgagggaa 300gtagttttta aatgtgagct tatagatngg aaacagaata tcaacttaat tatggaaatt 360gttagaaacc tgttctcttg ttatctgaat cttgattgca attactattg tactggatag 420actccagccc attgcaaagt ctcagatatc ttanctgtgt agttgaattc cttggaaatt 480ctttttaaga aaaaattgga gtttnaaaga aataaacccc tttgttaaat gaagcttggc 540tttttggtga aaaanaatca tcccgcaggg cttattgttt aaaaanggaa ttttaagcct 600ccctggaaaa anttgttaat taaatgggga aaatgntggg naaaaattat ccgttagggt 660ttaaagggaa aactta 676 67 620 DNA Homo sapien misc_feature (1)...(620) n = A,T,C or G 67caccattaaa gctgcttacc aagaacttcc ccagcatttt gacttccttg tttgatagct 60gaattgtgag caggtgatag aagagccttt ctagttgaac atacagataa tttgctgaat 120acattccatt taatgaaggg gttacatctg ttacgaagct actaagaagg agcaagagca 180taggggaaaa aaatctgatc agaacgcatc aaactcacat gtgccccctc tactacaaac 240agattgtagt gctgtggtgg tttattccgt tgtgcagaac ttgcaagctg agtcactaaa 300cccaaagaga ggaaattata ggttagttaa acattgtaat cccaggaact aagtttaatt 360cacttttgaa gtgttttgtt ttttattttt ggtttgtctg atttactttg ggggaaaang 420ctaaaaaaaa agggatatca atctctaatt cagtgcccac taaaagttgt ccctaaaaag 480tctttactgg aanttatggg actttttaag ctccaggtnt tttggtcctc caaattaacc 540ttgcatgggc cccttaaaat tgttgaangg cattcctgcc tctaagtttg gggaaaattc 600ccccnttttn aaaatttgga 620 68 551 DNA Homo sapien misc_feature (1)...(551) n = A,T,C or G 68actagtagct ggtacataat cactgaggag ctatttctta acatgctttt atagaccatg 60ctaatgctag accagtattt aagggctaat ctcacacctc cttagctgta agagtctggc 120ttagaacaga cctctctgtg caataacttg tggccactgg aaatccctgg gccggcattt 180gtattggggt tgcaatgact cccaagggcc aaaagagtta aaggcacgac tgggatttct 240tctgagactg tggtgaaact ccttccaagg ctgagggggt cagtangtgc tctgggaggg 300actcggcacc actttgatat tcaacaagcc acttgaagcc caattataaa attgttattt 360tacagctgat ggaactcaat ttgaaccttc aaaactttgt tagtttatcc tattatattg 420ttaaacctaa ttacatttgt ctagcattgg atttggttcc tgtngcatat gtttttttcn 480cctatgtgct cccctccccc nnatcttaat ttaaaccnca attttgcnat tcnccnnnnn 540nannnannna a 551 69 396 DNA Homo sapien misc_feature (1)...(396) n = A,T,C or G 69cagaaatgga aagcagagtt ttcatttctg tttataaacg tctccaaaca aaaatggaaa 60gcagagtttt cattaaatcc ttttaccttt tttttttctt ggtaatcccc tcaaataaca 120gtatgtggga tattgaatgt taaagggata tttttttcta ttatttttat aattgtacaa 180aattaagcaa atgttaaaag ttttatatgc tttattaatg ttttcaaaag gtatnataca 240tgtgatacat tttttaagct tcagttgctt gtcttctggt actttctgtt atgggctttt 300ggggagccan aaaccaatct acnatctctt tttgtttgcc aggacatgca ataaaattta 360aaaaataaat aaaaactatt nagaaattga aaaaaa 396 70 536 DNA Homo sapien misc_feature (1)...(536) n = A,T,C or G 70actagtgcaa aagcaaatat aaacatcgaa aaggcgttcc tcacgttagc tgaagatatc 60cttcgaaaga cccctgtaaa agagcccaac agtgaaaatg tagatatcag cagtggagga 120ggcgtgacag gctggaagag caaatgctgc tgagcattct cctgttccat cagttgccat 180ccactacccc gttttctctt cttgctgcaa aataaaccac tctgtccatt tttaactcta 240aacagatatt tttgtttctc atcttaacta tccaagccac ctattttatt tgttctttca 300tctgtgactg cttgctgact ttatcataat tttcttcaaa caaaaaaatg tatagaaaaa 360tcatgtctgt gacttcattt ttaaatgnta cttgctcagc tcaactgcat ttcagttgtt 420ttatagtcca gttcttatca acattnaaac ctatngcaat catttcaaat ctattctgca 480aattgtataa gaataaaagt tagaatttaa caattaaaaa aaaaaaaaaa aaaaaa 536 71 865 DNA Homo sapien misc_feature (1)...(865) n = A,T,C or G 71gacaaagcgt taggagaaga anagaggcag ggaanactnc ccaggcacga tggccncctt 60cccaccagca accagcgccc cccaccagcc cccaggcccg gacgacgaag actccatcct 120ggattaatct nacctctntc gcctgnccca ttcctacctc ggaggtggag gccggaaagg 180tcncaccaag aganaanctg ctgccaacac caaccgcccc agccctggcg ggcacganag 240gaaactggtg accaatctgc agaattctna gaggaanaag cnaggggccc cgcgctnaga 300cagagctgga tatgangcca gaccatggac nctacncccn ncaatncana cgggactgcg 360gaagatggan gacccncgac nngatcaggc cngctnncca nccccccacc cctatgaatt 420attcccgctg aangaatctc tgannggctt ccannaaagc gcctccccnc cnaacgnaan 480tncaacatng ggattanang ctgggaactg naaggggcaa ancctnnaat atccccagaa 540acaanctctc ccnaanaaac tggggcncct catnggtggn accaactatt aactaaaccg 600cacgccaagn aantataaaa ggggggcccc tccncggnng accccctttt gtcccttaat 660ganggttatc cnccttgcgt accatggtnc ccnnttctgt ntgnatgttt ccnctcccct 720ccncctatnt cnagccgaac tcnnatttnc ccgggggtgc natcnantng tncncctttn 780ttngttgncc cngccctttc cgncggaacn cgtttccccg ttantaacgg cacccggggn 840aagggtgntt ggccccctcc ctccc 865 72 560 DNA Homo sapien misc_feature (1)...(560) n = A,T,C or G 72cctggacttg tcttggttcc agaacctgac gacccggcga cggcgacgtc tcttttgact 60aaaagacagt gtccagtgct ccngcctagg agtctacggg gaccgcctcc cgcgccgcca 120ccatgcccaa cttctctggc aactggaaaa tcatccgatc ggaaaacttc gangaattgc 180tcnaantgct gggggtgaat gtgatgctna ngaanattgc tgtggctgca gcgtccaagc 240cagcagtgga gatcnaacag gagggagaca ctttctacat caaaacctcc accaccgtgc 300gcaccacaaa gattaacttc nnngttgggg aggantttga ggancaaact gtggatngga 360ngcctgtnaa aacctggtga aatgggagaa tganaataaa atggtctgtg ancanaaact 420cctgaaagga gaaggccccc anaactcctg gaccngaaaa actgacccnc cnatngggga 480actgatnctt gaaccctgaa cgggcgggat ganccttttt tnttgccncc naangggttc 540tttccntttc cccaaaaaaa 560 73 379 DNA Homo sapien misc_feature (1)...(379) n = A,T,C or G 73ctggggancc ggcggtnngc nccatntcnn gncgcgaagg tggcaataaa aanccnctga 60aaccgcncaa naaacatgcc naagatatgg acgaggaaga tngngctttc nngnacaanc 120gnanngagga acanaacaaa ctcnangagc tctcaagcta atgccgcggg gaaggggccc 180ttggccacnn gtggaattaa gaaatctggc aaanngtann tgttccttgt gcctnangag 240ataagngacc ctttatttca tctgtattta aacctctctn ttccctgnca taacttcttt 300tnccacgtan agntggaant anttgttgtc ttggactgtt gtncatttta gannaaactt 360ttgttcaaaa aaaaaataa 379 74 437 DNA Homo sapien misc_feature (1)...(437) n = A,T,C or G 74actagttcag actgccacgc caaccccaga aaatacccca catgccagaa aagtgaagtc 60ctaggtgttt ccatctatgt ttcaatctgt ccatctacca ggcctcgcga taaaaacaaa 120acaaaaaaac gctgccaggt tttanaagca gttctggtct caaaaccatc aggatcctgc 180caccagggtt cttttgaaat agtaccacat gtaaaaggga atttggcttt cacttcatct 240aatcactgaa ttgtcaggct ttgattgata attgtagaaa taagtagcct tctgttgtgg 300gaataagtta taatcagtat tcatctcttt gttttttgtc actcttttct ctctnattgt 360gtcatttgta ctgtttgaaa aatatttctt ctataaaatt aaactaacct gccttaaaaa 420aaaaaaaaaa aaaaaaa 437 75 579 DNA Homo sapien misc_feature (1)...(579) n = A,T,C or G 75ctccgtcgcc gccaagatga tgtgcggggc gccctccgcc acgcagccgg ccaccgccga 60gacccagcac atcgccgacc aggtgaggtc ccagcttgaa gagaaagaaa acaagaagtt 120ccctgtgttt aaggccgtgt cattcaagag ccaggtggtc gcggggacaa actacttcat 180caaggtgcac gtcggcgacg aggacttcgt acacctgcga gtgttccaat ctctccctca 240tgaaaacaag cccttgacct tatctaacta ccagaccaac aaagccaagc atgatgagct 300gacctatttc tgatcctgac tttggacaag gcccttcagc cagaagactg acaaagtcat 360cctccgtcta ccagagcgtg cacttgtgat cctaaaataa gcttcatctc cgggctgtgc 420ccttggggtg gaaggggcan gatctgcact gcttttgcat ttctcttcct aaatttcatt 480gtgttgattc tttccttcca ataggtgatc ttnattactt tcagaatatt ttccaaatna 540gatatatttt naaaatcctt aaaaaaaaaa aaaaaaaaa 579 76 666 DNA Homo sapien misc_feature (1)...(666) n = A,T,C or G 76gtttatccta tctctccaac cagattgtca gctccttgag ggcaagagcc acagtatatt 60tccctgtttc ttccacagtg cctaataata ctgtggaact aggttttaat aattttttaa 120ttgatgttgt tatgggcagg atggcaacca gaccattgtc tcagagcagg tgctggctct 180ttcctggcta ctccatgttg gctagcctct ggtaacctct tacttattat cttcaggaca 240ctcactacag ggaccaggga tgatgcaaca tccttgtctt tttatgacag gatgtttgct 300cagcttctcc aacaataaaa agcacgtggt aaaacacttg cggatattct ggactgtttt 360taaaaaatat acagtttacc gaaaatcata ttatcttaca atgaaaagga ntttatagat 420cagccagtga acaacctttt cccaccatac aaaaattcct tttcccgaan gaaaanggct 480ttctcaataa ncctcacttt cttaanatct tacaagatag ccccganatc ttatcgaaac 540tcattttagg caaatatgan ttttattgtn cgttacttgt ttcaaaattt ggtattgtga 600atatcaatta ccacccccat ctcccatgaa anaaanggga aanggtgaan ttcntaancg 660cttaaa 666 77 396 DNA Homo sapien misc_feature (1)...(396) n = A,T,C or G 77ctgcagcccg ggggatccac taatctacca nggttatttg gcagctaatt ctanatttgg 60atcattgccc aaagttgcac ttgctggtct cttgggattt ggccttggaa aggtatcata 120catanganta tgccanaata aattccattt ttttgaaaat canctccntg gggctggttt 180tggtccacag cataacangc actgcctcct tacctgtgag gaatgcaaaa taaagcatgg 240attaagtgag aagggagact ctcagccttc agcttcctaa attctgtgtc tgtgactttc 300gaagtttttt aaacctctga atttgtacac atttaaaatt tcaagtgtac tttaaaataa 360aatacttcta atgggaacaa aaaaaaaaaa aaaaaa 396 78 793 DNA Homo sapien misc_feature (1)...(793) n = A,T,C or G 78gcatcctagc cgccgactca cacaaggcag gtgggtgagg aaatccagag ttgccatgga 60gaaaattcca gtgtcagcat tcttgctcct tgtggccctc tcctacactc tggccagaga 120taccacagtc aaacctggag ccaaaaagga cacaaaggac tctcgaccca aactgcccca 180gaccctctcc agaggttggg gtgaccaact catctggact cagacatatg aagaagctct 240atataaatcc aagacaagca acaaaccctt gatgattatt catcacttgg atgagtgccc 300acacagtcna gctttaaaga aagtgtttgc tgaaaataaa gaaatccaga aattggcaga 360gcagtttgtc ctcctcaatc tggtttatga aacaactgac aaacaccttt ctcctgatgg 420ccagtatgtc ccaggattat gtttgttgac ccatctctga cagttgaagc cgatatcctg 480ggaagatatt cnaaccgtct ctatgcttac aaactgcaga tacgctctgt tgcttgacac 540atgaaaaagc tctcaagttg ctnaaaatga attgtaagaa aaaaaatctc cagccttctg 600tctgtcggct tgaaaattga aaccagaaaa atgtgaaaaa tggctattgt ggaacanatn 660gacacctgat taggttttgg ttatgttcac cactattttt aanaaaanan nttttaaaat 720ttggttcaat tntctttttn aaacaatntg tttctacntt gnganctgat ttctaaaaaa 780aataatnttt ggc 793 79 456 DNA Homo sapien misc_feature (1)...(456) n = A,T,C or G 79actagtatgg ggtgggaggc cccacccttc tcccctaggc gctgttcttg ctccaaaggg 60ctccgtggag agggactggc agagctgang ccacctgggg ctggggatcc cactcttctt 120gcagctgttg agcgcaccta accactggtc atgcccccac ccctgctctc cgcacccgct 180tcctcccgac cccangacca ggctacttct cccctcctct tgcctccctc ctgcccctgc 240tgcctctgat cgtangaatt gangantgtc ccgccttgtg gctganaatg gacagtggca 300ggggctggaa atgggtgtgt gtgtgtgtgt gtgtgtgtgt gtgtgtgtgt gcnccccccc 360tgcaagaccg agattgaggg aaancatgtc tgctgggtgt gaccatgttt cctctccata 420aantncccct gtgacnctca naaaaaaaaa aaaaaa 456 80 284 DNA Homo sapien misc_feature (1)...(284) n = A,T,C or G 80ctttgtacct ctagaaaaga taggtattgt gtcatgaaac ttgagtttaa attttatata 60taaaactaaa agtaatgctc actttagcaa cacatactaa aattggaacc atactgagaa 120gaatagcatg acctccgtgc aaacaggaca agcaaatttg tgatgtgttg attaaaaaga 180aataaataaa tgtgtatatg tgtaacttgt atgtttatgt ggaatacaga ttgggaaata 240aaatgtattt cttactgtga aaaaaaaaaa aaaaaaaaaa aana 284 81 671 DNA Homo sapien misc_feature (1)...(671) n = A,T,C or G 81gccaccaaca ttccaagcta ccctgggtac ctttgtgcag tagaagctag tgagcatgtg 60agcaagcggt gtgcacacgg agactcatcg ttataattta ctatctgcca agagtagaaa 120gaaaggctgg ggatatttgg gttggcttgg ttttgatttt ttgcttgttt gtttgttttg 180tactaaaaca gtattatctt ttgaatatcg tagggacata agtatataca tgttatccaa 240tcaagatggc tagaatggtg cctttctgag tgtctaaaac ttgacacccc tggtaaatct 300ttcaacacac ttccactgcc tgcgtaatga agttttgatt catttttaac cactggaatt 360tttcaatgcc gtcattttca gttagatnat tttgcacttt gagattaaaa tgccatgtct 420atttgattag tcttattttt ttatttttac aggcttatca gtctcactgt tggctgtcat 480tgtgacaaag tcaaataaac ccccnaggac aacacacagt atgggatcac atattgtttg 540acattaagct ttggccaaaa aatgttgcat gtgttttacc tcgacttgct aaatcaatan 600canaaaggct ggctnataat gttggtggtg aaataattaa tnantaacca aaaaaaaaan 660aaaaaaaaaa a 671 82 217 DNA Homo sapien misc_feature (1)...(217) n = A,T,C or G 82ctgcagatgt ttcttgaatg ctttgtcaaa ttaanaaagt taaagtgcaa taatgtttga 60agacaataag tggtggtgta tcttgtttct aataagataa acttttttgt ctttgcttta 120tcttattagg gagttgtatg tcagtgtata aaacatactg tgtggtataa caggcttaat 180aaattcttta aaaggaaaaa aaaaaaaaaa aaaaaaa 217 83 460 DNA Homo sapien misc_feature (1)...(460) n = A,T,C or G 83cgcgagtggg agcaccagga tctcgggctc ggaacgagac tgcacggatt gttttaagaa 60aatggcagac aaaccagaca tgggggaaat cgccagcttc gatnaggcca agctgaanaa 120aacggagacg caggagaaga acaccctgcc gaccaaagag accattgagc angagaagcg 180gagtgaaatt tcctaagatc ctggaggatt tcctaccccc gtcctcttcg agaccccagt 240cgtgatgtgg aggaagagcc acctgcaaga tggacacgag ccacaagctg cactgtgaac 300ctgggcactc cgcgccgatg ccaccggcct gtgggtctct gaagggaccc cccccaatcg 360gactgccaaa ttctccggtt tgccccggga tattatacaa nattatttgt atgaataatg 420annataaaac acacctcgtg gcancaaana aaaaaaaaaa 460 84 323 DNA Homo sapien misc_feature (1)...(323) n = A,T,C or G 84tggtggatct tggctctgtg gagctgctgg gacgggatct aaaagactat tctggaagct 60gtggtccaan gcattttgct ggcttaacgg gtcccggaac aaaggacacc agctctctaa 120aattgaagtt tacccganat aacaatcttt tgggcagaga tgcctatttt aacaaacncc 180gtccctgcgc aacaacnaac aatctctggg aaataccggc catgaacntg ctgtctcaat 240cnancatctc tctagctgac cgatcatatc gtcccagatt actacanatc ataataattg 300atttcctgta naaaaaaaaa aaa 323 85 771 DNA Homo sapien misc_feature (1)...(771) n = A,T,C or G 85aaactgggta ctcaacactg agcagatctg ttctttgagc taaaaaccat gtgctgtacc 60aanagtttgc tcctggctgc tttgatgtca gtgctgctac tccacctctg cggcgaatca 120gaagcaagca actttgactg ctgtcttgga tacacagacc gtattcttca tcctaaattt 180attgtgggct tcacacggca gctggccaat gaaggctgtg acatcaatgc tatcatcttt 240cacacaaaga aaaagttgtc tgtgtgcgca aatccaaaac agacttgggt gaaatatatt 300gtgcgtctcc tcagtaaaaa agtcaagaac atgtaaaaac tgtggctttt ctggaatgga 360attggacata gcccaagaac agaaagaact tgctggggtt ggaggtttca cttgcacatc 420atgganggtt tagtgcttat cttatttgtg cctcctggac ttgtccaatt natgaagtta 480atcatattgc atcatanttt gctttgttta acatcacatt naaattaaac tgtattttat 540gttatttata gctntaggtt ttctgtgttt aactttttat acnaantttc ctaaactatt 600ttggtntant gcaanttaaa aattatattt ggggggggaa taaatattgg antttctgca 660gccacaagct ttttttaaaa aaccantaca nccnngttaa atggtnggtc ccnaatggtt 720tttgcttttn antagaaaat ttnttagaac natttgaaaa aaaaaaaaaa a 771 86 628 DNA Homo sapien misc_feature (1)...(628) n = A,T,C or G 86actagtttgc tttacatttt tgaaaagtat tatttttgtc caagtgctta tcaactaaac 60cttgtgttag gtaagaatgg aatttattaa gtgaatcagt gtgacccttc ttgtcataag 120attatcttaa agctgaagcc aaaatatgct tcaaaagaaa angactttat tgttcattgt 180agttcataca ttcaaagcat ctgaactgta gtttctatag caagccaatt acatccataa 240gtggagaang aaatagatta atgtcnaagt atgattggtg gagggagcaa ggttgaagat 300aatctggggt tgaaattttc tagttttcat tctgtacatt tttagttnga catcagattt 360gaaatattaa tgtttacctt tcaatgtgtg gtatcagctg gactcantaa cacccctttc 420ttccctnggg gatggggaat ggattattgg aaaatggaaa gaaaaaagta cttaaagcct 480tcctttcnca gtttctggct cctaccctac tgatttancc agaataagaa aacattttat 540catcntctgc tttattccca ttaatnaant tttgatgaat aaatctgctt ttatgcnnac 600ccaaggaatt nagtggnttc ntcnttgt 628 87 518 DNA Homo sapien misc_feature (1)...(518) n = A,T,C or G 87ttttttattt tttttagaga gtagttcagc ttttatttat aaatttattg cctgttttat 60tataacaaca ttatactgtt tatggtttaa tacatatggt tcaaaatgta taatacatca 120agtagtacag ttttaaaatt ttatgcttaa aacaagtttt gtgtaaaaaa tgcagataca 180ttttacatgg caaatcaatt tttaagtcat cctaaaaatt gatttttttt tgaaatttaa 240aaacacattt aatttcaatt tctctcttat ataaccttta ttactatagc atggtttcca 300ctacagttta acaatgcagc aaaattccca tttcacggta aattgggttt taagcggcaa 360ggttaaaatg ctttgaggat cctnaatacc ctttgaactt caaatgaagg ttatggttgt 420naatttaacc ctcatgccat aagcagaagc acaagtttag ctgcattttg ctctaaactg 480taaaancgag ccccccgttg aaaaagcaaa agggaccc 518 88 1844 DNA Homo sapien 88gagacagtga atcctagtat caaaggattt ttggcctcag aaaaagttgt tgattatttt 60tattttattt tatttttcga gactccgtct caaaaaaaaa aaaaaaaaaa agaatcacaa 120ggtatttgct aaagcatttt gagctgcttg gaaaaaggga agtagttgca gtagagtttc 180ttccatcttc ttggtgctgg gaagccatat atgtgtcttt tactcaagct aaggggtata 240agcttatgtg ttgaatttgc tacatctata tttcacatat tctcacaata agagaatttt 300gaaatagaaa tatcatagaa catttaagaa agtttagtat aaataatatt ttgtgtgttt 360taatcccttt gaagggatct atccaaagaa aatattttac actgagctcc ttcctacacg 420tctcagtaac agatcctgtg ttagtctttg aaaatagctc attttttaaa tgtcagtgag 480tagatgtagc atacatatga tgtataatga cgtgtattat gttaacaatg tctgcagatt 540ttgtaggaat acaaaacatg gcctttttta taagcaaaac gggccaatga ctagaataac 600acatagggca atctgtgaat atgtattata agcagcattc cagaaaagta gttggtgaaa 660taattttcaa gtcaaaaagg gatatggaaa gggaattatg agtaacctct attttttaag 720ccttgctttt aaattaaacg ctacagccat ttaagccttg aggataataa agcttgagag 780taataatgtt aggttagcaa aggtttagat gtatcacttc atgcatgcta ccatgatagt 840aatgcagctc ttcgagtcat ttctggtcat tcaagatatt cacccttttg cccatagaaa 900gcaccctacc tcacctgctt actgacattg tcttagctga tcacaagatc attatcagcc 960tccattattc cttactgtat ataaaataca gagttttata ttttcctttc ttcgtttttc 1020accatattca aaacctaaat ttgtttttgc agatggaatg caaagtaatc aagtgttcgt 1080gctttcacct agaagggtgt ggtcctgaag gaaagaggtc cctaaatatc ccccaccctg 1140ggtgctcctc cttccctggt accctgacta ccagaagtca ggtgctagag cagctggaga 1200agtgcagcag cctgtgcttc cacagatggg ggtgctgctg caacaaggct ttcaatgtgc 1260ccatcttagg gggagaagct agatcctgtg cagcagcctg gtaagtcctg aggaggttcc 1320attgctcttc ctgctgctgt cctttgcttc tcaacggggc tcgctctaca gtctagagca 1380catgcagcta acttgtgcct ctgcttatgc atgagggtta aattaacaac cataaccttc 1440atttgaagtt caaaggtgta ttcaggatcc tcaaagcatt ttaaccttgc cgcttaaaac 1500ccaatttacc gtgaaatggg aattttgctg cattgttaaa ctgtagtgga aaccatgcta 1560tagtaataaa ggttatataa gagagaaatt gaaattaaat gtgtttttaa atttcaaaaa 1620aaaatcaatc tttaggatga cttaaaaatt gatttgccat gtaaaatgta tctgcatttt 1680ttacacaaaa cttgttttaa gcataaaatt ttaaaactgt actacttgat gtattataca 1740ttttgaacca tatgtattaa accataaaca gtataatgtt gttataataa aacaggcaat 1800aaatttataa ataaaagctg aaaaaaaaaa aaaaaaaaaa aaaa 1844 89 523 DNA Homo sapien misc_feature (1)...(523) n = A,T,C or G 89tttttttttt tttttttagt caatccacat ttattgatca cttattatgt accaggcact 60gggataaaga tgactgttag tcactcacag taaggaagaa aactagcaaa taagacgatt 120acaatatgat gtagaaaatg ctaagccaga gatatagaaa ggtcctattg ggtccttctg 180tcaccttgtc tttccacatc cctacccttc acaggccttc cctccagctt cctgcccccg 240ctccccactg cagatcccct gggattttgc ctagagctaa acgagganat gggccccctg 300gccctggcat gacttgaacc caaccacaga ctgggaaagg gagcctttcg anagtggatc 360actttgatna gaaaacacat agggaattga agagaaantc cccaaatggc cacccgtgct 420ggtgctcaag aaaagtttgc agaatggata aatgaaggat caagggaatt aatanatgaa 480taattgaatg gtggctcaat aagaatgact ncnttgaatg acc 523 90 604 DNA Homo sapien misc_feature (1)...(604) n = A,T,C or G 90ccagtgtggt ggaatgcaaa gattaccccg gaagctttcg agaagctggg attccctgca 60gcaaaggaaa tagccaatat gtgtcgtttc tatgaaatga agccagaccg agatgtcaat 120ctcacccacc aactaaatcc caaagtcaaa agcttcagcc agtttatctc agagaaccag 180gggagccttc aagggcatgt agaaaatcag ctgttcagat aggcctctgc accacacagc 240ctctttcctc tctgatcctt ttcctcttta cggcacaaca ttcatgtttg acagaacatg 300ctggaatgca attgtttgca acaccgaagg atttcctgcg gtcgcctctt cagtaggaag 360cactgcattg gtgataggac acggtaattt gattcacatt taacttgcta gttagtgata 420aggggtggta cacctgtttg gtaaaatgag aagcctcgga aacttgggag cttctctcct 480accactaatg gggagggcag attattactg ggatttctcc tggggtgaat taatttcaag 540ccctaattgc tgaaattccc ctnggcaggc tccagttttc tcaactgcat tgcaaaattc 600cccc 604 91 858 DNA Homo sapien misc_feature (1)...(858) n = A,T,C or G 91tttttttttt ttttttttta tgattattat tttttttatt gatctttaca tcctcagtgt 60tggcagagtt tctgatgctt aataaacatt tgttctgatc agataagtgg aaaaaattgt 120catttcctta ttcaagccat gcttttctgt gatattctga tcctagttga acatacagaa 180ataaatgtct aaaacagcac ctcgattctc gtctataaca ggactaagtt cactgtgatc 240ttaaataagc ttggctaaaa tgggacatga gtggaggtag tcacacttca gcgaagaaag 300agaatctcct gtataatctc accaggagat tcaacgaatt ccaccacact ggactagtgg 360atcccccggg ctgcaggaat tcgatatcaa gcttatcgat accgtcgacc tcgagggggg 420gcccggtacc caattcgccc tatagtgagt cgtattacgc gcgctcactg gccgtcgttt 480tacaacgtcg tgactgggaa aaccctggcg ttacccaact taatcgcctt gcagcacatc 540cccctttcgc cagctggcgt aatagcgaan agcccgcacc gatcgccctt ncaacagttg 600cgcagcctga atggcgaatg ggacgcgccc tgtagcggcg cattaaagcg cggcngggtg 660tggnggntcc cccacgtgac cgntacactt ggcagcgcct tacgccggtc nttcgctttc 720ttcccttcct ttctcgcacc gttcgccggg tttccccgnn agctnttaat cgggggnctc 780cctttanggg tncnaattaa nggnttacng gaccttngan cccaaaaact ttgattaggg 840ggaaggtccc cgaagggg 858 92 585 DNA Homo sapien misc_feature (1)...(585) n = A,T,C or G 92gttgaatctc ctggtgagat tatacaggag attctctttc ttcgctgaag tgtgactacc 60tccactcatg tcccatttta gccaagctta tttaagatca cagtgaactt agtcctgtta 120tagacgagaa tcgaggtgct gttttagaca tttatttctg tatgttcaac taggatcaga 180atatcacaga aaagcatggc ttgaataagg aaatgacaat tttttccact tatctgatca 240gaacaaatgt ttattaagca tcagaaactc tgccaacact gaggatgtaa agatcaataa 300aaaaaataat aatcatnann naaanannan nngaagggcg gccgccaccg cggtggagct 360ccagcttttg ttccctttag tgagggttaa ttgcgcgctt ggcgttaatc atggtcatag 420ctgtttcctg tgtgaaattg ttatccggct cacaattccn cncaacatac gagccgggaa 480gcntnangtg taaaagcctg ggggtgccta attgagtgag ctnactcaca ttaattgngt 540tgcgctccac ttgcccgctt ttccantccg ggaaacctgt tcgnc 585 93 567 DNA Homo sapien misc_feature (1)...(567) n = A,T,C or G 93cggcagtgtt gctgtctgcg tgtccacctt ggaatctggc tgaactggct gggaggacca 60agactgcggc tggggtgggc anggaaggga accgggggct gctgtgaagg atcttggaac 120ttccctgtac ccaccttccc cttgcttcat gtttgtanag gaaccttgtg ccggccaagc 180ccagtttcct tgtgtgatac actaatgtat ttgctttttt tgggaaatan anaaaaatca 240attaaattgc tantgtttct ttgaannnnn nnnnnnnnnn nnnnnnnggg ggggncgccc 300ccncggngga aacnccccct tttgttccct ttaattgaaa ggttaattng cncncntggc 360gttaanccnt gggccaaanc tngttncccg tgntgaaatt gttnatcccc tcccaaattc 420ccccccnncc ttccaaaccc ggaaancctn annntgttna ancccggggg gttgcctaan 480ngnaattnaa ccnaaccccc ntttaaatng nntttgcncn ccacnngccc cnctttccca 540nttcggggaa aaccctntcc gtgccca 567 94 620 DNA Homo sapien misc_feature (1)...(620) n = A,T,C or G 94actagtcaaa aatgctaaaa taatttggga gaaaatattt tttaagtagt gttatagttt 60catgtttatc ttttattatg ttttgtgaag ttgtgtcttt tcactaatta cctatactat 120gccaatattt ccttatatct atccataaca tttatactac atttgtaana naatatgcac 180gtgaaactta acactttata aggtaaaaat gaggtttcca anatttaata atctgatcaa 240gttcttgtta tttccaaata gaatggactt ggtctgttaa gggctaagga gaagaggaag 300ataaggttaa aagttgttaa tgaccaaaca ttctaaaaga aatgcaaaaa aaaagtttat 360tttcaagcct tcgaactatt taaggaaagc aaaatcattt cctaaatgca tatcatttgt 420gagaatttct cattaatatc ctgaatcatt catttcacta aggctcatgt tnactccgat 480atgtctctaa gaaagtacta tttcatggtc caaacctggt tgccatantt gggtaaaggc 540tttcccttaa gtgtgaaant atttaaaatg aaattttcct ctttttaaaa attctttana 600agggttaagg gtgttgggga 620 95 470 DNA Homo sapien misc_feature (1)...(470) n = A,T,C or G 95ctcgaccttc tctgcacagc ggatgaaccc tgagcagctg aagaccagaa aagccactat 60nactttntgc ttaattcang agcttacang attcttcaaa gagtgngtcc agcatccttt 120gaaacatgag ttcttaccag cagaagcaga cctttacccc accacctcag cttcaacagc 180agcaggtgaa acaacccatc cagcctccac ctnaggaaat atttgttccc acaaccaagg 240agccatgcca ctcaaaggtt ccacaacctg naaacacaaa nattccagag ccaggctgta 300ccaaggtccc tgagccaggg ctgtaccaan gtccctgagc caggttgtac caangtccct 360gagccaggat gtaccaaggt ccctgancca ggttgtccaa ggtccctgag ccaggctaca 420ccaagggcct gngccaggca gcatcaangt ccctgaccaa ggcttatcaa 470 96 660 DNA Homo sapien misc_feature (1)...(660) n = A,T,C or G 96tttttttttt tttttttttt ggaattaaaa gcaatttaat gagggcagag caggaaacat 60gcatttcttt tcattcgaat cttcagatga accctgagca gccgaagacc agaaaagcca 120tgaagacttt ctgcttaatt caggggctta caggattctt cagagtgtgt gtgaacaaaa 180gctttatagt acgtattttt aggatacaaa taagagagag actatggctt ggggtgagaa 240tgtactgatt acaaggtcta cagacaatta agacacagaa acagatggga agagggtgnc 300cagcatctgg nggttggctt ctcaagggct tgtctgtgca ccaaattact tctgcttggn 360cttctgctga gctgggcctg gagtgaccgt tgaaggacat ggctctggta cctttgtgta 420gcctgncaca ggaactttgg tgtatccttg ctcaggaact ttgatggcac ctggctcagg 480aaacttgatg aagccttggt caagggacct tgatgcttgc tggctcaggg accttggngn 540ancctgggct canggacctt tgncncaacc ttggcttcaa gggacccttg gnacatcctg 600gcnnagggac ccttgggncc aaccctgggc ttnagggacc ctttggntnc nanccttggc 660 97 441 DNA Homo sapien misc_feature (1)...(441) n = A,T,C or G 97gggaccatac anagtattcc tctcttcaca ccaggaccag ccactgttgc agcatgagtt 60cccagcagca gaagcagccc tgcatcccac cccctcagct tcagcagcag caggtgaaac 120agccttgcca gcctccacct caggaaccat gcatccccaa aaccaaggag ccctgccacc 180ccaaggtgcc tgagccctgc caccccaaag tgcctgagcc ctgccagccc aaggttccag 240agccatgcca ccccaaggtg cctgagccct gcccttcaat agtcactcca gcaccagccc 300agcagaanac caagcagaag taatgtggtc cacagccatg cccttgagga gccggccacc 360agatgctgaa tcccctatcc cattctgtgt atgagtccca tttgccttgc aattagcatt 420ctgtctcccc caaaaaaaaa a 441 98 600 DNA Homo sapien misc_feature (1)...(600) n = A,T,C or G 98gtattcctct cttcacacca ggaccagcca ctgttgcagc atgagttccc agcagcagaa 60gcagccctgc atcccacccc ctcagcttca gcagcagcag gtgaaacagc cttgccagcc 120tccacctcag gaaccatgca tccccaaaac caaggagccc tgccacccca aggtgcctga 180gccctgccac cccaaagtgc ctgagccctg ccagcccaag gttccagagc catgccaccc 240caaggtgcct gagccctgcc cttcaatagt cactccagca ccagcccagc agaanaccaa 300gcagaagtaa tgtggtccac agccatgccc ttgaggagcc ggccaccana tgctgaatcc 360cctatcccat tctgtgtatg agtcccattt gccttgcaat tagcattctg tctcccccaa 420aaaagaatgt gctatgaagc tttctttcct acacactctg agtctctgaa tgaagctgaa 480ggtcttaant acaganctag ttttcagctg ctcagaattc tctgaagaaa agatttaaga 540tgaaaggcaa atgattcagc tccttattac cccattaaat tcnctttcaa ttccaaaaaa 600 99 667 DNA Homo sapien misc_feature (1)...(667) n = A,T,C or G 99actagtgact gagttcctgg caaagaaatt tgacctggac cagttgataa ctcatgtttt 60accatttaaa aaaatcagtg aaggatttga gctgctcaat tcaggacaaa gcattcgaac 120ggtcctgacg ttttgagatc caaagtggca ggaggtctgt gttgtcatgg tgaactggag 180tttctcttgt gagagttccc tcatctgaaa tcatgtatct gtctcacaaa tacaagcata 240agtagaagat ttgttgaaga catagaaccc ttataaagaa ttattaacct ttataaacat 300ttaaagtctt gtgagcacct gggaattagt ataataacaa tgttnatatt tttgatttac 360attttgtaag gctataattg tatcttttaa gaaaacatac cttggatttc tatgttgaaa 420tggagatttt taagagtttt aaccagctgc tgcagatata ttactcaaaa cagatatagc 480gtataaagat atagtaaatg catctcctag agtaatattc acttaacaca ttggaaacta 540ttatttttta gatttgaata tnaatgttat tttttaaaca cttgttatga gttacttggg 600attacatttt gaaatcagtt cattccatga tgcanattac tgggattaga ttaagaaaga 660cggaaaa 667 100 583 DNA Homo sapien misc_feature (1)...(583) n = A,T,C or G 100gttttgtttg taagatgatc acagtcatgt tacactgatc taaaggacat atatataacc 60ctttaaaaaa aaaatcactg cctcattctt atttcaagat gaatttctat acagactaga 120tgtttttctg aagatcaatt agacattttg aaaatgattt aaagtgtttt ccttaatgtt 180ctctgaaaac aagtttcttt tgtagtttta accaaaaaag tgcccttttt gtcactggat 240tctcctagca ttcatgattt ttttttcata caatgaaatt aaaattgcta aaatcatgga 300ctggctttct ggttggattt caggtaagat gtgtttaagg ccagagcttt tctcagtatt 360tgattttttt ccccaatatt tgatttttta aaaatataca catnggtgct gcatttatat 420ctgctggttt aaaattctgt catatttcac ttctagcctt ttagttatgg caaatcatat 480tttactttta cttaaagcat ttggtnattt ggantatctg gttctannct aaaaaaanta 540attctatnaa ttgaantttt ggtactcnnc catatttgga tcc 583 101 592 DNA Homo sapien misc_feature (1)...(592) n = A,T,C or G 101gtggagacgt acaaagagca gccgctcaag acacctggga agaaaaagaa aggcaagccc 60gggaaacgca aggagcagga aaagaaaaaa cggcgaactc gctctgcctg gttagactct 120ggagtgactg ggagtgggct agaaggggac cacctgtctg acacctccac aacgtcgctg 180gagctcgatt cacggaggca ttgaaatttt cagcaganac cttccaagga catattgcag 240gattctgtaa tagtgaacat atggaaagta ttagaaatat ttattgtctg taaatactgt 300aaatgcattg gaataaaact gtctccccca ttgctctatg aaactgcaca ttggtcattg 360tgaatatttt tttttttgcc aaggctaatc caattattat tatcacattt accataattt 420attttgtcca ttgatgtatt tattttgtaa atgtatcttg gtgctgctga atttctatat 480tttttgtaca taatgcnttt anatatacct atcaagtttg ttgataaatg acncaatgaa 540gtgncncnan ttggnggttg aatttaatga atgcctaatt ttattatccc aa 592 102 587 DNA Homo sapien misc_feature (1)...(587) n = A,T,C or G 102cgtcctaagc acttagacta catcagggaa gaacacagac cacatccctg tcctcatgcg 60gcttatgttt tctggaagaa agtggagacc nagtccttgg ctttagggct ccccggctgg 120gggctgtgca ntccggtcag ggcgggaagg gaaatgcacc gctgcatgtg aacttacagc 180ccaggcggat gccccttccc ttagcactac ctggcctcct gcatcccctc gcctcatgtt 240cctcccacct tcaaanaatg aanaacccca tgggcccagc cccttgccct ggggaaccaa 300ggcagccttc caaaactcag gggctgaagc anactattag ggcaggggct gactttgggt 360gacactgccc attccctctc agggcagctc angtcacccn ggnctcttga acccagcctg 420ttcctttgaa aaagggcaaa actgaaaagg gcttttccta naaaaagaaa aaccagggaa 480ctttgccagg gcttcnntnt taccaaaacn ncttctcnng gatttttaat tccccattng 540gcctccactt accnggggcn atgccccaaa attaanaatt tcccatc 587 103 496 DNA Homo sapien misc_feature (1)...(496) n = A,T,C or G 103anaggactgg ccctacntgc tctctctcgt cctacctatc aatgcccaac atggcagaac 60ctgcanccct tggncactgc anatggaaac ctctcagtgt cttgacatca ccctacccnt 120gcggtgggtc tccaccacaa ccactttgac tctgtggtcc ctgnanggtg gnttctcctg 180actggcagga tggaccttan ccnacatatc cctctgttcc ctctgctnag anaaagaatt 240cccttaacat gatataatcc acccatgcaa ntngctactg gcccagctac catttaccat 300ttgcctacag aatttcattc agtctacact ttggcattct ctctggcgat agagtgtggc 360tgggctgacc gcaaaaggtg ccttacacac tggcccccac cctcaaccgt tgacncatca 420gangcttgcc tcctccttct gattnncccc catgttggat atcagggtgc tcnagggatt 480ggaaaagaaa caaaac 496 104 575 DNA Homo sapien misc_feature (1)...(575) n = A,T,C or G 104gcacctgctc tcaatccnnc tctcaccatg atcctccgcc tgcanaaact cctctgccaa 60ctatggangt ggtttcnggg gtggctcttg ccaactggga agaagccgtg gtgtctctac 120ctgttcaact cngtttgtgt ctgggggatc aactnggggc tatggaagcg gctnaactgt 180tgttttggtg gaagggctgg taattggctt tgggaagtng cttatngaag ttggcctngg 240gaagttgcta ttgaaagtng ccntggaagt ngntttggtg gggggttttg ctggtggcct 300ttgttnaatt tgggtgcttt gtnaatggcg gccccctcnc ctgggcaatg aaaaaaatca 360ccnatgcngn aaacctcnac nnaacagcct gggcttccct cacctcgaaa aaagttgctc 420cccccccaaa aaaggncaan cccctcaann tggaangttg aaaaaatcct cgaatgggga 480ncccnaaaac aaaaancccc ccntttcccn gnaanggggg aaataccncc cccccactta 540cnaaaaccct tntaaaaaac cccccgggaa aaaaa 575 105 619 DNA Homo sapien misc_feature (1)...(619) n = A,T,C or G 105cactagtagg atagaaacac tgtgtcccga gagtaaggag agaagctact attgattaga 60gcctaaccca ggttaactgc aagaagaggc gggatacttt cagctttcca tgtaactgta 120tgcataaagc caatgtagtc cagtttctaa gatcatgttc caagctaact gaatcccact 180tcaatacaca ctcatgaact cctgatggaa caataacagg cccaagcctg tggtatgatg 240tgcacacttg ctagactcan aaaaaatact actctcataa atgggtggga gtattttggt 300gacaacctac tttgcttggc tgagtgaagg aatgatattc atatattcat ttattccatg 360gacatttagt tagtgctttt tatataccag gcatgatgct gagtgacact cttgtgtata 420tttccaaatt tttgtacagt cgctgcacat atttgaaatc atatattaag acttccaaaa 480aatgaagtcc ctggtttttc atggcaactt gatcagtaaa ggattcncct ctgtttggta 540cttaaaacat ctactatatn gttnanatga aattcctttt ccccncctcc cgaaaaaana 600aagtggtggg gaaaaaaaa 619 106 506 DNA Homo sapien misc_feature (1)...(506) n = A,T,C or G 106cattggtnct ttcatttgct ntggaagtgt nnatctctaa cagtggacaa agttcccngt 60gccttaaact ctgtnacact tttgggaant gaaaanttng tantatgata ggttattctg 120angtanagat gttctggata ccattanatn tgcccccngt gtcagaggct catattgtgt 180tatgtaaatg gtatntcatt cgctactatn antcaattng aaatanggtc tttgggttat 240gaatantnng cagcncanct nanangctgt ctgtngtatt cattgtggtc atagcacctc 300acancattgt aacctcnatc nagtgagaca nactagnaan ttcctagtga tggctcanga 360ttccaaatgg nctcatntcn aatgtttaaa agttanttaa gtgtaagaaa tacagactgg 420atgttccacc aactagtacc tgtaatgacn ggcctgtccc aacacatctc ccttttccat 480gactgtggta ncccgcatcg gaaaaa 506 107 452 DNA Homo sapien misc_feature (1)...(452) n = A,T,C or G 107gttgagtctg tactaaacag taagatatct caatgaacca taaattcaac tttgtaaaaa 60tcttttgaag catagataat attgtttggt aaatgtttct tttgtttggt aaatgtttct 120tttaaagacc ctcctattct ataaaactct gcatgtagag gcttgtttac ctttctctct 180ctaaggttta caataggagt ggtgatttga aaaatataaa attatgagat tggttttcct 240gtggcataaa ttgcatcact gtatcatttt cttttttaac cggtaagant ttcagtttgt 300tggaaagtaa ctgtganaac ccagtttccc gtccatctcc cttagggact acccatagaa 360catgaaaagg tccccacnga agcaagaaga taagtctttc atggctgctg gttgcttaaa 420ccactttaaa accaaaaaat tccccttgga aa 452 108 502 DNA Homo sapien misc_feature (1)...(502) n = A,T,C or G 108atcttcttcc cttaattagt tnttatttat ntattaaatt ttattgcatg tcctggcaaa 60caaaaagaga ttgtagattg gcttctggct ccccaaaagc ccataacaga aagtaccaca 120agaccncaac tgaagcttaa aaaatctatc acatgtataa tacctttnga agaacattaa 180tanagcatat aaaactttta acatntgctt aatgttgtnc aattataaaa ntaatngaaa 240aaaatgtccc tttaacatnc aatatcccac atagtgttat ttnaggggat taccnngnaa 300naaaaaaagg gtagaaggga tttaatgaaa actctgcttn ccatttctgt ttanaaacgt 360ctccagaaca aaaacttntc aantctttca gctaaccgca tttgagctna ggccactcaa 420aaactccatt agncccactt tctaanggtc tctanagctt actaancctt ttgacccctt 480accctggnta ctcctgccct ca 502 109 1308 DNA Homo sapien 109acccgaggtc tcgctaaaat catcatggat tcacttggcg ccgtcagcac tcgacttggg 60tttgatcttt tcaaagagct gaagaaaaca aatgatggca acatcttctt ttcccctgtg 120ggcatcttga ctgcaattgg catggtcctc ctggggaccc gaggagccac cgcttcccag 180ttggaggagg tgtttcactc tgaaaaagag acgaagagct caagaataaa ggctgaagaa 240aaagaggtga ttgagaacac agaagcagta catcaacaat tccaaaagtt tttgactgaa 300ataagcaaac tcactaatga ttatgaactg aacataacca acaggctgtt tggagaaaaa 360acatacctct tccttcaaaa atacttagat tatgttgaaa aatattatca tgcatctctg 420gaacctgttg attttgtaaa tgcagccgat gaaagtcgaa agaagattaa ttcctgggtt 480gaaagcaaaa caaatgaaaa aatcaaggac ttgttcccag atggctctat tagtagctct 540accaagctgg tgctggtgaa catggtttat tttaaagggc aatgggacag ggagtttaag 600aaagaaaata ctaaggaaga gaaattttgg atgaataaga gcacaagtaa atctgtacag 660atgatgacac agagccattc ctttagcttc actttcctgg aggacttgca ggccaaaatt 720ctagggattc catataaaaa caacgaccta agcatgtttg tgcttctgcc caacgacatc 780gatggcctgg agaagataat agataaaata agtcctgaga aattggtaga gtggactagt 840ccagggcata tggaagaaag aaaggtgaat ctgcacttgc cccggtttga ggtggaggac 900agttacgatc tagaggcggt cctggctgcc atggggatgg gcgatgcctt cagtgagcac 960aaagccgact actcgggaat gtcgtcaggc tccgggttgt acgcccagaa gttcctgcac 1020agttcctttg tggcagtaac tgaggaaggc accgaggctg cagctgccac tggcataggc 1080tttactgtca catccgcccc aggtcatgaa aatgttcact gcaatcatcc cttcctgttc 1140ttcatcaggc acaatgaatc caacagcatc ctcttcttcg gcagattttc ttctccttaa 1200gatgatcgtt gccatggcat tgctgctttt agcaaaaaac aactaccagt gttactcata 1260tgattatgaa aatcgtccat tcttttaaat ggtggctcac ttgcattt 1308 110 391 PRT Homo sapien 110Met Asp Ser Leu Gly Ala Val Ser Thr Arg Leu Gly Phe Asp Leu Phe 1 5 10 15Lys Glu Leu Lys Lys Thr Asn Asp Gly Asn Ile Phe Phe Ser Pro Val 20 25 30Gly Ile Leu Thr Ala Ile Gly Met Val Leu Leu Gly Thr Arg Gly Ala 35 40 45Thr Ala Ser Gln Leu Glu Glu Val Phe His Ser Glu Lys Glu Thr Lys 50 55 60Ser Ser Arg Ile Lys Ala Glu Glu Lys Glu Val Ile Glu Asn Thr Glu65 70 75 80Ala Val His Gln Gln Phe Gln Lys Phe Leu Thr Glu Ile Ser Lys Leu 85 90 95Thr Asn Asp Tyr Glu Leu Asn Ile Thr Asn Arg Leu Phe Gly Glu Lys 100 105 110Thr Tyr Leu Phe Leu Gln Lys Tyr Leu Asp Tyr Val Glu Lys Tyr Tyr 115 120 125His Ala Ser Leu Glu Pro Val Asp Phe Val Asn Ala Ala Asp Glu Ser 130 135 140Arg Lys Lys Ile Asn Ser Trp Val Glu Ser Lys Thr Asn Glu Lys Ile145 150 155 160Lys Asp Leu Phe Pro Asp Gly Ser Ile Ser Ser Ser Thr Lys Leu Val 165 170 175Leu Val Asn Met Val Tyr Phe Lys Gly Gln Trp Asp Arg Glu Phe Lys 180 185 190Lys Glu Asn Thr Lys Glu Glu Lys Phe Trp Met Asn Lys Ser Thr Ser 195 200 205Lys Ser Val Gln Met Met Thr Gln Ser His Ser Phe Ser Phe Thr Phe 210 215 220Leu Glu Asp Leu Gln Ala Lys Ile Leu Gly Ile Pro Tyr Lys Asn Asn225 230 235 240Asp Leu Ser Met Phe Val Leu Leu Pro Asn Asp Ile Asp Gly Leu Glu 245 250 255Lys Ile Ile Asp Lys Ile Ser Pro Glu Lys Leu Val Glu Trp Thr Ser 260 265 270Pro Gly His Met Glu Glu Arg Lys Val Asn Leu His Leu Pro Arg Phe 275 280 285Glu Val Glu Asp Ser Tyr Asp Leu Glu Ala Val Leu Ala Ala Met Gly 290 295 300Met Gly Asp Ala Phe Ser Glu His Lys Ala Asp Tyr Ser Gly Met Ser305 310 315 320Ser Gly Ser Gly Leu Tyr Ala Gln Lys Phe Leu His Ser Ser Phe Val 325 330 335Ala Val Thr Glu Glu Gly Thr Glu Ala Ala Ala Ala Thr Gly Ile Gly 340 345 350Phe Thr Val Thr Ser Ala Pro Gly His Glu Asn Val His Cys Asn His 355 360 365Pro Phe Leu Phe Phe Ile Arg His Asn Glu Ser Asn Ser Ile Leu Phe 370 375 380Phe Gly Arg Phe Ser Ser Pro385 390 111 1419 DNA Homo sapien 111ggagaactat aaattaagga tcccagctac ttaattgact tatgcttcct agttcgttgc 60ccagccacca ccgtctctcc aaaaacccga ggtctcgcta aaatcatcat ggattcactt 120ggcgccgtca gcactcgact tgggtttgat cttttcaaag agctgaagaa aacaaatgat 180ggcaacatct tcttttcccc tgtgggcatc ttgactgcaa ttggcatggt cctcctgggg 240acccgaggag ccaccgcttc ccagttggag gaggtgtttc actctgaaaa agagacgaag 300agctcaagaa taaaggctga agaaaaagag gtggtaagaa taaaggctga aggaaaagag 360attgagaaca cagaagcagt acatcaacaa ttccaaaagt ttttgactga aataagcaaa 420ctcactaatg attatgaact gaacataacc aacaggctgt ttggagaaaa aacatacctc 480ttccttcaaa aatacttaga ttatgttgaa aaatattatc atgcatctct ggaacctgtt 540gattttgtaa atgcagccga tgaaagtcga aagaagatta attcctgggt tgaaagcaaa 600acaaatgaaa aaatcaagga cttgttccca gatggctcta ttagtagctc taccaagctg 660gtgctggtga acatggttta ttttaaaggg caatgggaca gggagtttaa gaaagaaaat 720actaaggaag agaaattttg gatgaataag agcacaagta aatctgtaca gatgatgaca 780cagagccatt cctttagctt cactttcctg gaggacttgc aggccaaaat tctagggatt 840ccatataaaa acaacgacct aagcatgttt gtgcttctgc ccaacgacat cgatggcctg 900gagaagataa tagataaaat aagtcctgag aaattggtag agtggactag tccagggcat 960atggaagaaa gaaaggtgaa tctgcacttg ccccggtttg aggtggagga cagttacgat 1020ctagaggcgg tcctggctgc catggggatg ggcgatgcct tcagtgagca caaagccgac 1080tactcgggaa tgtcgtcagg ctccgggttg tacgcccaga agttcctgca cagttccttt 1140gtggcagtaa ctgaggaagg caccgaggct gcagctgcca ctggcatagg ctttactgtc 1200acatccgccc caggtcatga aaatgttcac tgcaatcatc ccttcctgtt cttcatcagg 1260cacaatgaat ccaacagcat cctcttcttc ggcagatttt cttctcctta agatgatcgt 1320tgccatggca ttgctgcttt tagcaaaaaa caactaccag tgttactcat atgattatga 1380aaatcgtcca ttcttttaaa tggtggctca cttgcattt 1419 112 400 PRT Homo sapien 112Met Asp Ser Leu Gly Ala Val Ser Thr Arg Leu Gly Phe Asp Leu Phe 1 5 10 15Lys Glu Leu Lys Lys Thr Asn Asp Gly Asn Ile Phe Phe Ser Pro Val 20 25 30Gly Ile Leu Thr Ala Ile Gly Met Val Leu Leu Gly Thr Arg Gly Ala 35 40 45Thr Ala Ser Gln Leu Glu Glu Val Phe His Ser Glu Lys Glu Thr Lys 50 55 60Ser Ser Arg Ile Lys Ala Glu Glu Lys Glu Val Val Arg Ile Lys Ala65 70 75 80Glu Gly Lys Glu Ile Glu Asn Thr Glu Ala Val His Gln Gln Phe Gln 85 90 95Lys Phe Leu Thr Glu Ile Ser Lys Leu Thr Asn Asp Tyr Glu Leu Asn 100 105 110Ile Thr Asn Arg Leu Phe Gly Glu Lys Thr Tyr Leu Phe Leu Gln Lys 115 120 125Tyr Leu Asp Tyr Val Glu Lys Tyr Tyr His Ala Ser Leu Glu Pro Val 130 135 140Asp Phe Val Asn Ala Ala Asp Glu Ser Arg Lys Lys Ile Asn Ser Trp145 150 155 160Val Glu Ser Lys Thr Asn Glu Lys Ile Lys Asp Leu Phe Pro Asp Gly 165 170 175Ser Ile Ser Ser Ser Thr Lys Leu Val Leu Val Asn Met Val Tyr Phe 180 185 190Lys Gly Gln Trp Asp Arg Glu Phe Lys Lys Glu Asn Thr Lys Glu Glu 195 200 205Lys Phe Trp Met Asn Lys Ser Thr Ser Lys Ser Val Gln Met Met Thr 210 215 220Gln Ser His Ser Phe Ser Phe Thr Phe Leu Glu Asp Leu Gln Ala Lys225 230 235 240Ile Leu Gly Ile Pro Tyr Lys Asn Asn Asp Leu Ser Met Phe Val Leu 245 250 255Leu Pro Asn Asp Ile Asp Gly Leu Glu Lys Ile Ile Asp Lys Ile Ser 260 265 270Pro Glu Lys Leu Val Glu Trp Thr Ser Pro Gly His Met Glu Glu Arg 275 280 285Lys Val Asn Leu His Leu Pro Arg Phe Glu Val Glu Asp Ser Tyr Asp 290 295 300Leu Glu Ala Val Leu Ala Ala Met Gly Met Gly Asp Ala Phe Ser Glu305 310 315 320His Lys Ala Asp Tyr Ser Gly Met Ser Ser Gly Ser Gly Leu Tyr Ala 325 330 335Gln Lys Phe Leu His Ser Ser Phe Val Ala Val Thr Glu Glu Gly Thr 340 345 350Glu Ala Ala Ala Ala Thr Gly Ile Gly Phe Thr Val Thr Ser Ala Pro 355 360 365Gly His Glu Asn Val His Cys Asn His Pro Phe Leu Phe Phe Ile Arg 370 375 380His Asn Glu Ser Asn Ser Ile Leu Phe Phe Gly Arg Phe Ser Ser Pro385 390 395 400 113 957 DNA Homo sapien 113ctcgaccttc tctgcacagc ggatgaaccc tgagcagctg aagaccagaa aagccactat 60gactttctgc ttaattcagg agcttacagg attcttcaaa gagtgtgtcc agcatccttt 120gaaacatgag ttcttaccag cagaagcaga cctttacccc accacctcag cttcaacagc 180agcaggtgaa acaacccagc cagcctccac ctcaggaaat atttgttccc acaaccaagg 240agccatgcca ctcaaaggtt ccacaacctg gaaacacaaa gattccagag ccaggctgta 300ccaaggtccc tgagccaggc tgtaccaagg tccctgagcc aggttgtacc aaggtccctg 360agccaggatg taccaaggtc cctgagccag gttgtaccaa ggtccctgag ccaggctaca 420ccaaggtccc tgagccaggc agcatcaagg tccctgacca aggcttcatc aagtttcctg 480agccaggtgc catcaaagtt cctgagcaag gatacaccaa agttcctgtg ccaggctaca 540caaaggtacc agagccatgt ccttcaacgg tcactccagg cccagctcag cagaagacca 600agcagaagta atttggtgca cagacaagcc cttgagaagc caaccaccag atgctggaca 660ccctcttccc atctgtttct gtgtcttaat tgtctgtaga ccttgtaatc agtacattct 720caccccaagc catagtctct ctcttatttg tatcctaaaa atacggtact ataaagcttt 780tgttcacaca cactctgaag aatcctgtaa gcccctgaat taagcagaaa gtcttcatgg 840cttttctggt cttcggctgc tcagggttca tctgaagatt cgaatgaaaa gaaatgcatg 900tttcctgctc tgccctcatt aaattgcttt taattccaaa aaaaaaaaaa aaaaaaa 957 114 161 PRT Homo sapien 114Met Ser Ser Tyr Gln Gln Lys Gln Thr Phe Thr Pro Pro Pro Gln Leu 1 5 10 15Gln Gln Gln Gln Val Lys Gln Pro Ser Gln Pro Pro Pro Gln Glu Ile 20 25 30Phe Val Pro Thr Thr Lys Glu Pro Cys His Ser Lys Val Pro Gln Pro 35 40 45Gly Asn Thr Lys Ile Pro Glu Pro Gly Cys Thr Lys Val Pro Glu Pro 50 55 60Gly Cys Thr Lys Val Pro Glu Pro Gly Cys Thr Lys Val Pro Glu Pro65 70 75 80Gly Cys Thr Lys Val Pro Glu Pro Gly Cys Thr Lys Val Pro Glu Pro 85 90 95Gly Tyr Thr Lys Val Pro Glu Pro Gly Ser Ile Lys Val Pro Asp Gln 100 105 110Gly Phe Ile Lys Phe Pro Glu Pro Gly Ala Ile Lys Val Pro Glu Gln 115 120 125Gly Tyr Thr Lys Val Pro Val Pro Gly Tyr Thr Lys Val Pro Glu Pro 130 135 140Cys Pro Ser Thr Val Thr Pro Gly Pro Ala Gln Gln Lys Thr Lys Gln145 150 155 160Lys 115 506 DNA Homo sapien misc_feature (1)...(506) n = A,T,C or G 115cattggtnct ttcatttgct ntggaagtgt nnatctctaa cagtggacaa agttcccngt 60gccttaaact ctgtnacact tttgggaant gaaaanttng tantatgata ggttattctg 120angtanagat gttctggata ccattanatn tgcccccngt gtcagaggct catattgtgt 180tatgtaaatg gtatntcatt cgctactatn antcaattng aaatanggtc tttgggttat 240gaatantnng cagcncanct nanangctgt ctgtngtatt cattgtggtc atagcacctc 300acancattgt aacctcnatc nagtgagaca nactagnaan ttcctagtga tggctcanga 360ttccaaatgg nctcatntcn aatgtttaaa agttanttaa gtgtaagaaa tacagactgg 420atgttccacc aactagtacc tgtaatgacn ggcctgtccc aacacatctc ccttttccat 480gactgtggta ncccgcatcg gaaaaa 506 116 3079 DNA Homo sapien 116ggatccccgg gtttcctaaa ccccccacag agtcctgccc aggccaaaga gcaaggaaaa 60ggtcaaaggg cagaaaaaat gctgagttag gaggagctat ggaaggataa acctggcctt 120aaagaggtca aagtggttta tagggggcgc tgagggcttc ccacattctc tggcctaaac 180cttgcaggca gatctgccca gtgggctctg ggatagctgt gccttcccta acaaaaaaat 240tgtgcacaaa aggatgaaac tctattttcc ctctagcaca taaccaagaa tataaggcta 300cagattgcct ttcccagagg gaaaaccctg cagcaacctg ctgcctggaa aagtgtaaga 360gcagatcact ggggaatcgt ttgccccccg ctgatggaca gcttccccaa gctccaaggg 420caggtgctca gcatgtaccg tactgggatg gttgtcaata ctcctggtcc tgtaagagtc 480ccaggacact gccatgccaa tgccccctca gttcctggca tcctttttgg gctgctcaca 540gccccagcct ctatggtgaa gacatacttg ctagcagcgt caccaacttg ttgccaagag 600atcagtgctc gaaggcaagg ttatttctaa ctgagcagag cctgccagga agaaagcgtt 660tgcaccccac accactgtgc aggtgtgacc ggtgagctca cagctgcccc ccaggcatgc 720ccagcccact taatcatcac agctcgacag ctctctcgcc cagcccagtt ctggaaggga 780taaaaagggg catcaccgtt cctgggtaac agagccacct tctgcgtcct gctgagctct 840gttctctcca gcacctccca acccactagt gcctggttct cttgctccac caggaacaag 900ccaccatgtc tcgccagtca agtgtgtctt ccggagcggg gggcagtcgt agcttcagca 960ccgcctctgc catcaccccg tctgtctccc gcaccagctt cacctccgtg tcccggtccg 1020ggggtggcgg tggtggtggc ttcggcaggg tcagccttgc gggtgcttgt ggagtgggtg 1080gctatggcag ccggagcctc tacaacctgg ggggctccaa gaggatatcc atcagcacta 1140gtggtggcag cttcaggaac cggtttggtg ctggtgctgg aggcggctat ggctttggag 1200gtggtgccgg tagtggattt ggtttcggcg gtggagctgg tggtggcttt gggctcggtg 1260gcggagctgg ctttggaggt ggcttcggtg gccctggctt tcctgtctgc cctcctggag 1320gtatccaaga ggtcactgtc aaccagagtc tcctgactcc cctcaacctg caaatcgacc 1380ccagcatcca gagggtgagg accgaggagc gcgagcagat caagaccctc aacaataagt 1440ttgcctcctt catcgacaag gtgcggttcc tggagcagca gaacaaggtt ctggaaacaa 1500agtggaccct gctgcaggag cagggcacca agactgtgag gcagaacctg gagccgttgt 1560tcgagcagta catcaacaac ctcaggaggc agctggacag catcgtgggg gaacggggcc 1620gcctggactc agagctgaga aacatgcagg acctggtgga agacttcaag aacaagtatg 1680aggatgaaat caacaagcgt accactgctg agaatgagtt tgtgatgctg aagaaggatg 1740tagatgctgc ctacatgaac aaggtggagc tggaggccaa ggttgatgca ctgatggatg 1800agattaactt catgaagatg ttctttgatg cggagctgtc ccagatgcag acgcatgtct 1860ctgacacctc agtggtcctc tccatggaca acaaccgcaa cctggacctg gatagcatca 1920tcgctgaggt caaggcccag tatgaggaga ttgccaaccg cagccggaca gaagccgagt 1980cctggtatca gaccaagtat gaggagctgc agcagacagc tggccggcat ggcgatgacc 2040tccgcaacac caagcatgag atctctgaga tgaaccggat gatccagagg ctgagagccg 2100agattgacaa tgtcaagaaa cagtgcgcca atctgcagaa cgccattgcg gatgccgagc 2160agcgtgggga gctggccctc aaggatgcca ggaacaagct ggccgagctg gaggaggccc 2220tgcagaaggc caagcaggac atggcccggc tgctgcgtga gtaccaggag ctcatgaaca 2280ccaagctggc cctggacgtg gagatcgcca cttaccgcaa gctgctggag ggcgaggaat 2340gcagactcag tggagaagga gttggaccag tcaacatctc tgttgtcaca agcagtgttt 2400cctctggata tggcagtggc agtggctatg gcggtggcct cggtggaggt cttggcggcg 2460gcctcggtgg aggtcttgcc ggaggtagca gtggaagcta ctactccagc agcagtgggg 2520gtgtcggcct aggtggtggg ctcagtgtgg ggggctctgg cttcagtgca agcagtagcc 2580gagggctggg ggtgggcttt ggcagtggcg ggggtagcag ctccagcgtc aaatttgtct 2640ccaccacctc ctcctcccgg aagagcttca agagctaaga acctgctgca agtcactgcc 2700ttccaagtgc agcaacccag cccatggaga ttgcctcttc taggcagttg ctcaagccat 2760gttttatcct tttctggaga gtagtctaga ccaagccaat tgcagaacca cattctttgg 2820ttcccaggag agccccattc ccagcccctg gtctcccgtg ccgcagttct atattctgct 2880tcaaatcagc cttcaggttt cccacagcat ggcccctgct gacacgagaa cccaaagttt 2940tcccaaatct aaatcatcaa aacagaatcc ccaccccaat cccaaatttt gttttggttc 3000taactacctc cagaatgtgt tcaataaaat gttttataat ataagctggt gtgcagaatt 3060gttttttttt tctacccaa 3079 117 6921 DNA Homo sapien 117gaattctgac tgtccactca aaacttctat tccgatcaaa gctatctgtg actacagaca 60aattgagata accatttaca aagacgatga atgtgttttg gcgaataact ctcatcgtgc 120taaatggaag gtcattagtc ctactgggaa tgaggctatg gtcccatctg tgtgcttcac 180cgttcctcca ccaaacaaag aagcggtgga ccttgccaac agaattgagc aacagtatca 240gaatgtcctg actctttggc atgagtctca cataaacatg aagagtgtag tatcctggca 300ttatctcatc aatgaaattg atagaattcg agctagcaat gtggcttcaa taaagacaat 360gctacctggt gaacatcagc aagttctaag taatctacaa tctcgttttg aagattttct 420ggaagatagc caggaatccc aagtcttttc aggctcagat ataacacaac tggaaaagga 480ggttaatgta tgtaagcagt attatcaaga acttcttaaa tctgcagaaa gagaggagca 540agaggaatca gtttataatc tctacatctc tgaagttcga aacattagac ttcggttaga 600gaactgtgaa gatcggctga ttagacagat tcgaactccc ctggaaagag atgatttgca 660tgaaagtgtg ttcagaatca cagaacagga gaaactaaag aaagagctgg aacgacttaa 720agatgatttg ggaacaatca caaataagtg tgaggagttt ttcagtcaag cagcagcctc 780ttcatcagtc cctaccctac gatcagagct taatgtggtc cttcagaaca tgaaccaagt 840ctattctatg tcttccactt acatagataa gttgaaaact gttaacttgg tgttaaaaaa 900cactcaagct gcagaagccc tcgtaaaact ctatgaaact aaactgtgtg aagaagaagc 960agttatagct gacaagaata atattgagaa tctaataagt actttaaagc aatggagatc 1020tgaagtagat gaaaagagac aggtattcca tgccttagag gatgagttgc agaaagctaa 1080agccatcagt gatgaaatgt ttaaaacgta taaagaacgg gaccttgatt ttgactggca 1140caaagaaaaa gcagatcaat tagttgaaag gtggcaaaat gttcatgtgc agattgacaa 1200caggttacgg gacttagagg gcattggcaa atcactgaag tactacagag acacttacca 1260tcctttagat gattggatcc agcaggttga aactactcag agaaagattc aggaaaatca 1320gcctgaaaat agtaaaaccc tagccacaca gttgaatcaa cagaagatgc tggtgtccga 1380aatagaaatg aaacagagca aaatggacga gtgtcaaaaa tatgcagaac agtactcagc 1440tacagtgaag gactatgaat tacaaacaat gacctaccgg gccatggtag attcacaaca 1500aaaatctcca gtgaaacgcc gaagaatgca gagttcagca gatctcatta ttcaagagtt 1560catggaccta aggactcgat atactgccct ggtcactctc atgacacaat atattaaatt 1620tgctggtgat tcattgaaga ggctggaaga ggaggagatt aaaaggtgta aggagacttc 1680tgaacatggg gcatattcag atctgcttca gcgtcagaag gcaacagtgc ttgagaatag 1740caaacttaca ggaaagataa gtgagttgga aagaatggta gctgaactaa agaaacaaaa 1800gtcccgagta gaggaagaac ttccgaaggt cagggaggct gcagaaaatg aattgagaaa 1860gcagcagaga aatgtagaag atatctctct gcagaagata agggctgaaa gtgaagccaa 1920gcagtaccgc agggaacttg aaaccattgt gagagagaag gaagccgctg aaagagaact 1980ggagcgggtg aggcagctca ccatagaggc cgaggctaaa agagctgccg tggaagagaa 2040cctcctgaat tttcgcaatc agttggagga aaacaccttt accagacgaa cactggaaga 2100tcatcttaaa agaaaagatt taagtctcaa tgatttggag caacaaaaaa ataaattaat 2160ggaagaatta agaagaaaga gagacaatga ggaagaactc ttgaagctga taaagcagat 2220ggaaaaagac cttgcatttc agaaacaggt agcagagaaa cagttgaaag aaaagcagaa 2280aattgaattg gaagcaagaa gaaaaataac tgaaattcag tatacatgta gagaaaatgc 2340attgccagtg tgtccgatca cacaggctac atcatgcagg gcagtaacgg gtctccagca 2400agaacatgac aagcagaaag cagaagaact caaacagcag gtagatgaac taacagctgc 2460caatagaaag gctgaacaag acatgagaga gctgacatat gaacttaatg ccctccagct 2520tgaaaaaacg tcatctgagg aaaaggctcg tttgctaaaa gataaactag atgaaacaaa 2580taatacactc agatgcctta agttggagct ggaaaggaag gatcaggcgg agaaagggta 2640ttctcaacaa ctcagagagc ttggtaggca attgaatcaa accacaggta aagctgaaga 2700agccatgcaa gaagctagtg atctcaagaa aataaagcgc aattatcagt tagaattaga 2760atctcttaat catgaaaaag ggaaactaca aagagaagta gacagaatca caagggcaca 2820tgctgtagct gagaagaata ttcagcattt aaattcacaa attcattctt ttcgagatga 2880gaaagaatta gaaagactac aaatctgcca gagaaaatca gatcatctaa aagaacaatt 2940tgagaaaagc catgagcagt tgcttcaaaa tatcaaagct gaaaaagaaa ataatgataa 3000aatccaaagg ctcaatgaag aattggagaa aagtaatgag tgtgcagaga tgctaaaaca 3060aaaagtagag gagcttacta ggcagaataa tgaaaccaaa ttaatgatgc agagaattca 3120ggcagaatca gagaatatag ttttagagaa acaaactatc cagcaaagat gtgaagcact 3180gaaaattcag gcagatggtt ttaaagatca gctacgcagc acaaatgaac acttgcataa 3240acagacaaaa acagagcagg attttcaaag aaaaattaaa tgcctagaag aagacctggc 3300gaaaagtcaa aatttggtaa gtgaatttaa gcaaaagtgt gaccaacaga acattatcat 3360ccagaatacc aagaaagaag ttagaaatct gaatgcggaa ctgaatgctt ccaaagaaga 3420gaagcgacgc ggggagcaga aagttcagct acaacaagct caggtgcaag agttaaataa 3480caggttgaaa aaagtacaag acgaattaca cttaaagacc atagaggagc agatgaccca 3540cagaaagatg gttctgtttc aggaagaatc tggtaaattc aaacaatcag cagaggagtt 3600tcggaagaag atggaaaaat taatggagtc caaagtcatc actgaaaatg atatttcagg 3660cattaggctt gactttgtgt ctcttcaaca agaaaactct agagcccaag aaaatgctaa 3720gctttgtgaa acaaacatta aagaacttga aagacagctt caacagtatc gtgaacaaat 3780gcagcaaggg cagcacatgg aagcaaatca ttaccaaaaa tgtcagaaac ttgaggatga 3840gctgatagcc cagaagcgtg aggttgaaaa cctgaagcaa aaaatggacc aacagatcaa 3900agagcatgaa catcaattag ttttgctcca gtgtgaaatt caaaaaaaga gcacagccaa 3960agactgtacc ttcaaaccag attttgagat gacagtgaag gagtgccagc actctggaga 4020gctgtcctct agaaacactg gacaccttca cccaacaccc agatcccctc tgttgagatg 4080gactcaagaa ccacagccat tggaagagaa gtggcagcat cgggttgttg aacagatacc 4140caaagaagtc caattccagc caccaggggc tccactcgag aaagagaaaa gccagcagtg 4200ttactctgag tacttttctc agacaagcac cgagttacag ataacttttg atgagacaaa 4260ccccattaca agactgtctg aaattgagaa gataagagac caagccctga acaattctag 4320accacctgtt aggtatcaag ataacgcatg tgaaatggaa ctggtgaagg ttttgacacc 4380cttagagata gctaagaaca agcagtatga tatgcataca gaagtcacaa cattaaaaca 4440agaaaagaac ccagttccca gtgctgaaga atggatgctt gaagggtgca gagcatctgg 4500tggactcaag aaaggggatt tccttaagaa gggcttagaa ccagagacct tccagaactt 4560tgatggtgat catgcatgtt cagtcaggga tgatgaattt aaattccaag ggcttaggca 4620cactgtgact gccaggcagt tggtggaagc taagcttctg gacatgagaa caattgagca 4680gctgcgactc ggtcttaaga ctgttgaaga agttcagaaa actcttaaca agtttctgac 4740gaaagccacc tcaattgcag ggctttacct agaatctaca aaagaaaaga tttcatttgc 4800ctcagcggcc gagagaatca taatagacaa aatggtggct ttggcatttt tagaagctca 4860ggctgcaaca ggttttataa ttgatcccat ttcaggtcag acatattctg ttgaagatgc 4920agttcttaaa ggagttgttg accccgaatt cagaattagg cttcttgagg cagagaaggc 4980agctgtggga tattcttatt cttctaagac attgtcagtg tttcaagcta tggaaaatag 5040aatgcttgac agacaaaaag gtaaacatat cttggaagcc cagattgcca gtgggggtgt 5100cattgaccct gtgagaggca ttcgtgttcc tccagaaatt gctctgcagc aggggttgtt 5160gaataatgcc atcttacagt ttttacatga gccatccagc aacacaagag ttttccctaa 5220tcccaataac aagcaagctc tgtattactc agaattactg cgaatgtgtg tatttgatgt 5280agagtcccaa tgctttctgt ttccatttgg ggagaggaac atttccaatc tcaatgtcaa 5340gaaaacacat agaatttctg tagtagatac taaaacagga tcagaattga ccgtgtatga 5400ggctttccag agaaacctga ttgagaaaag tatatatctt gaactttcag ggcagcaata 5460tcagtggaag gaagctatgt tttttgaatc ctatgggcat tcttctcata tgctgactga 5520tactaaaaca ggattacact tcaatattaa tgaggctata gagcagggaa caattgacaa 5580agccttggtc aaaaagtatc aggaaggcct catcacactt acagaacttg ctgattcttt 5640gctgagccgg ttagtcccca agaaagattt gcacagtcct gttgcagggt attggctgac 5700tgctagtggg gaaaggatct ctgtactaaa agcctcccgt agaaatttgg ttgatcggat 5760tactgccctc cgatgccttg aagcccaagt cagtacaggg ggcataattg atcctcttac 5820tggcaaaaag taccgggtgg ccgaagcttt gcatagaggc ctggttgatg aggggtttgc 5880ccagcagctg cgacagtgtg aattagtaat cacagggatt ggccatccca tcactaacaa 5940aatgatgtca gtggtggaag ctgtgaatgc aaatattata aataaggaaa tgggaatccg 6000atgtttggaa tttcagtact tgacaggagg gttgatagag ccacaggttc actctcggtt 6060atcaatagaa gaggctctcc aagtaggtat tatagatgtc ctcattgcca caaaactcaa 6120agatcaaaag tcatatgtca gaaatataat atgccctcag acaaaaagaa agttgacata 6180taaagaagcc ttagaaaaag ctgattttga tttccacaca ggacttaaac tgttagaagt 6240atctgagccc ctgatgacag gaatttctag cctctactat tcttcctaat gggacatgtt 6300taaataactg tgcaaggggt gatgcaggct ggttcatgcc actttttcag agtatgatga 6360tatcggctac atatgcagtc tgtgaattat gtaacatact ctatttcttg agggctgcaa 6420attgctaagt gctcaaaata gagtaagttt taaattgaaa attacataag atttaatgcc 6480cttcaaatgg tttcatttag ccttgagaat ggttttttga aacttggcca cactaaaatg 6540tttttttttt tttacgtaga atgtgggata aacttgatga actccaagtt cacagtgtca 6600tttcttcaga actccccttc attgaatagt gatcatttat taaatgataa attgcactcg 6660ctgaaagagc acgtcatgaa gcaccatgga atcaaagaga aagatataaa ttcgttccca 6720cagccttcaa gctgcagtgt tttagattgc ttcaaaaaat gaaaaagttt tgcctttttc 6780gatatagtga ccttctttgc atattaaaat gtttaccaca atgtcccatt tctagttaag 6840tcttcgcact tgaaagctaa cattatgaat attatgtgtt ggaggagggg aaggattttc 6900ttcattctgt gtattttccg g 6921 118 946 DNA Homo sapien 118cttctgactg ggctcaggct gacaggtaga gctcaccatg gcttcttgtg tccttgtccc 60ctccccatca cagctgtggt gcagtccacc gtctccagtg gctatggcgg tgccagtggt 120gtcggcagtg gcttaggcct gggtggagga agcagctact cctatggcag tggtcttggc 180gttggaggtg gcttcagttc cagcagtggc agagccattg ggggtggcct cagctctgtt 240ggaggcggca gttccaccat caagtacacc accacctcct cctccagcag gaagagctat 300aagcactaaa gtgcgtctgc tagctctcgg tcccacagtc ctcaggcccc tctctggctg 360cagagccctc tcctcaggtt gcctgtcctc tcctggcctc cagtctcccc tgctgtccca 420ggtagagctg gggatgaatg cttagtgccc tcacttcttc tctctctctc tataccatct 480gagcacccat tgctcaccat cagatcaacc tctgatttta catcatgatg taatcaccac 540tggagcttca ctgttactaa attattaatt tcttgcctcc agtgttctat ctctgaggct 600gagcattata agaaaatgac ctctgctcct tttcattgca gaaaattgcc aggggcttat 660ttcagaacaa cttccactta ctttccactg gctctcaaac tctctaactt ataagtgttg 720tgaaccccca cccaggcagt atccatgaaa gcacaagtga ctagtcctat gatgtacaaa 780gcctgtatct ctgtgatgat ttctgtgctc ttcactgttt gcaattgcta aataaagcag 840atttataata catatattct tttactttgc cttgctttgg ggccaaagtt ttgggcttaa 900acttttttat ctgataagtg aatagttgtt tttaaaagat aatcta 946 119 8948 DNA Homo sapien 119tcaacagccc ctgctccttg ggcccctcca tgccatgccg taatctctcc cacccgacca 60acaccaacac ccagctccga cgcagctcct ctgcgccctt gccgccctcc gagccacagc 120tttcctcccg ctcctgcccc cggcccgtcg ccgtctccgc gctcgcagcg gcctcgggag 180ggcccaggta gcgagcagcg acctcgcgag ccttccgcac tcccgcccgg ttccccggcc 240gtccgcctat ccttggcccc ctccgctttc tccgcgccgg cccgcctcgc ttatgcctcg 300gcgctgagcc gctctcccga ttgcccgccg acatgagctg caacggaggc tcccacccgc 360ggatcaacac tctgggccgc atgatccgcg ccgagtctgg cccggacctg cgctacgagg 420tgaccagcgg cggcgggggc accagcagga tgtactattc tcggcgcggc gtgatcaccg 480accagaactc ggacggctac tgtcaaaccg gcacgatgtc caggcaccag aaccagaaca 540ccatccagga gctgctgcag aactgctccg actgcttgat gcgagcagag ctcatcgtgc 600agcctgaatt gaagtatgga gatggaatac aactgactcg gagtcgagaa ttggatgagt 660gttttgccca ggccaatgac caaatggaaa tcctcgacag cttgatcaga gagatgcggc 720agatgggcca gccctgtgat gcttaccaga aaaggcttct tcagctccaa gagcaaatgc 780gagcccttta taaagccatc agtgtccctc gagtccgcag ggccagctcc aagggtggtg 840gaggctacac ttgtcagagt ggctctggct gggatgagtt caccaaacat gtcaccagtg 900aatgtttggg gtggatgagg cagcaaaggg cggagatgga catggtggcc tggggtgtgg 960acctggcctc agtggagcag cacattaaca gccaccgggg catccacaac tccatcggcg 1020actatcgctg gcagctggac aaaatcaaag ccgacctgcg cgagaaatct gcgatctacc 1080agttggagga ggagtatgaa aacctgctga aagcgtcctt tgagaggatg gatcacctgc 1140gacagctgca gaacatcatt caggccacgt ccagggagat catgtggatc aatgactgcg 1200aggaggagga gctgctgtac gactggagcg acaagaacac caacatcgct cagaaacagg 1260aggccttctc catacgcatg agtcaactgg aagttaaaga aaaagagctc aataagctga 1320aacaagaaag tgaccaactt gtcctcaatc agcatccagc ttcagacaaa attgaggcct 1380atatggacac tctgcagacg cagtggagtt ggattcttca gatcaccaag tgcattgatg 1440ttcatctgaa agaaaatgct gcctactttc agttttttga agaggcgcag tctactgaag 1500catacctgaa ggggctccag gactccatca ggaagaagta cccctgcgac aagaacatgc 1560ccctgcagca cctgctggaa cagatcaagg agctggagaa agaacgagag aaaatccttg 1620aatacaagcg tcaggtgcag aacttggtaa acaagtctaa gaagattgta cagctgaagc 1680ctcgtaaccc agactacaga agcaataaac ccattattct cagagctctc tgtgactaca 1740aacaagatca gaaaatcgtg cataaggggg atgagtgtat cctgaaggac aacaacgagc 1800gcagcaagtg gtacgtgacg ggcccgggag gcgttgacat gcttgttccc tctgtggggc 1860tgatcatccc tcctccgaac ccactggccg tggacctctc ttgcaagatt gagcagtact 1920acgaagccat cttggctctg tggaaccagc tctacatcaa catgaagagc ctggtgtcct 1980ggcactactg catgattgac atagagaaga tcagggccat gacaatcgcc aagctgaaaa 2040caatgcggca ggaagattac atgaagacga tagccgacct tgagttacat taccaagagt 2100tcatcagaaa tagccaaggc tcagagatgt ttggagatga tgacaagcgg aaaatacagt 2160ctcagttcac cgatgcccag aagcattacc agaccctggt cattcagctc cctggctatc 2220cccagcacca gacagtgacc acaactgaaa tcactcatca tggaacctgc caagatgtca 2280accataataa agtaattgaa accaacagag aaaatgacaa gcaagaaaca tggatgctga 2340tggagctgca gaagattcgc aggcagatag agcactgcga gggcaggatg actctcaaaa 2400acctccctct agcagaccag gggtcttctc accacatcac agtgaaaatt aacgagctta 2460agagtgtgca gaatgattca caagcaattg ctgaggttct caaccagctt aaagatatgc 2520ttgccaactt cagaggttct gaaaagtact gctatttaca gaatgaagta tttggactat 2580ttcagaaact ggaaaatatc aatggtgtta cagatggcta cttaaatagc ttatgcacag 2640taagggcact gctccaggct attctccaaa cagaagacat gttaaaggtt tatgaagcca 2700ggctcactga ggaggaaact gtctgcctgg acctggataa agtggaagct taccgctgtg 2760gactgaagaa aataaaaaat gacttgaact tgaagaagtc gttgttggcc actatgaaga 2820cagaactaca gaaagcccag cagatccact ctcagacttc acagcagtat ccactttatg 2880atctggactt gggcaagttc ggtgaaaaag tcacacagct gacagaccgc tggcaaagga 2940tagataaaca gatcgacttt agattatggg acctggagaa acaaatcaag caattgagga 3000attatcgtga taactatcag gctttctgca agtggctcta tgatcgtaaa cgccgccagg 3060attccttaga atccatgaaa tttggagatt ccaacacagt catgcggttt ttgaatgagc 3120agaagaactt gcacagtgaa atatctggca aacgagacaa atcagaggaa gtacaaaaaa 3180ttgctgaact ttgcgccaat tcaattaagg attatgagct ccagctggcc tcatacacct 3240caggactgga aactctgctg aacataccta tcaagaggac catgattcag tccccttctg 3300gggtgattct gcaagaggct gcagatgttc atgctcggta cattgaacta cttacaagat 3360ctggagacta ttacaggttc ttaagtgaga tgctgaagag tttggaagat ctgaagctga 3420aaaataccaa gatcgaagtt ttggaagagg agctcagact ggcccgagat gccaactcgg 3480aaaactgtaa taagaacaaa ttcctggatc agaacctgca gaaataccag gcagagtgtt 3540cccagttcaa agcgaagctt gcgagcctgg aggagctgaa gagacaggct gagctggatg 3600ggaagtcggc taagcaaaat ctagacaagt gctacggcca aataaaagaa ctcaatgaga 3660agatcacccg actgacttat gagattgaag atgaaaagag aagaagaaaa tctgtggaag 3720acagatttga ccaacagaag aatgactatg accaactgca gaaagcaagg caatgtgaaa 3780aggagaacct tggttggcag aaattagagt ctgagaaagc catcaaggag aaggagtacg 3840agattgaaag gttgagggtt ctactgcagg aagaaggcac ccggaagaga gaatatgaaa 3900atgagctggc aaaggtaaga aaccactata atgaggagat gagtaattta aggaacaagt 3960atgaaacaga gattaacatt acgaagacca ccatcaagga gatatccatg caaaaagagg 4020atgattccaa aaatcttaga aaccagcttg atagactttc aagggaaaat cgagatctga 4080aggatgaaat tgtcaggctc aatgacagca tcttgcaggc cactgagcag cgaaggcgag 4140ctgaagaaaa cgcccttcag caaaaggcct gtggctctga gataatgcag aagaagcagc 4200atctggagat agaactgaag caggtcatgc agcagcgctc tgaggacaat gcccggcaca 4260agcagtccct ggaggaggct gccaagacca ttcaggacaa aaataaggag atcgagagac 4320tcaaagctga gtttcaggag gaggccaagc gccgctggga atatgaaaat gaactgagta 4380aggtaagaaa caattatgat gaggagatca ttagcttaaa aaatcagttt gagaccgaga 4440tcaacatcac caagaccacc atccaccagc tcaccatgca gaaggaagag gataccagtg 4500gctaccgggc tcagatagac aatctcaccc gagaaaacag gagcttatct gaagaaataa 4560agaggctgaa gaacactcta acccagacca cagagaatct caggagggtg gaagaagaca 4620tccaacagca aaaggccact ggctctgagg tgtctcagag gaaacagcag ctggaggttg 4680agctgagaca agtcactcag atgcgaacag aggagagcgt aagatataag caatctcttg 4740atgatgctgc caaaaccatc caggataaaa acaaggagat agaaaggtta aaacaactga 4800tcgacaaaga aacaaatgac cggaaatgcc tggaagatga aaacgcgaga ttacaaaggg 4860tccagtatga cctgcagaaa gcaaacagta gtgcgacgga gacaataaac aaactgaagg 4920ttcaggagca agaactgaca cgcctgagga tcgactatga aagggtttcc caggagagga 4980ctgtgaagga ccaggatatc acgcggttcc agaactctct gaaagagctg cagctgcaga 5040agcagaaggt ggaagaggag ctgaatcggc tgaagaggac cgcgtcagaa gactcctgca 5100agaggaagaa gctggaggaa gagctggaag gcatgaggag gtcgctgaag gagcaagcca 5160tcaaaatcac caacctgacc cagcagctgg agcaggcatc cattgttaag aagaggagtg 5220aggatgacct ccggcagcag agggacgtgc tggatggcca cctgagggaa aagcagagga 5280cccaggaaga gctgaggagg ctctcttctg aggtcgaggc cctgaggcgg cagttactcc 5340aggaacagga aagtgtcaaa caagctcact tgaggaatga gcatttccag aaggcgatag 5400aagataaaag cagaagctta aatgaaagca aaatagaaat tgagaggctg cagtctctca 5460cagagaacct gaccaaggag cacttgatgt tagaagaaga actgcggaac ctgaggctgg 5520agtacgatga cctgaggaga ggacgaagcg aagcggacag tgataaaaat gcaaccatct 5580tggaactaag gagccagctg cagatcagca acaaccggac cctggaactg caggggctga 5640ttaatgattt acagagagag agggaaaatt tgagacagga aattgagaaa ttccaaaagc 5700aggctttaga ggcatctaat aggattcagg aatcaaagaa tcagtgtact caggtggtac 5760aggaaagaga gagccttctg gtgaaaatca aagtcctgga gcaagacaag gcaaggctgc 5820agaggctgga ggatgagctg aatcgtgcaa aatcaactct agaggcagaa accagggtga 5880aacagcgcct ggagtgtgag aaacagcaaa ttcagaatga cctgaatcag tggaagactc 5940aatattcccg caaggaggag gctattagga agatagaatc ggaaagagaa aagagtgaga 6000gagagaagaa cagtcttagg agtgagatcg aaagactcca agcagagatc aagagaattg 6060aagagaggtg caggcgtaag ctggaggatt ctaccaggga gacacagtca cagttagaaa 6120cagaacgctc ccgatatcag agggagattg ataaactcag acagcgccca tatgggtccc 6180atcgagagac ccagactgag tgtgagtgga ccgttgacac ctccaagctg gtgtttgatg 6240ggctgaggaa gaaggtgaca gcaatgcagc tctatgagtg tcagctgatc gacaaaacaa 6300ccttggacaa actattgaag gggaagaagt cagtggaaga agttgcttct gaaatccagc 6360cattccttcg gggtgcagga tctatcgctg gagcatctgc ttctcctaag gaaaaatact 6420ctttggtaga ggccaagaga aagaaattaa tcagcccaga atccacagtc atgcttctgg 6480aggcccaggc agctacaggt ggtataattg atccccatcg gaatgagaag ctgactgtcg 6540acagtgccat agctcgggac ctcattgact tcgatgaccg tcagcagata tatgcagcag 6600aaaaagctat cactggtttt gatgatccat tttcaggcaa gacagtatct gtttcagaag 6660ccatcaagaa aaatttgatt gatagagaaa ccggaatgcg cctgctggaa gcccagattg 6720cttcaggggg tgtagtagac cctgtgaaca gtgtcttttt gccaaaagat gtcgccttgg 6780cccgggggct gattgataga gatttgtatc gatccctgaa tgatccccga gatagtcaga 6840aaaactttgt ggatccagtc accaaaaaga aggtcagtta cgtgcagctg aaggaacggt 6900gcagaatcga accacatact ggtctgctct tgctttcagt acagaagaga agcatgtcct 6960tccaaggaat cagacaacct gtgaccgtca ctgagctagt agattctggt atattgagac 7020cgtccactgt caatgaactg gaatctggtc agatttctta tgacgaggtt ggtgagagaa 7080ttaaggactt cctccagggt tcaagctgca tagcaggcat atacaatgag accacaaaac 7140agaagcttgg catttatgag gccatgaaaa ttggcttagt ccgacctggt actgctctgg 7200agttgctgga agcccaagca gctactggct ttatagtgga tcctgttagc aacttgaggt 7260taccagtgga ggaagcctac aagagaggtc tggtgggcat tgagttcaaa gagaagctcc 7320tgtctgcaga acgagctgtc actgggtata atgatcctga aacaggaaac atcatctctt 7380tgttccaagc catgaataag gaactcatcg aaaagggcca cggtattcgc ttattagaag 7440cacagatcgc aaccgggggg atcattgacc caaaggagag ccatcgttta ccagttgaca 7500tagcatataa gaggggctat ttcaatgagg aactcagtga gattctctca gatccaagtg 7560atgataccaa aggatttttt gaccccaaca ctgaagaaaa tcttacctat ctgcaactaa 7620aagaaagatg cattaaggat gaggaaacag ggctctgtct tctgcctctg aaagaaaaga 7680agaaacaggt gcagacatca caaaagaata ccctcaggaa gcgtagagtg gtcatagttg 7740acccagaaac caataaagaa atgtctgttc aggaggccta caagaagggc ctaattgatt 7800atgaaacctt caaagaactg tgtgagcagg aatgtgaatg ggaagaaata accatcacgg 7860gatcagatgg ctccaccagg gtggtcctgg tagatagaaa gacaggcagt cagtatgata 7920ttcaagatgc tattgacaag ggccttgttg acaggaagtt ctttgatcag taccgatccg 7980gcagcctcag cctcactcaa tttgctgaca tgatctcctt gaaaaatggt gtcggcacca 8040gcagcagcat gggcagtggt gtcagcgatg atgtttttag cagctcccga catgaatcag 8100taagtaagat ttccaccata tccagcgtca ggaatttaac cataaggagc agctcttttt 8160cagacaccct ggaagaatcg agccccattg cagccatctt tgacacagaa aacctggaga 8220aaatctccat tacagaaggt atagagcggg gcatcgttga cagcatcacg ggtcagaggc 8280ttctggaggc tcaggcctgc acaggtggca tcatccaccc aaccacgggc cagaagctgt 8340cacttcagga cgcagtctcc cagggtgtga ttgaccaaga catggccacc agcgtgaagc 8400ctgctcagaa agccttcata ggcttcgagg gtgtgaaggg aaagaagaag atgtcagcag 8460cagaggcagt gaaagaaaaa tggctcccgt atgaggctgg ccagcgcttc ctggagttcc 8520agtacctcac gggaggtctt gttgacccgg aagtgcatgg gaggataagc accgaagaag 8580ccatccggaa ggggttcata gatggccgcg ccgcacagag gctgcaagac accagcagct 8640atgccaaaat cctgacctgc cccaaaacca aattaaaaat atcctataag gatgccataa 8700atcgctccat ggtagaagat atcactgggc tgcgccttct ggaagccgcc tccgtgtcgt 8760ccaagggctt acccagccct tacaacatgt cttcggctcc ggggtcccgc tccggctccc 8820gctcgggatc tcgctccgga tctcgctccg ggtcccgcag tgggtcccgg agaggaagct 8880ttgacgccac agggaattct tcctactctt attcctactc atttagcagt agttctattg 8940ggcactag 8948 120 587 DNA Homo sapien misc_feature (1)...(587) n = A,T,C or G 120cgtcctaagc acttagacta catcagggaa gaacacagac cacatccctg tcctcatgcg 60gcttatgttt tctggaagaa agtggagacc nagtccttgg ctttagggct ccccggctgg 120gggctgtgca ntccggtcag ggcgggaagg gaaatgcacc gctgcatgtg aacttacagc 180ccaggcggat gccccttccc ttagcactac ctggcctcct gcatcccctc gcctcatgtt 240cctcccacct tcaaanaatg aanaacccca tgggcccagc cccttgccct ggggaaccaa 300ggcagccttc caaaactcag gggctgaagc anactattag ggcaggggct gactttgggt 360gacactgccc attccctctc agggcagctc angtcacccn ggnctcttga acccagcctg 420ttcctttgaa aaagggcaaa actgaaaagg gcttttccta naaaaagaaa aaccagggaa 480ctttgccagg gcttcnntnt taccaaaacn ncttctcnng gatttttaat tccccattng 540gcctccactt accnggggcn atgccccaaa attaanaatt tcccatc 587 121 619 DNA Homo sapien misc_feature (1)...(619) n = A,T,C or G 121cactagtagg atagaaacac tgtgtcccga gagtaaggag agaagctact attgattaga 60gcctaaccca ggttaactgc aagaagaggc gggatacttt cagctttcca tgtaactgta 120tgcataaagc caatgtagtc cagtttctaa gatcatgttc caagctaact gaatcccact 180tcaatacaca ctcatgaact cctgatggaa caataacagg cccaagcctg tggtatgatg 240tgcacacttg ctagactcan aaaaaatact actctcataa atgggtggga gtattttggt 300gacaacctac tttgcttggc tgagtgaagg aatgatattc atatattcat ttattccatg 360gacatttagt tagtgctttt tatataccag gcatgatgct gagtgacact cttgtgtata 420tttccaaatt tttgtacagt cgctgcacat atttgaaatc atatattaag acttccaaaa 480aatgaagtcc ctggtttttc atggcaactt gatcagtaaa ggattcncct ctgtttggta 540cttaaaacat ctactatatn gttnanatga aattcctttt ccccncctcc cgaaaaaana 600aagtggtggg gaaaaaaaa 619 122 1475 DNA Homo sapien 122tccacctgtc cccgcagcgc cggctcgcgc cctcctgccg cagccaccga gccgccgtct 60agcgccccga cctcgccacc atgagagccc tgctggcgcg cctgcttctc tgcgtcctgg 120tcgtgagcga ctccaaaggc agcaatgaac ttcatcaagt tccatcgaac tgtgactgtc 180taaatggagg aacatgtgtg tccaacaagt acttctccaa cattcactgg tgcaactgcc 240caaagaaatt cggagggcag cactgtgaaa tagataagtc aaaaacctgc tatgagggga 300atggtcactt ttaccgagga aaggccagca ctgacaccat gggccggccc tgcctgccct 360ggaactctgc cactgtcctt cagcaaacgt accatgccca cagatctgat gctcttcagc 420tgggcctggg gaaacataat tactgcagga acccagacaa ccggaggcga ccctggtgct 480atgtgcaggt gggcctaaag ccgcttgtcc aagagtgcat ggtgcatgac tgcgcagatg 540gaaaaaagcc ctcctctcct ccagaagaat taaaatttca gtgtggccaa aagactctga 600ggccccgctt taagattatt gggggagaat tcaccaccat cgagaaccag ccctggtttg 660cggccatcta caggaggcac cgggggggct ctgtcaccta cgtgtgtgga ggcagcctca 720tcagcccttg ctgggtgatc agcgccacac actgcttcat tgattaccca aagaaggagg 780actacatcgt ctacctgggt cgctcaaggc ttaactccaa cacgcaaggg gagatgaagt 840ttgaggtgga aaacctcatc ctacacaagg actacagcgc tgacacgctt gctcaccaca 900acgacattgc cttgctgaag atccgttcca aggagggcag gtgtgcgcag ccatcccgga 960ctatacagac catctgcctg ccctcgatgt ataacgatcc ccagtttggc acaagctgtg 1020agatcactgg ctttggaaaa gagaattcta ccgactatct ctatccggag cagctgaaga 1080tgactgttgt gaagctgatt tcccaccggg agtgtcagca gccccactac tacggctctg 1140aagtcaccac caaaatgctg tgtgctgctg acccacagtg gaaaacagat tcctgccagg 1200gagactcagg gggacccctc gtctgttccc tccaaggccg catgactttg actggaattg 1260tgagctgggg ccgtggatgt gccctgaagg acaagccagg cgtctacacg agagtctcac 1320acttcttacc ctggatccgc agtcacacca aggaagagaa tggcctggcc ctctgagggt 1380ccccagggag gaaacgggca ccacccgctt tcttgctggt tgtcattttt gcagtagagt 1440catctccatc agctgtaaga agagactggg aagat 1475 123 2294 DNA Homo sapien 123cagcgccggc tcgcgccctc ctgccgcagc caccgagccg ccgtctagcg ccccgacctc 60gccaccatga gagccctgct ggcgcgcctg cttctctgcg tcctggtcgt gagcgactcc 120aaaggcagca atgaacttca tcaagttcca tcgaactgtg actgtctaaa tggaggaaca 180tgtgtgtcca acaagtactt ctccaacatt cactggtgca actgcccaaa gaaattcgga 240gggcagcact gtgaaataga taagtcaaaa acctgctatg aggggaatgg tcacttttac 300cgaggaaagg ccagcactga caccatgggc cggccctgcc tgccctggaa ctctgccact 360gtccttcagc aaacgtacca tgcccacaga tctgatgctc ttcagctggg cctggggaaa 420cataattact gcaggaaccc agacaaccgg aggcgaccct ggtgctatgt gcaggtgggc 480ctaaagccgc ttgtccaaga gtgcatggtg catgactgcg cagatggaaa aaagccctcc 540tctcctccag aagaattaaa atttcagtgt ggccaaaaga ctctgaggcc ccgctttaag 600attattgggg gagaattcac caccatcgag aaccagccct ggtttgcggc catctacagg 660aggcaccggg ggggctctgt cacctacgtg tgtggaggca gcctcatcag cccttgctgg 720gtgatcagcg ccacacactg cttcattgat tacccaaaga aggaggacta catcgtctac 780ctgggtcgct caaggcttaa ctccaacacg caaggggaga tgaagtttga ggtggaaaac 840ctaatcctac acaaggacta cagcgctgac acgcttgctc accacaacga cattgccttg 900ctgaagatcc gttccaagga gggcaggtgt gcgcagccat cccggactat acagaccatc 960tgcctgccct cgatgtataa cgatccccag tttggcacaa gctgtgagat cactggcttt 1020ggaaaagaga attctaccga ctatctctat ccggagcagc tgaaaatgac tgttgtgaag 1080ctgatttccc accgggagtg tcagcagccc cactactacg gctctgaagt caccaccaaa 1140atgctgtgtg ctgctgaccc acagtggaaa acagattcct gccagggaga ctcaggggga 1200cccctcgtct gttccctcca aggccgcatg actttgactg gaattgtgag ctggggccgt 1260ggatgtgccc tgaaggacaa gccaggcgtc tacacgagag tctcacactt cttaccctgg 1320atccgcagtc acaccaagga agagaatggc ctggccctct gagggtcccc agggaggaaa 1380cgggcaccac ccgctttctt gctggttgct attttgcagt agagtcatct ccatcagctg 1440taagaagagc tgggaatata ggctctgcac agatggattt gcctgtgcca ccaccagggc 1500gaacgacaat agctttaccc tcaggcatag gcctgggtgc tggctgccca gacccctctg 1560gccaggatgg aggggtggtc ctgactcaac atgttactga ccagcaactt gtctttttct 1620ggactgaagc ctgcaggagt taaaaagggc agggcatctc ctgtgcatgg gctcgaaggg 1680agagccagct cccccgaccg gtgggcattt gtgaggccca tggttgagaa atgaataatt 1740tcccaattag gaagtgtaag cagctgaggt ctcttgaggg agcttagcca atgtgggagc 1800agcggtttgg ggagcagaga cactaacgac ttcagggcag ggctctgata ttccatgaat 1860gtatcaggaa atatatatgt gtgtgtatgt ttgcacactt gtgtgtgggc tgtgagtgta 1920agtgtgagta agagctggtg tctgattgtt aagtctaaat atttccttaa actgtgtgga 1980ctgtgatgcc acacagagtg gtctttctgg agaggttata ggtcactcct ggggcctctt 2040gggtccccca cgtgacagtg cctgggaatg tattattctg cagcatgacc tgtgaccagc 2100actgtctcag tttcactttc acatagatgt ccctttcttg gccagttatc ccttcctttt 2160agcctagttc atccaatcct cactgggtgg ggtgaggacc actcctgtac actgaatatt 2220tatatttcac tatttttatt tatatttttg taattttaaa taaaagtgat caataaaatg 2280tgatttttct gatg 2294 124 956 DNA Homo sapien 124gatgagttcc gcaccaagtt tgagacagac caggccctgc gcctgagtgt ggaggccgac 60atcaatggcc tgcgcagggt gctggatgag ctgaccctgg ccagagccga cctggagatg 120cagattgaga acctcaagga ggagctggcc tacctgaaga agaaccacga ggaggagatg 180aacgccctgc gaggccaggt gggtggtgag atcaatgtgg agatggacgc tgccccaggc 240gtggacctga gccgcatcct caacgagatg cgtgaccagt atgagaagat ggcagagaag 300aaccgcaagg atgccgagga ttggttcttc agcaagacag aggaactgaa ccgcgaggtg 360gccaccaaca gtgagctggt gcagagtggc aagagtgaga tctcggagct ccggcgcacc 420atgcaggcct tggagataga gctgcagtcc cagctcagca tgaaagcatc cctggagggc 480aacctggcgg agacagagaa ccgctactgc gtgcagctgt cccagatcca ggggctgatt 540ggcagcgtgg aggagcagct ggcccagctt cgctgcgaga tggagcagca gaaccaggaa 600tacaaaatcc tgctggatgt gaagacgcgg ctggagcagg agattgccac ctaccgccgc 660ctgctggagg gagaggatgc ccacctgact cagtacaaga aagaaccggt gaccacccgt 720caggtgcgta ccattgtgga agaggtccag gatggcaagg tcatctcctc ccgcgagcag 780gtccaccaga ccacccgctg aggactcagc taccccggcc ggccacccag gaggcaggga 840cgcagccgcc ccatctgccc cacagtctcc ggcctctcca gcctcagccc cctgcttcag 900tcccttcccc atgcttcctt gcctgatgac aataaaagct tgttgactca gctatg 956 125 486 DNA Homo sapien misc_feature (1)...(486) n = A,T,C or G 125aaattatata tagtgnttca gctcccattg tggtgttcat agtcttctag gaacagataa 60acttaagtat tcaattcact cttggcattt tttctttaat ataggctttt tagcctattt 120ttggaaaact gcttttcttc tgagaacctt attctgaatg tcatcaactt taccaaacct 180tctaagtcca gagctaactt agtactgttt aagttactat tgactgaatt ttcttcattt 240tctgtttagc cagtgttacc aaggtaagct ggggaatgaa gtataccaac ttctttcaga 300gcattttagg acattatggc agctttagaa ggctgtcttg tttctagcca agggagagcc 360agcgcaggtt ttggatacta gagaaagtca tttgcttgta ctattgccat tttagaaagc 420tctgatgtga attcaaattt tacctctgtt acttaaagcc aacaatttta aggcagtagt 480tttact 486 126 3552 DNA Homo sapien 126cggcaggcag gtctcgtctc ggcaccctcc cggcgcccgc gttctcctgg ccctgcccgg 60catcccgatg gccgccgctg ggccccggcg ctccgtgcgc ggagccgtct gcctgcatct 120gctgctgacc ctcgtgatct tcagtcgtgc tggtgaagcc tgcaaaaagg tgatacttaa 180tgtaccttct aaactagagg cagacaaaat aattggcaga gttaatttgg aagagtgctt 240caggtctgca gacctcatcc ggtcaagtga tcctgatttc agagttctaa atgatgggtc 300agtgtacaca gccagggctg ttgcgctgtc tgataagaaa agatcattta ccatatggct 360ttctgacaaa aggaaacaga cacagaaaga ggttactgtg ctgctagaac atcagaagaa 420ggtatcgaag acaagacaca ctagagaaac tgttctcagg cgtgccaaga ggagatgggc 480acctattcct tgctctatgc aagagaattc cttgggccct ttcccattgt ttcttcaaca 540agttgaatct gatgcagcac agaactatac tgtcttctac tcaataagtg gacgtggagt 600tgataaagaa cctttaaatt tgttttatat agaaagagac actggaaatc tattttgcac 660tcggcctgtg gatcgtgaag aatatgatgt ttttgatttg attgcttatg cgtcaactgc 720agatggatat tcagcagatc tgcccctccc actacccatc agggtagagg atgaaaatga 780caaccaccct gttttcacag aagcaattta taattttgaa gttttggaaa gtagtagacc 840tggtactaca gtgggggtgg tttgtgccac agacagagat gaaccggaca caatgcatac 900gcgcctgaaa tacagcattt tgcagcagac accaaggtca cctgggctct tttctgtgca 960tcccagcaca ggcgtaatca ccacagtctc tcattatttg gacagagagg ttgtagacaa 1020gtactcattg ataatgaaag tacaagacat ggatggccag ttttttggat tgataggcac 1080atcaacttgt atcataacag taacagattc aaatgataat gcacccactt tcagacaaaa 1140tgcttatgaa gcatttgtag aggaaaatgc attcaatgtg gaaatcttac gaatacctat 1200agaagataag gatttaatta acactgccaa ttggagagtc aattttacca ttttaaaggg 1260aaatgaaaat ggacatttca aaatcagcac agacaaagaa actaatgaag gtgttctttc 1320tgttgtaaag ccactgaatt atgaagaaaa ccgtcaagtg aacctggaaa ttggagtaaa 1380caatgaagcg ccatttgcta gagatattcc cagagtgaca gccttgaaca gagccttggt 1440tacagttcat gtgagggatc tggatgaggg gcctgaatgc actcctgcag cccaatatgt 1500gcggattaaa gaaaacttag cagtggggtc aaagatcaac ggctataagg catatgaccc 1560cgaaaataga aatggcaatg gtttaaggta caaaaaattg catgatccta aaggttggat 1620caccattgat gaaatttcag ggtcaatcat aacttccaaa atcctggata gggaggttga 1680aactcccaaa aatgagttgt ataatattac agtcctggca atagacaaag atgatagatc 1740atgtactgga acacttgctg tgaacattga agatgtaaat gataatccac cagaaatact 1800tcaagaatat gtagtcattt gcaaaccaaa aatggggtat accgacattt tagctgttga 1860tcctgatgaa cctgtccatg gagctccatt ttatttcagt ttgcccaata cttctccaga 1920aatcagtaga ctgtggagcc tcaccaaagt taatgataca gctgcccgtc tttcatatca 1980gaaaaatgct ggatttcaag aatataccat tcctattact gtaaaagaca gggccggcca 2040agctgcaaca aaattattga gagttaatct gtgtgaatgt actcatccaa ctcagtgtcg 2100tgcgacttca aggagtacag gagtaatact tggaaaatgg gcaatccttg caatattact 2160gggtatagca ctgctctttt ctgtattgct aactttagta tgtggagttt ttggtgcaac 2220taaagggaaa cgttttcctg aagatttagc acagcaaaac ttaattatat caaacacaga 2280agcacctgga gacgatagag tgtgctctgc caatggattt atgacccaaa ctaccaacaa 2340ctctagccaa ggtttttgtg gtactatggg atcaggaatg aaaaatggag ggcaggaaac 2400cattgaaatg atgaaaggag gaaaccagac cttggaatcc tgccgggggg ctgggcatca 2460tcataccctg gactcctgca ggggaggaca cacggaggtg gacaactgca gatacactta 2520ctcggagtgg cacagtttta ctcaaccccg tctcggtgaa aaattgcatc gatgtaatca 2580gaatgaagac cgcatgccat cccaagatta tgtcctcact tataactatg agggaagagg 2640atctccagct ggttctgtgg gctgctgcag tgaaaagcag gaagaagatg gccttgactt 2700tttaaataat ttggaaccca aatttattac attagcagaa gcatgcacaa agagataatg 2760tcacagtgct acaattaggt ctttgtcaga cattctggag gtttccaaaa ataatattgt 2820aaagttcaat ttcaacatgt atgtatatga tgattttttt ctcaattttg aattatgcta 2880ctcaccaatt tatattttta aagcaagttg ttgcttatct tttccaaaaa gtgaaaaatg 2940ttaaaacaga caactggtaa atctcaaact ccagcactgg aattaaggtc tctaaagcat 3000ctgctctttt ttttttttac agatatttta gtaataaata tgctggataa atattagtcc 3060aacaatagct aagttatgct aatatcacat tattatgtat tcactttaag tgatagttta 3120aaaaataaac aagaaatatt gagtatcact atgtgaagaa agttttggaa aagaaacaat 3180gaagactgaa ttaaattaaa aatgttgcag ctcataaaga attggactca cccctactgc 3240actaccaaat tcatttgact ttggaggcaa aatgtgttga agtgccctat gaagtagcaa 3300ttttctatag gaatatagtt ggaaataaat gtgtgtgtgt atattattat taatcaatgc 3360aatatttaaa tgaaatgaga acaaagagga aaatggtaaa aacttgaaat gaggctgggg 3420tatagtttgt cctacaatag aaaaaagaga gagcttccta ggcctgggct cttaaatgct 3480gcattataac tgagtctatg aggaaatagt tcctgtccaa tttgtgtaat ttgtttaaaa 3540ttgtaaataa at 3552 127 754 DNA Homo sapien 127tttttttttt ttgtcattgt tcattgattt taatgagaaa gctaagagag gaaataagta 60gcctttcaaa ggtcacacag aagtaagtga cagatccagg attcatatcc aagcattctg 120gctctagtgt ccatgcttct caaccattat gacccaatat tcaaccaaat caatactgaa 180ggacacgtga aatgtatccg gtattttact attacaaaca aaaatccaat gaacattctt 240gaagacatac acaaaaataa tggttacaat agaagttact ggaattgaaa ttttggttca 300acctatatta aaatgtaagg cttttgatat agctaataga tttttgaaat gatcagtctt 360aacgtttgta ggggagcaca ctcctgcatg gggaaaagat tcactgtgaa gcacagagca 420cctttatggt tggatcatct tgtcattaaa gttcaggcgt tatctatcct gtaagtggca 480gaatcaagac tgcaatatcg cctgcttttc tttttaactc atgttttccc ttgactacac 540tggtcctcaa agtaaaaccc ctgtgtcagt gtactattca tggaatactc tgcaattata 600accaccttct aatactttta atacccaatc aaaatttatt atacatatgt atcatagata 660ctcatctgta aagctgtgct tcaaaatagt gatctcttcc caacattaca atatatatta 720atgatgtcga acctgcccgg gcggccgctc gaag 754 128 374 DNA Homo sapien 128aggttttgat taaaaaggca aatgatttta ttgttcgata atcttttaaa aaaataagag 60gaaggagtaa aattaaagat gaaagatgat ttttatttcc ttgtgacctc tatatccccc 120ttcccctgcc cttggtaagt aactcttgat ggagaaagga ttaaagactc ttatttaacc 180aaaaaacaga gccagctaat catttccaaa ggttagtatc tccctgctga cctcttcttt 240ggtttaattg aataaaacta tatgttcata tatgtattaa aacaactcag aataacatct 300tttcttcctt agttaaggca ttataagggc tatactatca tccataataa ccaaggcaat 360aacttaaaaa gctg 374 129 546 DNA Homo sapien 129agtgtgatgg atatctgcag aattcgggct aagcgtggtc gcggcccgag gtctggaact 60tcccagcacy tgaaaaggag cctcctgagc tgactcggct aaagccccac tttcgctcct 120cctcatttct gcctactgat ttccttggag cattcatctg aatattaccg tttgctgtgt 180aacctggtac atacatagca tgactccctg gaatagagtg ggctggggtg cttatgctgg 240gagagtgatt gacatgcact ttcaagctat atctaccatt tgcagcaaag gagaaaaaat 300acctcgagta aattccatca ttttttataa catcagcacc tgctccatca tcaaggagtc 360tcagcgtaac aggatctcca gtctctggct caactgtggc agtgacagtg gcattaagaa 420tgggataaaa tccctgtttc acattggcat aaatcatcac aggatgagga aaatggaggc 480tgtctctttc cacaaaggct tccacagtgg ctgggggcac agacctgccc gggcggccgc 540tcgaaa 546 130 5156 DNA Homo sapien 130accaaccgag gcgccgggca gcgacccctg cagcggagac agagactgag cggcccggca 60ccgccatgcc tgcgctctgg ctgggctgct gcctctgctt gtcgctcctc ctgcccgcag 120cccgggccac ctccaggagg gaagtctgtg attgcaatgg gaagtccagg cagtgtatct 180ttgatcggga acttcacaga caaactggta atggattccg ctgcctcaac tgcaatgaca 240acactgatgg cattcactgc gagaagtgca agaatggctt ttaccggcac agagaaaggg 300accgctgttt gccctgcaat tgtaactcca aaggttctct tagtgctcga tgtgacaact 360ccggacggtg cagctgtaaa ccaggtgtga caggagccag atgcgaccga tgtctgccag 420gcttccacat gctcacggat gcggggtgca cccaagacca gagactgcta gactccaagt 480gtgactgtga cccagctggc atcgcagggc cctgtgacgc gggccgctgt gtctgcaagc 540cagctgtcac tggagaacgc tgtgataggt gtcgatcagg ttactataat ctggatgggg 600ggaaccctga gggctgtacc cagtgtttct gctatgggca ttcagccagc tgccgcagct 660ctgcagaata cagtgtccat aagatcacct ctacctttca tcaagatgtt gatggctgga 720aggctgtcca acgaaatggg tctcctgcaa agctccaatg gtcacagcgc catcaagatg 780tgtttagctc agcccaacga ctagaccctg tctattttgt ggctcctgcc aaatttcttg 840ggaatcaaca ggtgagctat ggtcaaagcc tgtcctttga ctaccgtgtg gacagaggag 900gcagacaccc atctgcccat gatgtgattc tggaaggtgc tggtctacgg atcacagctc 960ccttgatgcc acttggcaag acactgcctt gtgggctcac caagacttac acattcaggt 1020taaatgagca tccaagcaat aattggagcc cccagctgag ttactttgag tatcgaaggt 1080tactgcggaa tctcacagcc ctccgcatcc gagctacata tggagaatac agtactgggt 1140acattgacaa tgtgaccctg atttcagccc gccctgtctc tggagcccca gcaccctggg 1200ttgaacagtg tatatgtcct gttgggtaca aggggcaatt ctgccaggat tgtgcttctg 1260gctacaagag agattcagcg agactggggc cttttggcac ctgtattcct tgtaactgtc 1320aagggggagg ggcctgtgat ccagacacag gagattgtta ttcaggggat gagaatcctg 1380acattgagtg tgctgactgc ccaattggtt tctacaacga tccgcacgac ccccgcagct 1440gcaagccatg tccctgtcat aacgggttca gctgctcagt gatgccggag acggaggagg 1500tggtgtgcaa taactgccct cccggggtca ccggtgcccg ctgtgagctc tgtgctgatg 1560gctactttgg ggaccccttt ggtgaacatg gcccagtgag gccttgtcag ccctgtcaat 1620gcaacaacaa tgtggacccc agtgcctctg ggaattgtga ccggctgaca ggcaggtgtt 1680tgaagtgtat ccacaacaca gccggcatct actgcgacca gtgcaaagca ggctacttcg 1740gggacccatt ggctcccaac ccagcagaca agtgtcgagc ttgcaactgt aaccccatgg 1800gctcagagcc tgtaggatgt cgaagtgatg gcacctgtgt ttgcaagcca ggatttggtg 1860gccccaactg tgagcatgga gcattcagct gtccagcttg ctataatcaa gtgaagattc 1920agatggatca gtttatgcag cagcttcaga gaatggaggc cctgatttca aaggctcagg 1980gtggtgatgg agtagtacct gatacagagc tggaaggcag gatgcagcag gctgagcagg 2040cccttcagga cattctgaga gatgcccaga tttcagaagg tgctagcaga tcccttggtc 2100tccagttggc caaggtgagg agccaagaga acagctacca gagccgcctg gatgacctca 2160agatgactgt ggaaagagtt cgggctctgg gaagtcagta ccagaaccga gttcgggata 2220ctcacaggct catcactcag atgcagctga gcctggcaga aagtgaagct tccttgggaa 2280acactaacat tcctgcctca gaccactacg tggggccaaa tggctttaaa agtctggctc 2340aggaggccac aagattagca gaaagccacg ttgagtcagc cagtaacatg gagcaactga 2400caagggaaac tgaggactat tccaaacaag ccctctcact ggtgcgcaag gccctgcatg 2460aaggagtcgg aagcggaagc ggtagcccgg acggtgctgt ggtgcaaggg cttgtggaaa 2520aattggagaa aaccaagtcc ctggcccagc agttgacaag ggaggccact caagcggaaa 2580ttgaagcaga taggtcttat cagcacagtc tccgcctcct ggattcagtg tctcggcttc 2640agggagtcag tgatcagtcc tttcaggtgg aagaagcaaa gaggatcaaa caaaaagcgg 2700attcactctc aagcctggta accaggcata tggatgagtt caagcgtaca cagaagaatc 2760tgggaaactg gaaagaagaa gcacagcagc tcttacagaa tggaaaaagt gggagagaga 2820aatcagatca gctgctttcc cgtgccaatc ttgctaaaag cagagcacaa gaagcactga 2880gtatgggcaa tgccactttt tatgaagttg agagcatcct taaaaacctc agagagtttg 2940acctgcaggt ggacaacaga aaagcagaag ctgaagaagc catgaagaga ctctcctaca 3000tcagccagaa ggtttcagat gccagtgaca agacccagca agcagaaaga gccctgggga 3060gcgctgctgc tgatgcacag agggcaaaga atggggccgg ggaggccctg gaaatctcca 3120gtgagattga acaggagatt gggagtctga acttggaagc caatgtgaca gcagatggag 3180ccttggccat ggaaaaggga ctggcctctc tgaagagtga gatgagggaa gtggaaggag 3240agctggaaag gaaggagctg gagtttgaca cgaatatgga tgcagtacag atggtgatta 3300cagaagccca gaaggttgat accagagcca agaacgctgg ggttacaatc caagacacac 3360tcaacacatt agacggcctc ctgcatctga tggaccagcc tctcagtgta gatgaagagg 3420ggctggtctt actggagcag aagctttccc gagccaagac ccagatcaac agccaactgc 3480ggcccatgat gtcagagctg gaagagaggg cacgtcagca gaggggccac ctccatttgc 3540tggagacaag catagatggg attctggctg atgtgaagaa cttggagaac attagggaca 3600acctgccccc aggctgctac aatacccagg ctcttgagca acagtgaagc tgccataaat 3660atttctcaac tgaggttctt gggatacaga tctcagggct cgggagccat gtcatgtgag 3720tgggtgggat ggggacattt gaacatgttt aatgggtatg ctcaggtcaa ctgacctgac 3780cccattcctg atcccatggc caggtggttg tcttattgca ccatactcct tgcttcctga 3840tgctgggcaa tgaggcagat agcactgggt gtgagaatga tcaaggatct ggaccccaaa 3900gaatagactg gatggaaaga caaactgcac aggcagatgt ttgcctcata atagtcgtaa 3960gtggagtcct ggaatttgga caagtgctgt tgggatatag tcaacttatt ctttgagtaa 4020tgtgactaaa ggaaaaaact ttgactttgc ccaggcatga aattcttcct aatgtcagaa 4080cagagtgcaa cccagtcaca ctgtggccag taaaatacta ttgcctcata ttgtcctctg 4140caagcttctt gctgatcaga gttcctccta cttacaaccc agggtgtgaa catgttctcc 4200attttcaagc tggaagaagt gagcagtgtt ggagtgagga cctgtaaggc aggcccattc 4260agagctatgg tgcttgctgg tgcctgccac cttcaagttc tggacctggg catgacatcc 4320tttcttttaa tgatgccatg gcaacttaga gattgcattt ttattaaagc atttcctacc 4380agcaaagcaa atgttgggaa agtatttact ttttcggttt caaagtgata gaaaagtgtg 4440gcttgggcat tgaaagaggt aaaattctct agatttatta gtcctaattc aatcctactt 4500ttagaacacc aaaaatgatg cgcatcaatg tattttatct tattttctca atctcctctc 4560tctttcctcc acccataata agagaatgtt cctactcaca cttcagctgg gtcacatcca 4620tccctccatt catccttcca tccatctttc catccattac ctccatccat ccttccaaca 4680tatatttatt gagtacctac tgtgtgccag gggctggtgg gacagtggtg acatagtctc 4740tgccctcata gagttgattg tctagtgagg aagacaagca tttttaaaaa ataaatttaa 4800acttacaaac tttgtttgtc acaagtggtg tttattgcaa taaccgcttg gtttgcaacc 4860tctttgctca acagaacata tgttgcaaga ccctcccatg ggggcacttg agttttggca 4920aggctgacag agctctgggt tgtgcacatt tctttgcatt ccagctgtca ctctgtgcct 4980ttctacaact gattgcaaca gactgttgag ttatgataac accagtggga attgctggag 5040gaaccagagg cacttccacc ttggctggga agactatggt gctgccttgc ttctgtattt 5100ccttggattt tcctgaaagt gtttttaaat aaagaacaat tgttagaaaa aaaaaa 5156 131 671 DNA Homo sapien 131aggtctggag ggcccacagc cggatgtggg acaccgggaa aaagtggtca tagcacacat 60ttttgcatcc cggttgcagt gtgttgcaga cgaagtcctc ttgctcgtca ccccacactt 120cctgggcagc caycacgagg atcatgactc ggaaaataaa gatgactgtg atccacacct 180tcccgatgct ggtggagtgt ttgttgacac ccccgatgaa agtgtgcagc gtcccccaat 240ccattgcgct ggtttatccc tgagtcctgt ttccaacgac tgccagtgtt tcagacccaa 300agaatgaggg caagatccct ctgcgagggt ttcagacctc cttctcctac cccactggag 360tgcctagaag ccaatgggtg cacagtgatg atacgaatgt caatctttgc tcggtcagtg 420aggatgtcgc ctggaatatt caaattgaat tacagatgca tgaagagggc gtacaagtta 480gaatttttct ttcgccatac agaaattgtt tagccagatc ttctgtactt cttttccttc 540cctgaccctt cctgctcccc aggaagggag gtcagccccg tttgcaaaac acaggatgcc 600cgtgacaccg gagacaggtc ttcttcaccg acaggaagtg ccttctggtg cctgcacgtt 660ttaactgcta t 671 132 590 DNA Homo sapien 132ctgaatggaa aagcttatgg ctctgtgatg atattagtga ccagcggaga tgataagctt 60cttggcaatt gcttacccac tgtgctcagc agtggttcaa caattcactc cattgccctg 120ggttcatctg cagccccaaa tctggaggaa ttatcacgtc ttacaggagg tttaaagttc 180tttgttccag atatatcaaa ctccaatagc atgattgatg ctttcagtag aatttcctct 240ggaactggag acattttcca gcaacatatt cagcttgaaa gtacaggtga aaatgtcaaa 300cctcaccatc aattgaaaaa cacagtgact gtggataata ctgtgggcaa cgacactatg 360tttctagtta cgtggcaggc cagtggtcct cctgagatta tattatttga tcctgatgga 420cgaaaatact acacaaataa ttttatcacc aatctaactt ttcggacagc tagtctttgg 480attccaggaa cagctaagcc tgggcactgg acttacaccc tgaacaatac ccatcattct 540ctgcaagccc tgaaagtgac agtgacctct cgcgcctcca actcagacct 590 133 581 DNA Homo sapien 133aggtcctgtc cgggggcact gagaactccc tctggaattc ttggggggtg ttggggagag 60actgtgggcc tggagataaa acttgtctcc tctaccacca ccctgtaccc tagcctgcac 120ctgtcctcat ctctgcaaag ttcagcttcc ttccccaggt ctctgtgcac tctgtcttgg 180atgctctggg gagctcatgg gtggaggagt ctccaccaga gggaggctca ggggactggt 240tgggccaggg atgaatattt gagggataaa aattgtgtaa gagccaaaga attggtagta 300gggggagaac agagaggagc tgggctatgg gaaatgattt gaataatgga gctgggaata 360tggctggata tctggtacta aaaaagggtc tttaagaacc tacttcctaa tctcttcccc 420aatccaaacc atagctgtct gtccagtgct ctcttcctgc ctccagctct gccccaggct 480cctcctagac tctgtccctg ggctagggca ggggaggagg gagagcaggg ttgggggaga 540ggctgaggag agtgtgacat gtggggagag gaccagacct c 581 134 4797 DNA Homo sapien misc_feature (1)...(4797) n = A,T,C or G 134cctgggacca aagtgctgcc cagagctgag ggtcctggag ccacatgaga aggcttctcc 60ctgtgtacct gtgcagcaca gggtagggtg agtccactca gctgtctagg agaggaccca 120ggagcagcag agacncgcca agcctttact cataccatat tctgatcctt ttccagcaaa 180ttgtggctac taatttgccc cctgaagatc aagatggctc tggggatgac tctgacaact 240tctccggctc aggtgcaggt gaggttgtca tgggggcccc ccccacccaa gacggcaaca 300ggtcatgcct gggggcagtg gtcaggcagt ctcctgtgtt tactgagcat gtactgagtg 360caccctgcct gccctgtctc cacccagctg gctccaaagg gcaatgctga ggagaggaat 420ggggtcgtga gctgctgtta aggagagctc atgcttggag gtgaggtgaa ggctgtgagc 480tccagaaggc cccagggcgc nctgctgcac gcaggctcat attcactagg aatagcttta 540ctcactaaga aacctctgga acccccttca gaaggttatt tgactcctga gcctctattt 600tctcatctgc aaaatgggaa taataccttg acctgataag cttgtggagc tgtaaggcag 660cacagagcca gctggggtgt agctcttcca tccaagctcc cttccttact tcccctttcc 720tgtggggact gggggagaga agtccctgag ctggaggtgg tcagggaagc ttcacagagg 780aggtggctct tgagtggacc tcaggaagag gggtgagaga gctaaggaag gaggctgagg 840tcatccctgg ggaagtgacc tagcggaggc ctgagagctg caaggtagga tatctgttgt 900tggaagtgtc tgttgttgga agtgggggcc tttttttcag ggagggtggg gccagagaag 960tgtgtgccct gggataagta ggataaccac agtagttatg cccctaaggg atgcccaccc 1020cacccctgtg gtcacagaaa agctttccca ggtggcctag gcacctgtct cgtggctcca 1080gagacaggct gcacctgaca cacacaatgg aaggacagct ctccttgtcc attttccaag 1140gagcttagcc tcagctgcct tgtccaggta ctagcctccc tcatagcctg agcttggcca 1200gcccaggtgc tctggagcct cccccgaccc acccaacaca ctctgcttct ggtcctcccc 1260accccccacc tccccaacac actctgcttc tggtcctgca ggtgctttgc aagatatcac 1320cttgtcacag cagaccccct ccacttggaa ggacacgcag ctcctgacgg ctattcccac 1380gtctccagaa cccaccggcc tggaggctac agctgcctcc acctccaccc tgccggctgg 1440agaggggccc aaggagggag aggctgtagt cctgccagaa gtggagcctg gcctcaccgc 1500ccgggagcag gaggccaccc cccgacccag ggagaccaca cagctcccga ccactcatca 1560ggcctcaacg accacagcca ccacggccca ggagcccgcc acctcccacc cccacaggga 1620catgcagcct ggccaccatg agacctcaac ccctgcagga cccagccaag ctgaccttca 1680cactccccac acagaggatg gaggtccttc tgccaccgag agggctgctg aggatggagc 1740ctccagtcag ctcccagcag cagagggctc tggggagcag gtgagtggcc tctgcattcc 1800ttgggaaatt gagtgggttg gtcctaatgc ctggcacttg gcaggcccta cacctgtgcc 1860ctgcgcgatc tcgtattcct caccaggaag acagggcaca ggggccgcct tcccctaccc 1920ccagggcctc gcagagcagg acagactaac tatgagatca gagcagaagc acccttaaag 1980atcacccaag agagggctcc caaactcaca atccaaactt gcagccctcg tcgaagagtg 2040aacgttatac cagtcatttt atttatagct tcgtggattt acgcttacac taaatagtct 2100gctattcata caaaatgtgt gctttgtatc actttttgtg atatccatgc catggtccag 2160ccagggtccg gagttgatgt ggcaagaagg cctggctttc gggccctgtg cgatcctggt 2220ttgggtgcat ctgagtgggt ggtggcaaag atcagggagg caggagctgc ttctgggtct 2280gtagtggagc tggttgctgc tgctggcggt gacctggcca acccaatctg cccctgccct 2340cccacaggac ttcacctttg aaacctcggg ggagaatacg gctgtagtgg ccgtggagcc 2400tgaccgccgg aaccagtccc cagtggatca gggggccacg ggggcctcac agggcctcct 2460ggacaggaaa gaggtgctgg gaggtgagtt ttctttcagg ggggtagttt ggggtgaatt 2520gctgctgtgg ggtcagggtg gggctgacca cagccaaggc cactgctttg ggagggtctg 2580cacgagagcc caaggagccg ctgagctgag ctggccccgt ctacctgccc taggggtcat 2640tgccggaggc ctcgtggggc tcatctttgc tgtgtgcctg gtgggtttca tgctgtaccg 2700catgaagaag aaggacgaag gcagctactc cttggaggag ccgaaacaag ccaacggcgg 2760ggcctaccag aagcccacca aacaggagga attctatgcc tgacgcggga gccatgcgcc 2820ccctccgccc tgccactcac taggccccca cttgcctctt ccttgaagaa ctgcaggccc 2880tggcctcccc tgccaccagg ccacctcccc agcattccag cccctctggt cgctcctgcc 2940cacggagtcg tgggtgtgct gggagctcca ctctgcttct ctgacttctg cctggagact 3000tagggcacca ggggtttctc gcataggacc tttccaccac agccagcacc tggcatcgca 3060ccattctgac tcggtttctc caaactgaag cagcctctcc ccaggtccag ctctggaggg 3120gagggggatc cgactgcttt ggacctaaat ggcctcatgt ggctggaaga tcctgcgggt 3180ggggcttggg gctcacacac ctgtagcact tactggtagg accaagcatc ttgggggggt 3240ggccgctgag tggcagggga caggagtcac tttgtttcgt ggggaggtct aatctagata 3300tcgacttgtt tttgcacatg tttcctctag ttctttgttc atagcccagt agaccttgtt 3360acttctgagg taagttaagt aagttgattc ggtatccccc catcttgctt ccctaatcta 3420tggtcgggag acagcatcag ggttaagaag actttttttt ttttttttaa actaggagaa 3480ccaaatctgg aagccaaaat gtaggcttag tttgtgtgtt gtctcttgag tttgtcgctc 3540atgtgtgcaa cagggtatgg actatctgtc tggtggcccc gttctggtgg tctgttggca 3600ggctggccag tccaggctgc cgtggggccg ccgcctcttt caagcagtcg tgcctgtgtc 3660catgcgctca gggccatgct gaggcctggg ccgctgccac gttggagaag cccgtgtgag 3720aagtgaatgc tgggactcag ccttcagaca gagaggactg tagggagggc ggcaggggcc 3780tggagatcct cctgcaggct cacgcccgtc ctcctgtggc gccgtctcca ggggctgctt 3840cctcctggaa attgacgagg ggtgtcttgg gcagagctgg ctctgagcgc ctccatccaa 3900ggccaggttc tccgttagct cctgtggccc caccctgggc cctgggctgg aatcaggaat 3960attttccaaa gagtgatagt cttttgcttt tggcaaaact ctacttaatc caatgggttt 4020ttccctgtac agtagatttt ccaaatgtaa taaactttaa tataaagtag tctgtgaatg 4080ccactgcctt cgcttcttgc ctctgtgctg tgtgtgacgt gaccggactt ttctgcaaac 4140accaacatgt tgggaaactt ggctcgaatc tctgtgcctt cgtctttccc atggggaggg 4200attctggttc cagggtccct ctgtgtattt gcttttttgt tttggctgaa attctcctgg 4260aggtcggtag gttcagccaa ggttttataa ggctgatgtc aatttctgtg ttgccaagct 4320ccaagcccat cttctaaatg gcaaaggaag gtggatggcc ccagcacagc ttgacctgag 4380gctgtggtca cagcggaggt gtggagccga ggcctacccc ncagacacct tggacatcct 4440cctcccaccc ggctgcagag gccaganncc agcccagggt cctgcactta cttgcttatt 4500tgacaacgtt tcagcgactc cgttggccac tccgagagtg ggccagtctg tggatcagag 4560atgcaccacc aagccaaggg aacctgtgtc cggtattcga tactgcgact ttctgcctgg 4620agtgtatgac tgcacatgac tcgggggtgg ggaaaggggt cggctgacca tgctcatctg 4680ctggtccgtg ggacggtncc caagccagag gtgggttcat ttgtgtaacg acaataaacg 4740gtacttgtca tttcgggcaa cggctgctgt ggtggtggtt gagtctcttc ttggcct 4797 135 2856 DNA Homo sapien 135tagtcgcggg tccccgagtg agcacgccag ggagcaggag accaaacgac gggggtcgga 60gtcagagtcg cagtgggagt ccccggaccg gagcacgagc ctgagcggga gagcgccgct 120cgcacgcccg tcgccacccg cgtacccggc gcagccagag ccaccagcgc agcgctgcca 180tggagcccag cagcaagaag ctgacgggtc gcctcatgct ggctgtggga ggagcagtgc 240ttggctccct gcagtttggc tacaacactg gagtcatcaa tgccccccag aaggtgatcg 300aggagttcta caaccagaca tgggtccacc gctatgggga gagcatcctg cccaccacgc 360tcaccacgct ctggtccctc tcagtggcca tcttttctgt tgggggcatg attggctcct 420tctctgtggg ccttttcgtt aaccgctttg gccggcggaa ttcaatgctg atgatgaacc 480tgctggcctt cgtgtccgcc gtgctcatgg gcttctcgaa actgggcaag tcctttgaga 540tgctgatcct gggccgcttc atcatcggtg tgtactgcgg cctgaccaca ggcttcgtgc 600ccatgtatgt gggtgaagtg tcacccacag cctttcgtgg ggccctgggc accctgcacc 660agctgggcat cgtcgtcggc atcctcatcg cccaggtgtt cggcctggac tccatcatgg 720gcaacaagga cctgtggccc ctgctgctga gcatcatctt catcccggcc ctgctgcagt 780gcatcgtgct gcccttctgc cccgagagtc cccgcttcct gctcatcaac cgcaacgagg 840agaaccgggc caagagtgtg ctaaagaagc tgcgcgggac agctgacgtg acccatgacc 900tgcaggagat gaaggaagag agtcggcaga tgatgcggga gaagaaggtc accatcctgg 960agctgttccg ctcccccgcc taccgccagc ccatcctcat cgctgtggtg ctgcagctgt 1020cccagcagct gtctggcatc aacgctgtct tctattactc cacgagcatc ttcgagaagg 1080cgggggtgca gcagcctgtg tatgccacca ttggctccgg tatcgtcaac acggccttca 1140ctgtcgtgtc gctgtttgtg gtggagcgag caggccggcg gaccctgcac ctcataggcc 1200tcgctggcat ggcgggttgt gccatactca tgaccatcgc gctagcactg ctggagcagc 1260taccctggat gtcctatctg agcatcgtgg ccatctttgg ctttgtggcc ttctttgaag 1320tgggtcctgg ccccatccca tggttcatcg tggctgaact cttcagccag ggtccacgtc 1380cagctgccat tgccgttgca ggcttctcca actggacctc aaatttcatt gtgggcatgt 1440gcttccagta tgtggagcaa ctgtgtggtc cctacgtctt catcatcttc actgtgctcc 1500tggttctgtt cttcatcttc acctacttca aagttcctga gactaaaggc cggaccttcg 1560atgagatcgc ttccggcttc cggcaggggg gagccagcca aagtgataag acacccgagg 1620agctgttcca tcccctgggg gctgattccc aagtgtgagt cgccccagat caccagcccg 1680gcctgctccc agcagcccta aggatctctc aggagcacag gcagctggat gagacttcca 1740aacctgacag atgtcagccg agccgggcct ggggctcctt tctccagcca gcaatgatgt 1800ccagaagaat attcaggact taacggctcc aggattttaa caaaagcaag actgttgctc 1860aaatctattc agacaagcaa caggttttat aattttttta ttactgattt tgttattttt 1920atatcagcct gagtctcctg tgcccacatc ccaggcttca ccctgaatgg ttccatgcct 1980gagggtggag actaagccct gtcgagacac ttgccttctt cacccagcta atctgtaggg 2040ctggacctat gtcctaagga cacactaatc gaactatgaa ctacaaagct tctatcccag 2100gaggtggcta tggccacccg ttctgctggc ctggatctcc ccactctagg ggtcaggctc 2160cattaggatt tgccccttcc catctcttcc tacccaacca ctcaaattaa tctttcttta 2220cctgagacca gttgggagca ctggagtgca gggaggagag gggaagggcc agtctgggct 2280gccgggttct agtctccttt gcactgaggg ccacactatt accatgagaa gagggcctgt 2340gggagcctgc aaactcactg ctcaagaaga catggagact cctgccctgt tgtgtataga 2400tgcaagatat ttatatatat ttttggttgt caatattaaa tacagacact aagttatagt 2460atatctggac aagccaactt gtaaatacac cacctcactc ctgttactta cctaaacaga 2520tataaatggc tggtttttag aaacatggtt ttgaaatgct tgtggattga gggtaggagg 2580tttggatggg agtgagacag aagtaagtgg ggttgcaacc actgcaacgg cttagacttc 2640gactcaggat ccagtccctt acacgtacct ctcatcagtg tcctcttgct caaaaatctg 2700tttgatccct gttacccaga gaatatatac attctttatc ttgacattca aggcatttct 2760atcacatatt tgatagttgg tgttcaaaaa aacactagtt ttgtgccagc cgtgatgctc 2820aggcttgaaa tcgcattatt ttgaatgtga agggaa 2856 136 356 DNA Homo sapien 136ggtggagcca aatgaagaaa atgaagatga aagagacaga cacctcagtt tttctggatc 60aggcattgat gatgatgaag attttatctc cagcaccatt tcaaccacac cacgggcttt 120tgaccacaca aaacagaacc aggactggac tcagtggaac ccaagccatt caaatccgga 180agtgctactt cagacaacca caaggatgac tgatgtagac agaaatggca ccactgctta 240tgaaggaaac tggaacccag aagcacaccc tcccctcatt caccatgagc atcatgagga 300agaagagacc ccacattcta caagcacaat ccaggcaact cctagtagta caacgg 356 137 356 DNA Homo sapien misc_feature (1)...(356) n = A,T,C or G 137gcaggtggag aagacatttt attgttcctg gggtctctgg aggcccattg gtggggctgg 60gtcactggct gcccccggaa cagggcgctg ctccatggct ctgcttgtgg tagtctgtgg 120ctatgtctcc cagcaaggac agaaactcag aaaaatcaat cttcttatcc tcattcttgt 180cctttttctc aaagacatcg gcgaggtaat ttgtgccctt tttacctcgg cccgcgacca 240cgctaaggcc aaanttccag acanayggcc gggccggtnc nataggggan cccaacttgg 300ggacccaaac tctggcgcgg aaacacangg gcataagctt gnttcctgtg gggaaa 356 138 353 DNA Homo sapien 138aggtccagtc ctccacttgg cctgatgaga gtggggagtg gcaagggacg tttctcctgc 60aatagacact tagatttctc tcttgtggga agaaaccacc tgtccatcca ctgactcttc 120tacattgatg tggaaattgc tgctgctacc accacctcct gaagaggctt ccctgatgcc 180aatgccagcc atcttggcat cctggccctc gagcaggctg cggtaagtag cgatctcctg 240ctccagccgt gtctttatgt caagcagcat cttgtactcc tggttctgag cctccatctc 300gcatcggagc tcactcagac ctcgsccgsg mssmcgctam gccgaattcc agc 353 139 371 DNA Homo sapien 139agcgtggtcg cggccgaggt ccatccgaag caagattgca gatggcagtg tgaagagaga 60agacatattc tacacttcaa agctttggtg caattcccat cgaccagagt tggtccgacc 120agccttggaa aggtcactga aaaatcttca attggattat gttgacctct accttattca 180ttttccagtg tctgtaaagc caggtgagga agtgatccca aaagatgaaa atggaaaaat 240actatttgac acagtggatc tctgtgccac gtgggaggcc gtggagaagt gtaaagatgc 300aggattggac ctgcccgggc ggccgctcga aagccgaatt ccagcacact ggcggccgtt 360actagtggat c 371 140 370 DNA Homo sapien 140tagcgtggtc gcggccgagg tccatctccc tttgggaact agggggctgc tggtgggaaa 60tgggagccag ggcagatgtt gcattccttt gtgtccctgt aaatgtggga ctacaagaag 120aggagctgcc tgagtggtac tttctcttcc tggtaatcct ctggcccagc ctcatggcag 180aatagaggta tttttaggct atttttgtaa tatggcttct ggtcaaaatc cctgtgtagc 240tgaattccca agccctgcat tgtacagccc cccactcccc tcaccaccta ataaaggaat 300agttaacact caaaaaaaaa aaaaaacctg cccgggcggc cgctcgaaag ccgaattcca 360gcacactggc 370 141 371 DNA Homo sapien 141tagcgtggtc gcggccgagg tcctctgtgc tgcctgtcac agcccgatgg taccagcgca 60gggtgtaggc agtgcaggag ccctcatcca gtggcaggga acaggggtca tcactatccc 120aaggagcttc agggtcctgg tactcctcca cagaatactc ggagtattca gagtactcat 180catcctcagg gggtacccgc tcttcctcct ctgcatgaga gacgcggagc acaggcacag 240catggagctg ggagccggca gtgtctgcag cataactagg gaggggtcgt gatccagatg 300cgatgaactg gccctggcag gcacagtgct gactcatctc ttggcgacct gcccgggcgg 360ccgctcgaag c 371 142 343 DNA Homo sapien 142gcgttttgag gccaatggtg taaaaggaaa tatcttcaca taaaaactag atggaagcat 60tgtcagaaac ctctttgtga tgtttgcttt caactcacag agttgaacat tccttttcat 120agagcagttt tgaaacactc ttttgtagaa tttgcaagcg gatgattgga tcgctatgag 180gtcttcattg gaaacgggat acctttacat aaaaactaga cagtagcatt ctcagaaatt 240tctttgggat gtgggcattc aacccacaga ggagaacttc atttgataga gcagttttga 300aacacccttt ttgtagaatc tacaggtgga catttagagt gct 343 143 354 DNA Homo sapien 143aggtctgatg gcagaaaaac tcagactgtc tgcaacttta cagatggtgc attggttcag 60catcaggagt gggatgggaa ggaaagcaca ataacaagaa aattgaaaga tgggaaatta 120gtggtggagt gtgtcatgaa caatgtcacc tgtactcgga tctatgaaaa agtagaataa 180aaattccatc atcactttgg acaggagtta attaagagaa tgaccaagct cagttcaatg 240agcaaatctc catactgttt ctttcttttt tttttcatta ctgtgttcaa ttatctttat 300cataaacatt ttacatgcag ctatttcaaa gtgtgttgga ttaattagga tcat 354 144 353 DNA Homo sapien 144ggtcaaggac ctgggggacc cccaggtcca gcagccacat gattctgcag cagacaggga 60cctagagcac atctggatct cagccccacc cctggcaacc tgcctgccta gagaactccc 120aagatgacag actaagtagg attctgccat ttagaataat tctggtatcc tgggcgttgc 180gttaagttgc ttaactttca ttctgtctta cgatagtctt cagaggtggg aacagatgaa 240gaaaccatgc cccagagaag gttaagtgac ttcctcttta tggagccagt gttccaacct 300aggtttgcct gataccagac ctgtggcccc acctcccatg caggtctctg tgg 353 145 371 DNA Homo sapien 145caggtctgtc ataaactggt ctggagtttc tgacgactcc ttgttcacca aatgcaccat 60ttcctgagac ttgctggcct ctccgttgag tccacttggc tttctgtcct ccacagctcc 120attgccactg ttgatcacta gctttttctt ctgcccacac cttcttcgac tgttgactgc 180aatgcaaact gcaagaatca aagccaaggc caagagggat gccaagatga tcagccattc 240tggaatttgg ggtgtcctta taggaccaga ggttgtgttt gctccacctt cttgactccc 300atgtgagacc tcggccgcga ccacgctaag ccgaattcca gcacactggc ggcccgttac 360tagtggatcc g 371 146 355 DNA Homo sapien 146ggtcctccgt cctcttccca gaggtgtcgg ggcttggccc cagcctccat cttcgtctct 60caggatggcg agtagcagcg gctccaaggc tgaattcatt gtcggaggga aatataaact 120ggtacggaag atcgggtctg gctccttcgg ggacatctat ttggcgatca acatcaccaa 180cggcgaggaa gtggcagtga agctagaatc tcagaaggcc aggcatcccc agttgctgta 240cgagagcaag ctctataaga ttcttcaagg tggggttggc atcccccaca tacggtggta 300tggtcaggaa aaagactaca atgtactagt catggatctt ctgggaccta gcctc 355 147 355 DNA Homo sapien 147ggtctgttac aaaatgaaga cagacaacac aacatttact ctgtggagat atcctactca 60tactatgcac gtgctgtgat tttgaacata actcgtccca aaaacttgtc acgatcatcc 120tgacttttta ggttggctga tccatcaatc ttgcactcaa ctgttacttc tttcccagtg 180ttgttaggag caaagctgac ctgaacagca accaatggct gtagataccc aacatgcagt 240tttttcccat aatatgggaa atattttaag tctatcattc cattatgagg ataaactgct 300acatttggta tatcttcatt ctttgaaaca caatctatcc ttggcactcc ttcag 355 148 369 DNA Homo sapien 148aggtctctct ccccctctcc ctctcctgcc agccaagtga agacatgctt acttcccctt 60caccttcctt catgatgtgg gaagagtgct gcaacccagc cctagccaac accgcatgag 120agggagtgtg ccgagggctt ctgagaaggt ttctctcaca tctagaaaga agcgcttaag 180atgtggcagc ccctcttctt caagtggctc ttgtcctgtt gccctgggag ttctcaaatt 240gctgcagcag cctccatcca gcctgaggat gacatcaata cacagaggaa gaagagtcag 300gaaaagatga gagaagttac agactctcct gggcgacccc gagagcttac cattcctcag 360acttcttca 369 149 620 DNA Homo sapien misc_feature (1)...(620) n = A,T,C or G 149actagtcaaa aatgctaaaa taatttggga gaaaatattt tttaagtagt gttatagttt 60catgtttatc ttttattatg ttttgtgaag ttgtgtcttt tcactaatta cctatactat 120gccaatattt ccttatatct atccataaca tttatactac atttgtaana naatatgcac 180gtgaaactta acactttata aggtaaaaat gaggtttcca anatttaata atctgatcaa 240gttcttgtta tttccaaata gaatggactt ggtctgttaa gggctaagga gaagaggaag 300ataaggttaa aagttgttaa tgaccaaaca ttctaaaaga aatgcaaaaa aaaagtttat 360tttcaagcct tcgaactatt taaggaaagc aaaatcattt cctaaatgca tatcatttgt 420gagaatttct cattaatatc ctgaatcatt catttcacta aggctcatgt tnactccgat 480atgtctctaa gaaagtacta tttcatggtc caaacctggt tgccatantt gggtaaaggc 540tttcccttaa gtgtgaaant atttaaaatg aaattttcct ctttttaaaa attctttana 600agggttaagg gtgttgggga 620 150 371 DNA Homo sapien 150ggtccgatca aaacctgcta cctccccaag actttactag tgccgataaa ctttctcaaa 60gagcaaccag tatcacttcc ctgtttataa aacctctaac catctctttg ttctttgaac 120atgctgaaaa ccacctggtc tgcatgtatg cccgaatttg yaattctttt ctctcaaatg 180aaaatttaat tttagggatt catttctata ttttcacata tgtagtatta ttatttcctt 240atatgtgtaa ggtgaaattt atggtatttg agtgtgcaag aaaatatatt tttaaagctt 300tcatttttcc cccagtgaat gatttagaat tttttatgta aatatacaga atgttttttc 360ttacttttat a 371 151 4655 DNA Homo sapien 151gggacttgag ttctgttatc ttcttaagta gattcatatt gtaagggtct cggggtgggg 60gggttggcaa aatcctggag ccagaagaaa ggacagcagc attgatcaat cttacagcta 120acatgttgta cctggaaaac aatgcccaga ctcaatttag tgagccacag tacacgaacc 180tggggctcct gaacagcatg gaccagcaga ttcagaacgg ctcctcgtcc accagtccct 240ataacacaga ccacgcgcag aacagcgtca cggcgccctc gccctacgca cagcccagct 300ccaccttcga tgctctctct ccatcacccg ccatcccctc caacaccgac tacccaggcc 360cgcacagttt cgacgtgtcc ttccagcagt cgagcaccgc caagtcggcc acctggacgt 420attccactga actgaagaaa ctctactgcc aaattgcaaa gacatgcccc atccagatca 480aggtgatgac cccacctcct cagggagctg ttatccgcgc catgcctgtc tacaaaaaag 540ctgagcacgt cacggaggtg gtgaagcggt gccccaacca tgagctgagc cgtgaattca 600acgagggaca gattgcccct yctagtcatt tgattcgagt agaggggaac agccatgccc 660agtatgtaga agatcccatc acaggaagac agagtgtgct ggtaccttat gagccacccc 720aggttggcac tgaattcacg acagtcttgt acaatttcat gtgtaacagc agttgtgttg 780gagggatgaa ccgccgtcca attttaatca ttgttactct ggaaaccaga gatgggcaag 840tcctgggccg acgctgcttt gaggcccgga tctgtgcttg cccaggaaga gacaggaagg 900cggatgaaga tagcatcaga aagcagcaag tttcggacag tacaaagaac ggtgatggta 960cgaagcgccc gtttcgtcag aacacacatg gtatccagat gacatccatc aagaaacgaa 1020gatccccaga tgatgaactg gtatacttac cagtgagggg ccgtgagact tatgaaatgc 1080tggtgaagat caaagagtcc ctggaactca tgcagtacct tcttcagcac acaattgaaa 1140cgtacaggca acagcaacag cagcagcacc agcacttact tcagaaacag acctcaatac 1200agtctccatc ttcatatggt aacagctccc cacctctgaa caaaatgaac agcatgaaca 1260agctgccttc tgtgagccag cttatcaacc ctcagcagcg caacgccctc actcctacaa 1320ccattcctga tggcatggga gccaacattc ccatgatggg cacccacatg ccaatggctg 1380gagacatgaa tggactcagc cccacccagg cactccctcc cccactctcc atgccatcca 1440cctcccactg cacaccccca cctccgtatc ccacagattg cagcattgtc agtttcttag 1500cgaggttggg ctgttcatca tgtctggact atttcacgac ccaggggctg accaccatct 1560atcagattga gcattactcc atggatgatc tggcaagtct gaaaatccct gagcaatttc 1620gacatgcgat ctggaagggc atcctggacc accggcagct ccacgaattc tcctcccctt 1680ctcatctcct gcggacccca agcagtgcct ctacagtcag tgtgggctcc agtgagaccc 1740ggggtgagcg tgttattgat gctgtgcgat tcaccctccg ccagaccatc tctttcccac 1800cccgagatga gtggaatgac ttcaactttg acatggatgc tcgccgcaat aagcaacagc 1860gcatcaaaga ggagggggag tgagcctcac catgtgagct cttcctatcc ctctcctaac 1920tgccagcccc ctaaaagcac tcctgcttaa tcttcaaagc cttctcccta gctcctcccc 1980ttcctcttgt ctgatttctt aggggaagga gaagtaagag gcttacttct taccctaacc 2040atctgacctg gcatctaatt ctgattctgg ctttaagcct tcaaaactat agcttgcaga 2100actgtagctt gccatggcta ggtagaagtg agcaaaaaag agttgggtgt ctccttaagc 2160tgcagagatt tctcattgac ttttataaag catgttcacc cttatagtct aagactatat 2220atataaatgt ataaatatac agtatagatt tttgggtggg gggcattgag tattgtttaa 2280aatgtaattt aaatgaaaga aaattgagtt gcacttattg accatttttt aatttacttg 2340ttttggatgg cttgtctata ctccttccct taaggggtat catgtatggt gataggtatc 2400tagagcttaa tgctacatgt gagtgacgat gatgtacaga ttctttcagt tctttggatt 2460ctaaatacat gccacatcaa acctttgagt agatccattt ccattgctta ttatgtaggt 2520aagactgtag atatgtattc ttttctcagt gttggtatat tttatattac tgacatttct 2580tctagtgatg atggttcacg ttggggtgat ttaatccagt tataagaaga agttcatgtc 2640caaacgtcct ctttagtttt tggttgggaa tgaggaaaat tcttaaaagg cccatagcag 2700ccagttcaaa aacacccgac gtcatgtatt tgagcatatc agtaaccccc ttaaatttaa 2760taccagatac cttatcttac aatattgatt gggaaaacat ttgctgccat tacagaggta 2820ttaaaactaa atttcactac tagattgact aactcaaata cacatttgct actgttgtaa 2880gaattctgat tgatttgatt gggatgaatg ccatctatct agttctaaca gtgaagtttt 2940actgtctatt aatattcagg gtaaatagga atcattcaga aatgttgagt ctgtactaaa 3000cagtaagata tctcaatgaa ccataaattc aactttgtaa aaatcttttg aagcatagat 3060aatattgttt ggtaaatgtt tcttttgttt ggtaaatgtt tcytttaaag accctcctat 3120tctataaaac tctgcatgta gaggcttgtt tacctttctc tctctaaggt ttacaatagg 3180agtggtgatt tgaaaaatat aaaattatga gattggtttt cctgtggcat aaattgcatc 3240actgtatcat tttctttttt aaccggtaag agtttcagtt tgttggaaag taactgtgag 3300aacccagttt cccgtccatc tcccttaggg actacccata gacatgaaag gtccccacag 3360agcaagagat aagtctttca tggctgctgt tgcttaaacc acttaaacga agagttccct 3420tgaaactttg ggaaaacatg ttaatgacaa tattccagat ctttcagaaa tataacacat 3480ttttttgcat gcatgcaaat gagctctgaa atcttcccat gcattctggt caagggctgt 3540cattgcacat aagcttccat tttaatttta aagtgcaaaa gggccagcgt ggctctaaaa 3600ggtaatgtgt ggattgcctc tgaaaagtgt gtatatattt tgtgtgaaat tgcatacttt 3660gtattttgat tatttttttt ttcttcttgg gatagtggga tttccagaac cacacttgaa 3720accttttttt atcgtttttg tattttcatg aaaataccat ttagtaagaa taccacatca 3780aataagaaat aatgctacaa ttttaagagg ggagggaagg gaaagttttt ttttttatta 3840tttttttaaa attttgtatg ttaaagagaa tgagtccttg atttcaaagt tttgttgtac 3900ttaaatggta ataagcactg taaacttctg caacaagcat gcagctttgc aaacccatta 3960aggggaagaa tgaaagctgt tccttggtcc tagtaagaag acaaactgct tcccttactt 4020tgctgagggt ttgaataaac ctaggacttc cgagctatgt cagtactatt caggtaacac 4080tagggccttg gaaatccctg tactgtgtct catggatttg gcactagcca aagcgaggca 4140ccccttactg gcttacctcc tcatggcagc ctactctcct tgagtgtatg agtagccagg 4200gtaaggggta aaaggatagt aagcatagaa accactagaa agtgggctta atggagttct 4260tgtggcctca gctcaatgca gttagctgaa gaattgaaaa gtttttgttt ggagacgttt 4320ataaacagaa atggaaagca gagttttcat taaatccttt tacctttttt ttttcttggt 4380aatcccctaa aataacagta tgtgggatat tgaatgttaa agggatattt ttttctatta 4440tttttataat tgtacaaaat taagcaaatg ttaaaagttt tatatgcttt attaatgttt 4500tcaaaaggta ttatacatgt gatacatttt ttaagcttca gttgcttgtc ttctggtact 4560ttctgttatg ggcttttggg gagccagaag ccaatctaca atctcttttt gtttgccagg 4620acatgcaata aaatttaaaa aataaataaa aacta 4655 152 586 PRT Homo sapien 152Met Leu Tyr Leu Glu Asn Asn Ala Gln Thr Gln Phe Ser Glu Pro Gln 1 5 10 15Tyr Thr Asn Leu Gly Leu Leu Asn Ser Met Asp Gln Gln Ile Gln Asn 20 25 30Gly Ser Ser Ser Thr Ser Pro Tyr Asn Thr Asp His Ala Gln Asn Ser 35 40 45Val Thr Ala Pro Ser Pro Tyr Ala Gln Pro Ser Ser Thr Phe Asp Ala 50 55 60Leu Ser Pro Ser Pro Ala Ile Pro Ser Asn Thr Asp Tyr Pro Gly Pro65 70 75 80His Ser Phe Asp Val Ser Phe Gln Gln Ser Ser Thr Ala Lys Ser Ala 85 90 95Thr Trp Thr Tyr Ser Thr Glu Leu Lys Lys Leu Tyr Cys Gln Ile Ala 100 105 110Lys Thr Cys Pro Ile Gln Ile Lys Val Met Thr Pro Pro Pro Gln Gly 115 120 125Ala Val Ile Arg Ala Met Pro Val Tyr Lys Lys Ala Glu His Val Thr 130 135 140Glu Val Val Lys Arg Cys Pro Asn His Glu Leu Ser Arg Glu Phe Asn145 150 155 160Glu Gly Gln Ile Ala Pro Ser Ser His Leu Ile Arg Val Glu Gly Asn 165 170 175Ser His Ala Gln Tyr Val Glu Asp Pro Ile Thr Gly Arg Gln Ser Val 180 185 190Leu Val Pro Tyr Glu Pro Pro Gln Val Gly Thr Glu Phe Thr Thr Val 195 200 205Leu Tyr Asn Phe Met Cys Asn Ser Ser Cys Val Gly Gly Met Asn Arg 210 215 220Arg Pro Ile Leu Ile Ile Val Thr Leu Glu Thr Arg Asp Gly Gln Val225 230 235 240Leu Gly Arg Arg Cys Phe Glu Ala Arg Ile Cys Ala Cys Pro Gly Arg 245 250 255Asp Arg Lys Ala Asp Glu Asp Ser Ile Arg Lys Gln Gln Val Ser Asp 260 265 270Ser Thr Lys Asn Gly Asp Gly Thr Lys Arg Pro Phe Arg Gln Asn Thr 275 280 285His Gly Ile Gln Met Thr Ser Ile Lys Lys Arg Arg Ser Pro Asp Asp 290 295 300Glu Leu Val Tyr Leu Pro Val Arg Gly Arg Glu Thr Tyr Glu Met Leu305 310 315 320Val Lys Ile Lys Glu Ser Leu Glu Leu Met Gln Tyr Leu Leu Gln His 325 330 335Thr Ile Glu Thr Tyr Arg Gln Gln Gln Gln Gln Gln His Gln His Leu 340 345 350Leu Gln Lys Gln Thr Ser Ile Gln Ser Pro Ser Ser Tyr Gly Asn Ser 355 360 365Ser Pro Pro Leu Asn Lys Met Asn Ser Met Asn Lys Leu Pro Ser Val 370 375 380Ser Gln Leu Ile Asn Pro Gln Gln Arg Asn Ala Leu Thr Pro Thr Thr385 390 395 400Ile Pro Asp Gly Met Gly Ala Asn Ile Pro Met Met Gly Thr His Met 405 410 415Pro Met Ala Gly Asp Met Asn Gly Leu Ser Pro Thr Gln Ala Leu Pro 420 425 430Pro Pro Leu Ser Met Pro Ser Thr Ser His Cys Thr Pro Pro Pro Pro 435 440 445Tyr Pro Thr Asp Cys Ser Ile Val Ser Phe Leu Ala Arg Leu Gly Cys 450 455 460Ser Ser Cys Leu Asp Tyr Phe Thr Thr Gln Gly Leu Thr Thr Ile Tyr465 470 475 480Gln Ile Glu His Tyr Ser Met Asp Asp Leu Ala Ser Leu Lys Ile Pro 485 490 495Glu Gln Phe Arg His Ala Ile Trp Lys Gly Ile Leu Asp His Arg Gln 500 505 510Leu His Glu Phe Ser Ser Pro Ser His Leu Leu Arg Thr Pro Ser Ser 515 520 525Ala Ser Thr Val Ser Val Gly Ser Ser Glu Thr Arg Gly Glu Arg Val 530 535 540Ile Asp Ala Val Arg Phe Thr Leu Arg Gln Thr Ile Ser Phe Pro Pro545 550 555 560Arg Asp Glu Trp Asn Asp Phe Asn Phe Asp Met Asp Ala Arg Arg Asn 565 570 575Lys Gln Gln Arg Ile Lys Glu Glu Gly Glu 580 585 153 2007 DNA Homo sapien 153gaattcgtcg ctgctccagg gaaagttctg ttactccact gactctctct tttcctgata 60acatggccag caagaaagta attacagtgt ttggagcaac aggagctcaa ggtggctctg 120tggccagggc aattttggag agcaaaaaat ttgcagtgag agcagtgacc agggatgtga 180cttgaccaaa tgccctggag ctccagcgcc ttggagctga ggtggtcaaa ggtgacctga 240atgataaagc atcggtggac agtgccttaa aaggtgtcta tggggccttc ttggtgacca 300acttctggga ccctctcaac caagataagg aagtgtgtcg ggggaagctg gtggcagact 360ccgccaagca cctgggtctg aagcacgtgg tgtacagcgg cctggagaac gtcaagcgac 420tgacggatgg caagctggag gtgccgcact ttgacagcaa gggcgaggtg gaggagtact 480tctggtccat tggcatcccc atgaccagtg tccgcgtggc ggcctacttt gaaaactttc 540tcgcggcgtg gcggcccgtg aaagcctctg atggagatta ctacaccttg gctgtaccga 600tgggagatgt accaatggat ggtatctctg ttgctgatat tggagcagcc gtctctagca 660tttttaattc tccagaggaa tttttaggca aggccgtggg gctcagtgca gaagcactaa 720caatacagca atatgctgat gttttgtcca aggctttggg gaaagaagtc cgagatgcaa 780agattacccc ggaagctttc gagaagctgg gattccctgc agcaaaggaa atagccaata 840tgtgtcgttt ctatgaaatg aagccagacc gagatgtcaa tctcacccac caactaaatc 900ccaaagtcaa aagcttcagc cagtttatct cagagaacca gggagccttc aagggcatgt 960agaaaatcag ctgttcagat aggcctctgc accacacagc ctctttcctc tctgatcctt 1020ttcctcttta cggcacaaca ttcatgttga cagaacatgc tggaatgcaa ttgtttgcaa 1080caccgaagga tttcctgcgg tcgcctcttc agtaggaagc actgcattgg tgataggaca 1140cggtaatttg attcacattt aacttgctag ttagtgataa gggtggtaca actgtttggt 1200aaaatgagaa gcctcggaac ttggagcttc tctcctacca ctaatgggag ggcagattat 1260actgggattt ctcctgggtg agtaatttca agccctaatg ctgaaattcc cctaggcagc 1320tccagttttc tcaactgcat tgcaaaattc ccagtgaact tttaagtact tttaacttaa 1380aaaaatgaac atctttgtag agaattttct ggggaacatg gtgttcaatg aacaagcaca 1440agcattggaa atgctaaaat tcagttttgc ctcaagattg gaagtttatt ttctgactca 1500ttcatgaagt catctattga gccaccattc aattattcat ctattaattc cttgatcctt 1560catttatcca ttctgcaaac ttttcttgag caccagcacg ggtggccatt tgtggacttc 1620tcttcattcc tatgtgtttt cttatcaaag tgatccactc tcgaaaggct cctttccagt 1680ctgtggttgg gttcaagtca tgccagggcc agggggccca tctcctcgtt tagctctagg 1740caaaatccag gggatctgca gtggggagcg ggggcaggaa gctggaggga aggcctgtga 1800agggtaggga tgtggaaaga caaggtgaca gaaggaccca ataggacctt tctatatctc 1860tggcttagca ttttctacat catattgtaa tcgtcttatt tgctagtttt cttccttact 1920gtgagtgact aacagtcatc tttatcccag tgcctggtac ataataagtg atcaataaat 1980gttgattgac taaaaaaaaa aaaaaaa 2007 154 2148 DNA Homo sapien 154gaattcgtcg ctgctccagg gaaagttctg ttactccact gactctctct tttcctgata 60acatggccag caagaaagta attacagtgt ttggagcaac aggagctcaa ggtggctctg 120tggccagggc aattttggag agcaaaaaat ttgcagtgag agcagtgacc agggatgtga 180cttgaccaaa tgccctggag ctccagcgcc ttggagctga ggtggtcaaa ggtgacctga 240atgataaagc atcggtggac agtgccttaa aaggggaagc tggtggcaga ctccgccaag 300cacctgggtc tgaagcacgt ggtgtacagc ggcctggaga acgtcaagcg actgacggat 360ggcaagctgg aggtgccgca ctttgacagc aagggcgagg tggaggagta cttctggtcc 420attggcatcc ccatgaccag tgtccgcgtg gcggcctact ttgaaaactt tctcgcggcg 480tggcggcccg tgaaagcctc tgatggagat tactacacct tggctgtacc gatgggagat 540gtaccaatgg atggtatctc tgttgctgat attggagcag ccgtctctag catttttaat 600tctccagagg aatttttagg caaggccgtg gggctcagtg cagaagcact aacaatacag 660caatatgctg atgttttgtc caaggctttg gggaaagaag tccgagatgc aaagactatc 720tgtgctatag atgaccagaa aacagtggaa gaaggtttca tggaagacgt gggcttgagt 780tggtccttga gggaacatga ccatgtatag acagaggagg catcaagaag gctggcctgg 840ctaattctgg aataaacacg acaaaccaga ggcagtacgg gaaggaggca aattctggct 900ctgcctctat ccttgattac cccggaagct ttcgagaagc tgggattccc tgcagcaaag 960gaaatagcca atatgtgtcg tttctatgaa atgaagccag accgagatgt caatctcacc 1020caccaactaa atcccaaagt caaaagcttc agccatttta tctcagagaa ccagggagcc 1080ttcaagggca tgtagaaaat cagctgttca gataggcctc tgcaccacac agcctctttc 1140ctctctgatc cttttcctct ttacggcaca acattcatgt tgacagaaca tgctggaatg 1200caattgtttg caacaccgaa ggatttcctg cggtcgcctc ttcagtagga agcactgcat 1260tggtgatagg acacggtaat ttgattcaca tttaacttgc tagttagtga taagggtggt 1320acaactgttt ggtaaaatga gaagcctcgg aacttggagc ttctctccta ccactaatgg 1380gagggcagat tatactggga tttctcctgg gtgagtaatt tcaagcccta atgctgaaat 1440tcccctaggc agctccagtt ttctcaactg cattgcaaaa ttcccagtga acttttaagt 1500acttttaact taaaaaaatg aacatctttg tagagaattt tctggggaac atggtgttca 1560atgaacaagc acaagcattg gaaatgctaa aattcagttt tgcctcaaga ttggaagttt 1620attttctgac tcattcatga agtcatctat tgagccacca ttcaattatt catctattaa 1680ttccttgatc cttcatttat ccattctgca aacttttctt gagcaccagc acgggtggcc 1740atttgtggac ttctcttcat tcctatgtgt tttcttatca aagtgatcca ctctcgaaag 1800gctcctttcc agtctgtggt tgggttcaag tcatgccagg gccagggggc ccatctcctc 1860gtttagctct aggcaaaatc caggggatct gcagtgggga gcgggggcag gaagctggag 1920ggaaggcctg tgaagggtag ggatgtggaa agacaaggtg acagaaggac ccaataggac 1980ctttctatat ctctggctta gcattttcta catcatattg taatcgtctt atttgctagt 2040tttcttcctt actgtgagtg actaacagtc atctttatcc cagtgcctgg tacataataa 2100gtgatcaata aatgttgatt gactaaatga aaaaaaaaaa aaaaaaaa 2148 155 153 PRT Homo sapien 155Met Thr Ser Val Arg Val Ala Ala Tyr Phe Glu Asn Phe Leu Ala Ala 1 5 10 15Trp Arg Pro Val Lys Ala Ser Asp Gly Asp Tyr Tyr Thr Leu Ala Val 20 25 30Pro Met Gly Asp Val Pro Met Asp Gly Ile Ser Val Ala Asp Ile Gly 35 40 45Ala Ala Val Ser Ser Ile Phe Asn Ser Pro Glu Glu Phe Leu Gly Lys 50 55 60Ala Val Gly Leu Ser Ala Glu Ala Leu Thr Ile Gln Gln Tyr Ala Asp65 70 75 80Val Leu Ser Lys Ala Leu Gly Lys Glu Val Arg Asp Ala Lys Ile Thr 85 90 95Pro Glu Ala Phe Glu Lys Leu Gly Phe Pro Ala Ala Lys Glu Ile Ala 100 105 110Asn Met Cys Arg Phe Tyr Glu Met Lys Pro Asp Arg Asp Val Asn Leu 115 120 125Thr His Gln Leu Asn Pro Lys Val Lys Ser Phe Ser Gln Phe Ile Ser 130 135 140Glu Asn Gln Gly Ala Phe Lys Gly Met145 150 156 128 PRT Homo sapien 156Met Thr Ser Val Arg Val Ala Ala Tyr Phe Glu Asn Phe Leu Ala Ala 1 5 10 15Trp Arg Pro Val Lys Ala Ser Asp Gly Asp Tyr Tyr Thr Leu Ala Val 20 25 30Pro Met Gly Asp Val Pro Met Asp Gly Ile Ser Val Ala Asp Ile Gly 35 40 45Ala Ala Val Ser Ser Ile Phe Asn Ser Pro Glu Glu Phe Leu Gly Lys 50 55 60Ala Val Gly Leu Ser Ala Glu Ala Leu Thr Ile Gln Gln Tyr Ala Asp65 70 75 80Val Leu Ser Lys Ala Leu Gly Lys Glu Val Arg Asp Ala Lys Thr Ile 85 90 95Cys Ala Ile Asp Asp Gln Lys Thr Val Glu Glu Gly Phe Met Glu Asp 100 105 110Val Gly Leu Ser Trp Ser Leu Arg Glu His Asp His Val Ala Gly Ala 115 120 125 157 424 DNA Homo sapien misc_feature (1)...(424) n = A,T,C or G 157ctgcagcccg ggggatccac tagtccagtg tggtggaatt cattggtctt tacaagactt 60ggatacatta cagcagacat ggaaatataa ttttaaaaaa tttctctcca acctccttca 120aattcagtca ccactgttat attaccttct ccaggaaccc tccagtgggg aaggctgcga 180tattagattt ccttgtatgc aaagtttttg ttgaaagctg tgctcagagg aggtgagagg 240agaggaagga gaaaactgca tcataacttt acagaattga atctagagtc ttccccgaaa 300agcccagaaa cttctctgcn gnatctggct tgtccatctg gtctaaggtg gctgcttctt 360ccccagccat cgagtcagtt tgtgcccatg aataatacac gacctgctat ttcccatgac 420tgct 424 158 2099 DNA Homo sapien 158ccgcggttaa aaggcgcagc aggtgggagc cggggccttc acccgaaacc cgacgagagc 60ccgacagccg gcggcgcccg agcccgacct gcctgcccag ccggagcgaa gggcgccgcc 120ccgcgcagag cccgcgccag ggccgccggc cgcagagcag ttaaaacgtg caggcaccag 180aaggcacttc ctgtcggtga agaagacctg tctccggtgt cacgggcatc ctgtgttttg 240caaacggggc tgacctccct tcctggggag caggaagggt cagggaagga aaagaagtac 300agaagatctg gctaaacaat ttctgtatgg cgaaagaaaa attctaactt gtacgccctc 360ttcatgcatc tttaattcaa tttgaatatt ccaggcgaca tcctcactga ccgagcaaag 420attgacattc gtatcatcac tgtgcaccat tggcttctag gcactccagt ggggtaggag 480aaggaggtct gaaaccctcg cagagggatc ttgccctcat tctttgggtc tgaaacactg 540gcagtcgttg gaaacaggac tcagggataa accagcgcaa tggattgggg gacgctgcac 600actttcatcg ggggtgtcaa caaacactcc accagcatcg ggaaggtgtg gatcacagtc 660atctttattt tccgagtcat gatcctcgtg gtggctgccc aggaagtgtg gggtgacgag 720caagaggact tcgtctgcaa cacactgcaa ccgggatgca aaaatgtgtg ctatgaccac 780tttttcccgg tgtcccacat ccggctgtgg gccctccagc tgatcttcgt ctccacccca 840gcgctgctgg tggccatgca tgtggcctac tacaggcacg aaaccactcg caagttcagg 900cgaggagaga agaggaatga tttcaaagac atagaggaca ttaaaaagca gaaggttcgg 960atagaggggt cgctgtggtg gacgtacacc agcagcatct ttttccgaat catctttgaa 1020gcagccttta tgtatgtgtt ttacttcctt tacaatgggt accacctgcc ctgggtgttg 1080aaatgtggga ttgacccctg ccccaacctt gttgactgct ttatttctag gccaacagag 1140aagaccgtgt ttaccatttt tatgatttct gcgtctgtga tttgcatgct gcttaacgtg 1200gcagagttgt gctacctgct gctgaaagtg tgttttagga gatcaaagag agcacagacg 1260caaaaaaatc accccaatca tgccctaaag gagagtaagc agaatgaaat gaatgagctg 1320atttcagata gtggtcaaaa tgcaatcaca ggttcccaag ctaaacattt caaggtaaaa 1380tgtagctgcg tcataaggag acttctgtct tctccagaag gcaataccaa cctgaaagtt 1440ccttctgtag cctgaagagt ttgtaaatga ctttcataat aaatagacac ttgagttaac 1500tttttgtagg atacttgctc cattcataca caacgtaatc aaatatgtgg tccatctctg 1560aaaacaagag actgcttgac aaaggagcat tgcagtcact ttgacaggtt ccttttaagt 1620ggactctctg acaaagtggg tactttctga aaatttatat aactgttgtt gataaggaac 1680atttatccag gaattgatac gtttattagg aaaagatatt tttataggct tggatgtttt 1740tagttctgac tttgaattta tataaagtat ttttataatg actggtcttc cttacctgga 1800aaaacatgcg atgttagttt tagaattaca ccacaagtat ctaaatttgg aacttacaaa 1860gggtctatct tgtaaatatt gttttgcatt gtctgttggc aaatttgtga actgtcatga 1920tacgcttaag gtggaaagtg ttcattgcac aatatatttt tactgctttc tgaatgtaga 1980cggaacagtg tggaagcaga aggctttttt aactcatccg tttgccaatc attgcaaaca 2040actgaaatgt ggatgtgatt gcctcaataa agctcgtccc cattgcttaa aaaaaaaaa 2099 159 291 PRT Homo sapien 159Met Asp Trp Gly Thr Leu His Thr Phe Ile Gly Gly Val Asn Lys His 1 5 10 15Ser Thr Ser Ile Gly Lys Val Trp Ile Thr Val Ile Phe Ile Phe Arg 20 25 30Val Met Ile Leu Val Val Ala Ala Gln Glu Val Trp Gly Asp Glu Gln 35 40 45Glu Asp Phe Val Cys Asn Thr Leu Gln Pro Gly Cys Lys Asn Val Cys 50 55 60Tyr Asp His Phe Phe Pro Val Ser His Ile Arg Leu Trp Ala Leu Gln65 70 75 80Leu Ile Phe Val Ser Thr Pro Ala Leu Leu Val Ala Met His Val Ala 85 90 95Tyr Tyr Arg His Glu Thr Thr Arg Lys Phe Arg Arg Gly Glu Lys Arg 100 105 110Asn Asp Phe Lys Asp Ile Glu Asp Ile Lys Lys Gln Lys Val Arg Ile 115 120 125Glu Gly Ser Leu Trp Trp Thr Tyr Thr Ser Ser Ile Phe Phe Arg Ile 130 135 140Ile Phe Glu Ala Ala Phe Met Tyr Val Phe Tyr Phe Leu Tyr Asn Gly145 150 155 160Tyr His Leu Pro Trp Val Leu Lys Cys Gly Ile Asp Pro Cys Pro Asn 165 170 175Leu Val Asp Cys Phe Ile Ser Arg Pro Thr Glu Lys Thr Val Phe Thr 180 185 190Ile Phe Met Ile Ser Ala Ser Val Ile Cys Met Leu Leu Asn Val Ala 195 200 205Glu Leu Cys Tyr Leu Leu Leu Lys Val Cys Phe Arg Arg Ser Lys Arg 210 215 220Ala Gln Thr Gln Lys Asn His Pro Asn His Ala Leu Lys Glu Ser Lys225 230 235 240Gln Asn Glu Met Asn Glu Leu Ile Ser Asp Ser Gly Gln Asn Ala Ile 245 250 255Thr Gly Ser Gln Ala Lys His Phe Lys Val Lys Cys Ser Cys Val Ile 260 265 270Arg Arg Leu Leu Ser Ser Pro Glu Gly Asn Thr Asn Leu Lys Val Pro 275 280 285Ser Val Ala 290 160 3951 DNA Homo sapien 160tctgcatcca tattgaaaac ctgacacaat gtatgcagca ggctcagtgt gagtgaactg 60gaggcttctc tacaacatga cccaaaggag cattgcaggt cctatttgca acctgaagtt 120tgtgactctc ctggttgcct taagttcaga actcccattc ctgggagctg gagtacagct 180tcaagacaat gggtataatg gattgctcat tgcaattaat cctcaggtac ctgagaatca 240gaacctcatc tcaaacatta aggaaatgat aactgaagct tcattttacc tatttaatgc 300taccaagaga agagtatttt tcagaaatat aaagatttta atacctgcca catggaaagc 360taataataac agcaaaataa aacaagaatc atatgaaaag gcaaatgtca tagtgactga 420ctggtatggg gcacatggag atgatccata caccctacaa tacagagggt gtggaaaaga 480gggaaaatac attcatttca cacctaattt cctactgaat gataacttaa cagctggcta 540cggatcacga ggccgagtgt ttgtccatga atgggcccac ctccgttggg gtgtgttcga 600tgagtataac aatgacaaac ctttctacat aaatgggcaa aatcaaatta aagtgacaag 660gtgttcatct gacatcacag gcatttttgt gtgtgaaaaa ggtccttgcc cccaagaaaa 720ctgtattatt agtaagcttt ttaaagaagg atgcaccttt atctacaata gcacccaaaa 780tgcaactgca tcaataatgt tcatgcaaag tttatcttct gtggttgaat tttgtaatgc 840aagtacccac aaccaagaag caccaaacct acagaaccag atgtgcagcc tcagaagtgc 900atgggatgta atcacagact ctgctgactt tcaccacagc tttcccatga acgggactga 960gcttccacct cctcccacat tctcgcttgt agaggctggt gacaaagtgg tctgtttagt 1020gctggatgtg tccagcaaga tggcagaggc tgacagactc cttcaactac aacaagccgc 1080agaattttat ttgatgcaga ttgttgaaat tcataccttc gtgggcattg ccagtttcga 1140cagcaaagga gagatcagag cccagctaca ccaaattaac agcaatgatg atcgaaagtt 1200gctggtttca tatctgccca ccactgtatc agctaaaaca gacatcagca tttgttcagg 1260gcttaagaaa ggatttgagg tggttgaaaa actgaatgga aaagcttatg gctctgtgat 1320gatattagtg accagcggag atgataagct tcttggcaat tgcttaccca ctgtgctcag 1380cagtggttca acaattcact ccattgccct gggttcatct gcagccccaa atctggagga 1440attatcacgt cttacaggag gtttaaagtt ctttgttcca gatatatcaa actccaatag 1500catgattgat gctttcagta gaatttcctc tggaactgga gacattttcc agcaacatat 1560tcagcttgaa agtacaggtg aaaatgtcaa acctcaccat caattgaaaa acacagtgac 1620tgtggataat actgtgggca acgacactat gtttctagtt acgtggcagg ccagtggtcc 1680tcctgagatt atattatttg atcctgatgg acgaaaatac tacacaaata attttatcac 1740caatctaact tttcggacag ctagtctttg gattccagga acagctaagc ctgggcactg 1800gacttacacc ctgaacaata cccatcattc tctgcaagcc ctgaaagtga cagtgacctc 1860tcgcgcctcc aactcagctg tgcccccagc cactgtggaa gcctttgtgg aaagagacag 1920cctccatttt cctcatcctg tgatgattta tgccaatgtg aaacagggat tttatcccat 1980tcttaatgcc actgtcactg ccacagttga gccagagact ggagatcctg ttacgctgag 2040actccttgat gatggagcag gtgctgatgt tataaaaaat gatggaattt actcgaggta 2100ttttttctcc tttgctgcaa atggtagata tagcttgaaa gtgcatgtca atcactctcc 2160cagcataagc accccagccc actctattcc agggagtcat gctatgtatg taccaggtta 2220cacagcaaac ggtaatattc agatgaatgc tccaaggaaa tcagtaggca gaaatgagga 2280ggagcgaaag tggggcttta gccgagtcag ctcaggaggc tccttttcag tgctgggagt 2340tccagctggc ccccaccctg atgtgtttcc accatgcaaa attattgacc tggaagctgt 2400aaaagtagaa gaggaattga ccctatcttg gacagcacct ggagaagact ttgatcaggg 2460ccaggctaca agctatgaaa taagaatgag taaaagtcta cagaatatcc aagatgactt 2520taacaatgct attttagtaa atacatcaaa gcgaaatcct cagcaagctg gcatcaggga 2580gatatttacg ttctcacccc aaatttccac gaatggacct gaacatcagc caaatggaga 2640aacacatgaa agccacagaa tttatgttgc aatacgagca atggatagga actccttaca 2700gtctgctgta tctaacattg cccaggcgcc tctgtttatt ccccccaatt ctgatcctgt 2760acctgccaga gattatctta tattgaaagg agttttaaca gcaatgggtt tgataggaat 2820catttgcctt attatagttg tgacacatca tactttaagc aggaaaaaga gagcagacaa 2880gaaagagaat ggaacaaaat tattataaat aaatatccaa agtgtcttcc ttcttagata 2940taagacccat ggccttcgac tacaaaaaca tactaacaaa gtcaaattaa catcaaaact 3000gtattaaaat gcattgagtt tttgtacaat acagataaga tttttacatg gtagatcaac 3060aaattctttt tgggggtaga ttagaaaacc cttacacttt ggctatgaac aaataataaa 3120aattattctt taaagtaatg tctttaaagg caaagggaag ggtaaagtcg gaccagtgtc 3180aaggaaagtt tgttttattg aggtggaaaa atagccccaa gcagagaaaa ggagggtagg 3240tctgcattat aactgtctgt gtgaagcaat catttagtta ctttgattaa tttttctttt 3300ctccttatct gtgcagaaca ggttgcttgt ttacaactga agatcatgct atatttcata 3360tatgaagccc ctaatgcaaa gctctttacc tcttgctatt ttgttatata tattacagat 3420gaaatctcac tgctaatgct cagagatctt ttttcactgt aagaggtaac ctttaacaat 3480atgggtatta cctttgtctc ttcataccgg ttttatgaca aaggtctatt gaatttattt 3540gtttgtaagt ttctactccc atcaaagcag ctttttaagt tattgccttg gttattatgg 3600atgatagtta tagcccttat aatgccttaa ctaaggaaga aaagatgtta ttctgagttt 3660gttttaatac atatatgaac atatagtttt attcaattaa accaaagaag aggtcagcag 3720ggagatacta acctttggaa atgattagct ggctctgttt tttggttaaa taagagtctt 3780taatcctttc tccatcaaga gttacttacc aagggcaggg gaagggggat atagaggtcc 3840caaggaaata aaaatcatct ttcatcttta attttactcc ttcctcttat ttttttaaaa 3900gattatcgaa caataaaatc atttgccttt ttaattaaaa acataaaaaa a 3951 161 943 PRT Homo sapien 161Met Thr Gln Arg Ser Ile Ala Gly Pro Ile Cys Asn Leu Lys Phe Val 1 5 10 15Thr Leu Leu Val Ala Leu Ser Ser Glu Leu Pro Phe Leu Gly Ala Gly 20 25 30Val Gln Leu Gln Asp Asn Gly Tyr Asn Gly Leu Leu Ile Ala Ile Asn 35 40 45Pro Gln Val Pro Glu Asn Gln Asn Leu Ile Ser Asn Ile Lys Glu Met 50 55 60Ile Thr Glu Ala Ser Phe Tyr Leu Phe Asn Ala Thr Lys Arg Arg Val65 70 75 80Phe Phe Arg Asn Ile Lys Ile Leu Ile Pro Ala Thr Trp Lys Ala Asn 85 90 95Asn Asn Ser Lys Ile Lys Gln Glu Ser Tyr Glu Lys Ala Asn Val Ile 100 105 110Val Thr Asp Trp Tyr Gly Ala His Gly Asp Asp Pro Tyr Thr Leu Gln 115 120 125Tyr Arg Gly Cys Gly Lys Glu Gly Lys Tyr Ile His Phe Thr Pro Asn 130 135 140Phe Leu Leu Asn Asp Asn Leu Thr Ala Gly Tyr Gly Ser Arg Gly Arg145 150 155 160Val Phe Val His Glu Trp Ala His Leu Arg Trp Gly Val Phe Asp Glu 165 170 175Tyr Asn Asn Asp Lys Pro Phe Tyr Ile Asn Gly Gln Asn Gln Ile Lys 180 185 190Val Thr Arg Cys Ser Ser Asp Ile Thr Gly Ile Phe Val Cys Glu Lys 195 200 205Gly Pro Cys Pro Gln Glu Asn Cys Ile Ile Ser Lys Leu Phe Lys Glu 210 215 220Gly Cys Thr Phe Ile Tyr Asn Ser Thr Gln Asn Ala Thr Ala Ser Ile225 230 235 240Met Phe Met Gln Ser Leu Ser Ser Val Val Glu Phe Cys Asn Ala Ser 245 250 255Thr His Asn Gln Glu Ala Pro Asn Leu Gln Asn Gln Met Cys Ser Leu 260 265 270Arg Ser Ala Trp Asp Val Ile Thr Asp Ser Ala Asp Phe His His Ser 275 280 285Phe Pro Met Asn Gly Thr Glu Leu Pro Pro Pro Pro Thr Phe Ser Leu 290 295 300Val Glu Ala Gly Asp Lys Val Val Cys Leu Val Leu Asp Val Ser Ser305 310 315 320Lys Met Ala Glu Ala Asp Arg Leu Leu Gln Leu Gln Gln Ala Ala Glu 325 330 335Phe Tyr Leu Met Gln Ile Val Glu Ile His Thr Phe Val Gly Ile Ala 340 345 350Ser Phe Asp Ser Lys Gly Glu Ile Arg Ala Gln Leu His Gln Ile Asn 355 360 365Ser Asn Asp Asp Arg Lys Leu Leu Val Ser Tyr Leu Pro Thr Thr Val 370 375 380Ser Ala Lys Thr Asp Ile Ser Ile Cys Ser Gly Leu Lys Lys Gly Phe385 390 395 400Glu Val Val Glu Lys Leu Asn Gly Lys Ala Tyr Gly Ser Val Met Ile 405 410 415Leu Val Thr Ser Gly Asp Asp Lys Leu Leu Gly Asn Cys Leu Pro Thr 420 425 430Val Leu Ser Ser Gly Ser Thr Ile His Ser Ile Ala Leu Gly Ser Ser 435 440 445Ala Ala Pro Asn Leu Glu Glu Leu Ser Arg Leu Thr Gly Gly Leu Lys 450 455 460Phe Phe Val Pro Asp Ile Ser Asn Ser Asn Ser Met Ile Asp Ala Phe465 470 475 480Ser Arg Ile Ser Ser Gly Thr Gly Asp Ile Phe Gln Gln His Ile Gln 485 490 495Leu Glu Ser Thr Gly Glu Asn Val Lys Pro His His Gln Leu Lys Asn 500 505 510Thr Val Thr Val Asp Asn Thr Val Gly Asn Asp Thr Met Phe Leu Val 515 520 525Thr Trp Gln Ala Ser Gly Pro Pro Glu Ile Ile Leu Phe Asp Pro Asp 530 535 540Gly Arg Lys Tyr Tyr Thr Asn Asn Phe Ile Thr Asn Leu Thr Phe Arg545 550 555 560Thr Ala Ser Leu Trp Ile Pro Gly Thr Ala Lys Pro Gly His Trp Thr 565 570 575Tyr Thr Leu Asn Asn Thr His His Ser Leu Gln Ala Leu Lys Val Thr 580 585 590Val Thr Ser Arg Ala Ser Asn Ser Ala Val Pro Pro Ala Thr Val Glu 595 600 605Ala Phe Val Glu Arg Asp Ser Leu His Phe Pro His Pro Val Met Ile 610 615 620Tyr Ala Asn Val Lys Gln Gly Phe Tyr Pro Ile Leu Asn Ala Thr Val625 630 635 640Thr Ala Thr Val Glu Pro Glu Thr Gly Asp Pro Val Thr Leu Arg Leu 645 650 655Leu Asp Asp Gly Ala Gly Ala Asp Val Ile Lys Asn Asp Gly Ile Tyr 660 665 670Ser Arg Tyr Phe Phe Ser Phe Ala Ala Asn Gly Arg Tyr Ser Leu Lys 675 680 685Val His Val Asn His Ser Pro Ser Ile Ser Thr Pro Ala His Ser Ile 690 695 700Pro Gly Ser His Ala Met Tyr Val Pro Gly Tyr Thr Ala Asn Gly Asn705 710 715 720Ile Gln Met Asn Ala Pro Arg Lys Ser Val Gly Arg Asn Glu Glu Glu 725 730 735Arg Lys Trp Gly Phe Ser Arg Val Ser Ser Gly Gly Ser Phe Ser Val 740 745 750Leu Gly Val Pro Ala Gly Pro His Pro Asp Val Phe Pro Pro Cys Lys 755 760 765Ile Ile Asp Leu Glu Ala Val Lys Val Glu Glu Glu Leu Thr Leu Ser 770 775 780Trp Thr Ala Pro Gly Glu Asp Phe Asp Gln Gly Gln Ala Thr Ser Tyr785 790 795 800Glu Ile Arg Met Ser Lys Ser Leu Gln Asn Ile Gln Asp Asp Phe Asn 805 810 815Asn Ala Ile Leu Val Asn Thr Ser Lys Arg Asn Pro Gln Gln Ala Gly 820 825 830Ile Arg Glu Ile Phe Thr Phe Ser Pro Gln Ile Ser Thr Asn Gly Pro 835 840 845Glu His Gln Pro Asn Gly Glu Thr His Glu Ser His Arg Ile Tyr Val 850 855 860Ala Ile Arg Ala Met Asp Arg Asn Ser Leu Gln Ser Ala Val Ser Asn865 870 875 880Ile Ala Gln Ala Pro Leu Phe Ile Pro Pro Asn Ser Asp Pro Val Pro 885 890 895Ala Arg Asp Tyr Leu Ile Leu Lys Gly Val Leu Thr Ala Met Gly Leu 900 905 910Ile Gly Ile Ile Cys Leu Ile Ile Val Val Thr His His Thr Leu Ser 915 920 925Arg Lys Lys Arg Ala Asp Lys Lys Glu Asn Gly Thr Lys Leu Leu 930 935 940 162 498 DNA Homo sapien 162tggagaacca cgtggacagc accatgaaca tgttgggcgg gggaggcagt gctggccgga 60agcccctcaa gtcgggtatg aaggagctgg ccgtgttccg ggagaaggtc actgagcagc 120accggcagat gggcaagggt ggcaagcatc accttggcct ggaggagccc aagaagctgc 180gaccaccccc tgccaggact ccctgccaac aggaactgga ccaggtcctg gagcggatct 240ccaccatgcg ccttccggat gagcggggcc ctctggagca cctctactcc ctgcacatcc 300ccaactgtga caagcatggc ctgtacaacc tcaaacagtg gcaagatgtc tctgaacggg 360cagcgtgggg agtgctggtg tgtgaacccc aacaccggga agctgatcca gggagccccc 420accatccggg gggaccccga gtgtcatctc ttctacaatg agcagcagga ggctcgcggg 480gtgcacaccc cagcggat 498 163 1128 DNA Homo sapien 163gccacctggc cctcctgatc gacgacacac gcacttgaaa cttgttctca gggtgtgtgg 60aatcaacttt ccggaagcaa ccagcccacc agaggaggtc ccgagcgcga gcggagacga 120tgcagcggag actggttcag cagtggagcg tcgcggtgtt cctgctgagc tacgcggtgc 180cctcctgcgg gcgctcggtg gagggtctca gccgccgcct caaaagagct gtgtctgaac 240atcagctcct ccatgacaag gggaagtcca tccaagattt acggcgacga ttcttccttc 300accatctgat cgcagaaatc cacacagctg aaatcagagc tacctcggag gtgtccccta 360actccaagcc ctctcccaac acaaagaacc accccgtccg atttgggtct gatgatgagg 420gcagatacct aactcaggaa actaacaagg tggagacgta caaagagcag ccgctcaaga 480cacctgggaa gaaaaagaaa ggcaagcccg ggaaacgcaa ggagcaggaa aagaaaaaac 540ggcgaactcg ctctgcctgg ttagactctg gagtgactgg gagtgggcta gaaggggacc 600acctgtctga cacctccaca acgtcgctgg agctcgattc acggaggcat tgaaattttc 660agcagagacc ttccaaggac atattgcagg attctgtaat agtgaacata tggaaagtat 720tagaaatatt tattgtctgt aaatactgta aatgcattgg aataaaactg tctcccccat 780tgctctatga aactgcacat tggtcattgt gaatattttt ttttttgcca aggctaatcc 840aattattatt atcacattta ccataattta ttttgtccat tgatgtattt attttgtaaa 900tgtatcttgg tgctgctgaa tttctatatt ttttgtaaca taatgcactt tagatataca 960tatcaagtat gttgataaat gacacaatga agtgtctcta ttttgtggtt gattttaatg 1020aatgcctaaa tataattatc caaattgatt ttcctttgtg catgtaaaaa taacagtatt 1080ttaaatttgt aaagaatgtc taataaaata taatctaatt acatcatg 1128 164 1310 DNA Homo sapien 164gggcctggtt cgcaaagaag ctgacttcag agggggaaac tttcttcttt taggaggcgg 60ttagccctgt tccacgaacc caggagaact gctggccaga ttaattagac attgctatgg 120gagacgtgta aacacactac ttatcattga tgcatatata aaaccatttt attttcgcta 180ttatttcaga ggaagcgcct ctgatttgtt tcttttttcc ctttttgctc tttctggctg 240tgtggtttgg agaaagcaca gttggagtag ccggttgcta aataagtccc gagcgcgagc 300ggagacgatg cagcggagac tggttcagca gtggagcgtc gcggtgttcc tgctgagcta 360cgcggtgccc tcctgcgggc gctcggtgga gggtctcagc cgccgcctca aaagagctgt 420gtctgaacat cagctcctcc atgacaaggg gaagtccatc caagatttac ggcgacgatt 480cttccttcac catctgatcg cagaaatcca cacagctgaa atcagagcta cctcggaggt 540gtcccctaac tccaagccct ctcccaacac aaagaaccac cccgtccgat ttgggtctga 600tgatgagggc agatacctaa ctcaggaaac taacaaggtg gagacgtaca aagagcagcc 660gctcaagaca cctgggaaga aaaagaaagg caagcccggg aaacgcaagg agcaggaaaa 720gaaaaaacgg cgaactcgct ctgcctggtt agactctgga gtgactggga gtgggctaga 780aggggaccac ctgtctgaca cctccacaac gtcgctggag ctcgattcac ggaggcattg 840aaattttcag cagagacctt ccaaggacat attgcaggat tctgtaatag tgaacatatg 900gaaagtatta gaaatattta ttgtctgtaa atactgtaaa tgcattggaa taaaactgtc 960tcccccattg ctctatgaaa ctgcacattg gtcattgtga atattttttt ttttgccaag 1020gctaatccaa ttattattat cacatttacc ataatttatt ttgtccattg atgtatttat 1080tttgtaaatg tatcttggtg ctgctgaatt tctatatttt ttgtaacata atgcacttta 1140gatatacata tcaagtatgt tgataaatga cacaatgaag tgtctctatt ttgtggttga 1200ttttaatgaa tgcctaaata taattatcca aattgatttt cctttgtgcc cgtaaaaata 1260acagtatttt aaatttgtaa agaatgtcta ataaaatata atctaattac 1310 165 177 PRT Homo sapien 165Met Gln Arg Arg Leu Val Gln Gln Trp Ser Val Ala Val Phe Leu Leu 1 5 10 15Ser Tyr Ala Val Pro Ser Cys Gly Arg Ser Val Glu Gly Leu Ser Arg 20 25 30Arg Leu Lys Arg Ala Val Ser Glu His Gln Leu Leu His Asp Lys Gly 35 40 45Lys Ser Ile Gln Asp Leu Arg Arg Arg Phe Phe Leu His His Leu Ile 50 55 60Ala Glu Ile His Thr Ala Glu Ile Arg Ala Thr Ser Glu Val Ser Pro65 70 75 80Asn Ser Lys Pro Ser Pro Asn Thr Lys Asn His Pro Val Arg Phe Gly 85 90 95Ser Asp Asp Glu Gly Arg Tyr Leu Thr Gln Glu Thr Asn Lys Val Glu 100 105 110Thr Tyr Lys Glu Gln Pro Leu Lys Thr Pro Gly Lys Lys Lys Lys Gly 115 120 125Lys Pro Gly Lys Arg Lys Glu Gln Glu Lys Lys Lys Arg Arg Thr Arg 130 135 140Ser Ala Trp Leu Asp Ser Gly Val Thr Gly Ser Gly Leu Glu Gly Asp145 150 155 160His Leu Ser Asp Thr Ser Thr Thr Ser Leu Glu Leu Asp Ser Arg Arg 165 170 175His 166 177 PRT Homo sapien 166Met Gln Arg Arg Leu Val Gln Gln Trp Ser Val Ala Val Phe Leu Leu 1 5 10 15Ser Tyr Ala Val Pro Ser Cys Gly Arg Ser Val Glu Gly Leu Ser Arg 20 25 30Arg Leu Lys Arg Ala Val Ser Glu His Gln Leu Leu His Asp Lys Gly 35 40 45Lys Ser Ile Gln Asp Leu Arg Arg Arg Phe Phe Leu His His Leu Ile 50 55 60Ala Glu Ile His Thr Ala Glu Ile Arg Ala Thr Ser Glu Val Ser Pro65 70 75 80Asn Ser Lys Pro Ser Pro Asn Thr Lys Asn His Pro Val Arg Phe Gly 85 90 95Ser Asp Asp Glu Gly Arg Tyr Leu Thr Gln Glu Thr Asn Lys Val Glu 100 105 110Thr Tyr Lys Glu Gln Pro Leu Lys Thr Pro Gly Lys Lys Lys Lys Gly 115 120 125Lys Pro Gly Lys Arg Lys Glu Gln Glu Lys Lys Lys Arg Arg Thr Arg 130 135 140Ser Ala Trp Leu Asp Ser Gly Val Thr Gly Ser Gly Leu Glu Gly Asp145 150 155 160His Leu Ser Asp Thr Ser Thr Thr Ser Leu Glu Leu Asp Ser Arg Arg 165 170 175His 167 3362 DNA Homo sapien 167cacaatgtat gcagcaggct cagtgtgagt gaactggagg cttctctaca acatgaccca 60aaggagcatt gcaggtccta tttgcaacct gaagtttgtg actctcctgg ttgccttaag 120ttcagaactc ccattcctgg gagctggagt acagcttcaa gacaatgggt ataatggatt 180gctcattgca attaatcctc aggtacctga gaatcagaac ctcatctcaa acattaagga 240aatgataact gaagcttcat tttacctatt taatgctacc aagagaagag tatttttcag 300aaatataaag attttaatac ctgccacatg gaaagctaat aataacagca aaataaaaca 360agaatcatat gaaaaggcaa atgtcatagt gactgactgg tatggggcac atggagatga 420tccatacacc ctacaataca gagggtgtgg aaaagaggga aaatacattc atttcacacc 480taatttccta ctgaatgata acttaacagc tggctacgga tcacgaggcc gagtgtttgt 540ccatgaatgg gcccacctcc gttggggtgt gttcgatgag tataacaatg acaaaccttt 600ctacataaat gggcaaaatc aaattaaagt gacaaggtgt tcatctgaca tcacaggcat 660ttttgtgtgt gaaaaaggtc cttgccccca agaaaactgt attattagta agctttttaa 720agaaggatgc acctttatct acaatagcac ccaaaatgca actgcatcaa taatgttcat 780gcaaagttta tcttctgtgg ttgaattttg taatgcaagt acccacaacc aagaagcacc 840aaacctacag aaccagatgt gcagcctcag aagtgcatgg gatgtaatca cagactctgc 900tgactttcac cacagctttc ccatgaacgg gactgagctt ccacctcctc ccacattctc 960gcttgtagag gctggtgaca aagtggtctg tttagtgctg gatgtgtcca gcaagatggc 1020agaggctgac agactccttc aactacaaca agccgcagaa ttttatttga tgcagattgt 1080tgaaattcat accttcgtgg gcattgccag tttcgacagc aaaggagaga tcagagccca 1140gctacaccaa attaacagca atgatgatcg aaagttgctg gtttcatatc tgcccaccac 1200tgtatcagct aaaacagaca tcagcatttg ttcagggctt aagaaaggat ttgaggtggt 1260tgaaaaactg aatggaaaag cttatggctc tgtgatgata ttagtgacca gcggagatga 1320taagcttctt ggcaattgct tacccactgt gctcagcagt ggttcaacaa ttcactccat 1380tgccctgggt tcatctgcag ccccaaatct ggaggaatta tcacgtctta caggaggttt 1440aaagttcttt gttccagata tatcaaactc caatagcatg attgatgctt tcagtagaat 1500ttcctctgga actggagaca ttttccagca acatattcag cttgaaagta caggtgaaaa 1560tgtcaaacct caccatcaat tgaaaaacac agtgactgtg gataatactg tgggcaacga 1620cactatgttt ctagttacgt ggcaggccag tggtcctcct gagattatat tatttgatcc 1680tgatggacga aaatactaca caaataattt tatcaccaat ctaacttttc ggacagctag 1740tctttggatt ccaggaacag ctaagcctgg gcactggact tacaccctga tgtgtttcca 1800ccatgcaaaa ttattgacct ggaagctgta aaagtagaag aggaattgac cctatcttgg 1860acagcacctg gagaagactt tgatcagggc caggctacaa gctatgaaat aagaatgagt 1920aaaagtctac agaatatcca agatgacttt aacaatgcta ttttagtaaa tacatcaaag 1980cgaaatcctc agcaagctgg catcagggag atatttacgt tctcacccca aatttccacg 2040aatggacctg aacatcagcc aaatggagaa acacatgaaa gccacagaat ttatgttgca 2100atacgagcaa tggataggaa ctccttacag tctgctgtat ctaacattgc ccaggcgcct 2160ctgtttattc cccccaattc tgatcctgta cctgccagag attatcttat attgaaagga 2220gttttaacag caatgggttt gataggaatc atttgcctta ttatagttgt gacacatcat 2280actttaagca ggaaaaagag agcagacaag aaagagaatg gaacaaaatt attataaata 2340aatatccaaa gtgtcttcct tcttagatat aagacccatg gccttcgact acaaaaacat 2400actaacaaag tcaaattaac atcaaaactg tattaaaatg cattgagttt ttgtacaata 2460cagataagat ttttacatgg tagatcaaca aattcttttt gggggtagat tagaaaaccc 2520ttacactttg gctatgaaca aataataaaa attattcttt aaagtaatgt ctttaaaggc 2580aaagggaagg gtaaagtcgg accagtgtca aggaaagttt gttttattga ggtggaaaaa 2640tagccccaag cagagaaaag gagggtaggt ctgcattata actgtctgtg tgaagcaatc 2700atttagttac tttgattaat ttttcttttc tccttatctg tgcagaacag gttgcttgtt 2760tacaactgaa gatcatgcta tatttcatat atgaagcccc taatgcaaag ctctttacct 2820cttgctattt tgttatatat attacagatg aaatctcact gctaatgctc agagatcttt 2880tttcactgta agaggtaacc tttaacaata tgggtattac ctttgtctct tcataccggt 2940tttatgacaa aggtctattg aatttatttg tttgtaagtt tctactccca tcaaagcagc 3000tttctaagtt attgccttgg ttattatgga tgatagttat agcccttata atgccttaac 3060taaggaagaa aagatgttat tctgagtttg ttttaataca tatatgaaca tatagtttta 3120ttcaattaaa ccaaagaaga ggtcagcagg gagatactaa cctttggaaa tgattagctg 3180gctctgtttt ttggttaaat aagagtcttt aatcctttct ccatcaagag ttacttacca 3240agggcagggg aagggggata tagaggtcac aaggaaataa aaatcatctt tcatctttaa 3300ttttactcct tcctcttatt tttttaaaag attatcgaac aataaaatca tttgcctttt 3360tt 3362 168 2784 DNA Homo sapien 168tctgcatcca tattgaaaac ctgacacaat gtatgcagca ggctcagtgt gagtgaactg 60gaggcttctc tacaacatga cccaaaggag cattgcaggt cctatttgca acctgaagtt 120tgtgactctc ctggttgcct taagttcaga actcccattc ctgggagctg gagtacagct 180tcaagacaat gggtataatg gattgctcat tgcaattaat cctcaggtac ctgagaatca 240gaacctcatc tcaaacatta aggaaatgat aactgaagct tcattttacc tatttaatgc 300taccaagaga agagtatttt tcagaaatat aaagatttta atacctgcca catggaaagc 360taataataac agcaaaataa aacaagaatc atatgaaaag gcaaatgtca tagtgactga 420ctggtatggg gcacatggag atgatccata caccctacaa tacagagggt gtggaaaaga 480gggaaaatac attcatttca cacctaattt cctactgaat gataacttaa cagctggcta 540cggatcacga ggccgagtgt ttgtccatga atgggcccac ctccgttggg gtgtgttcga 600tgagtataac aatgacaaac ctttctacat aaatgggcaa aatcaaatta aagtgacaag 660gtgttcatct gacatcacag gcatttttgt gtgtgaaaaa ggtccttgcc cccaagaaaa 720ctgtattatt agtaagcttt ttaaagaagg atgcaccttt atctacaata gcacccaaaa 780tgcaactgca tcaataatgt tcatgcaaag tttatcttct gtggttgaat tttgtaatgc 840aagtacccac aaccaagaag caccaaacct acagaaccag atgtgcagcc tcagaagtgc 900atgggatgta atcacagact ctgctgactt tcaccacagc tttcccatga acgggactga 960gcttccacct cctcccacat tctcgcttgt agaggctggt gacaaagtgg tctgtttagt 1020gctggatgtg tccagcaaga tggcagaggc tgacagactc cttcaactac aacaagccgc 1080agaattttat ttgatgcaga ttgttgaaat tcataccttc gtgggcattg ccagtttcga 1140cagcaaagga gagatcagag cccagctaca ccaaattaac agcaatgatg atcgaaagtt 1200gctggtttca tatctgccca ccactgtatc agctaaaaca gacatcagca tttgttcagg 1260gcttaagaaa ggatttgagg tggttgaaaa actgaatgga aaagcttatg gctctgtgat 1320gatattagtg accagcggag atgataagct tcttggcaat tgcttaccca ctgtgctcag 1380cagtggttca acaattcact ccattgccct gggttcatct gcagccccaa atctggagga 1440attatcacgt cttacaggag gtttaaagtt ctttgttcca gatatatcaa actccaatag 1500catgattgat gctttcagta gaatttcctc tggaactgga gacattttcc agcaacatat 1560tcagcttgaa agtacaggtg aaaatgtcaa acctcaccat caattgaaaa acacagtgac 1620tgtggataat actgtgggca acgacactat gtttctagtt acgtggcagg ccagtggtcc 1680tcctgagatt atattatttg atcctgatgg acgaaaatac tacacaaata attttatcac 1740caatctaact tttcggacag ctagtctttg gattccagga acagctaagc ctgggcactg 1800gacttacacc ctgaacaata cccatcattc tctgcaagcc ctgaaagtga cagtgacctc 1860tcgcgcctcc aactcagctg tgcccccagc cactgtggaa gcctttgtgg aaagagacag 1920cctccatttt cctcatcctg tgatgattta tgccaatgtg aaacagggat tttatcccat 1980tcttaatgcc actgtcactg ccacagttga gccagagact ggagatcctg ttacgctgag 2040actccttgat gatggagcag gtgctgatgt tataaaaaat gatggaattt actcgaggta 2100ttttttctcc tttgctgcaa atggtagata tagcttgaaa gtgcatgtca atcactctcc 2160cagcataagc accccagccc actctattcc agggagtcat gctatgtatg taccaggtta 2220cacagcaaac ggtaatattc agatgaatgc tccaaggaaa tcagtaggca gaaatgagga 2280ggagcgaaag tggggcttta gccgagtcag ctcaggaggc tccttttcag tgctgggagt 2340tccagctggc ccccaccctg atgtgtttcc accatgcaaa attattgacc tggaagctgt 2400aaatagaaga ggaattgacc ctatcttgga cagcacctgg agaagacttt gatcagggcc 2460aggctacaag ctatgaaata agaatgagta aaagtctaca gaatatccaa gatgacttta 2520acaatgctat tttagtaaat acatcaaagc gaaatcctca gcaagctggc atcagggaga 2580tatttacgtt ctcaccccaa atttccacga atggacctga acatcagcca aatggagaaa 2640cacatgaaag ccacagaatt tatgttgcaa tacgagcaat ggataggaac tccttacagt 2700ctgctgtatc taacattgcc caggcgcctc tgtttattcc ccccaattct gatcctgtac 2760ctgccagaga ttatcttata ttga 2784 169 592 PRT Homo sapien 169Met Thr Gln Arg Ser Ile Ala Gly Pro Ile Cys Asn Leu Lys Phe Val 1 5 10 15Thr Leu Leu Val Ala Leu Ser Ser Glu Leu Pro Phe Leu Gly Ala Gly 20 25 30Val Gln Leu Gln Asp Asn Gly Tyr Asn Gly Leu Leu Ile Ala Ile Asn 35 40 45Pro Gln Val Pro Glu Asn Gln Asn Leu Ile Ser Asn Ile Lys Glu Met 50 55 60Ile Thr Glu Ala Ser Phe Tyr Leu Phe Asn Ala Thr Lys Arg Arg Val65 70 75 80Phe Phe Arg Asn Ile Lys Ile Leu Ile Pro Ala Thr Trp Lys Ala Asn 85 90 95Asn Asn Ser Lys Ile Lys Gln Glu Ser Tyr Glu Lys Ala Asn Val Ile 100 105 110Val Thr Asp Trp Tyr Gly Ala His Gly Asp Asp Pro Tyr Thr Leu Gln 115 120 125Tyr Arg Gly Cys Gly Lys Glu Gly Lys Tyr Ile His Phe Thr Pro Asn 130 135 140Phe Leu Leu Asn Asp Asn Leu Thr Ala Gly Tyr Gly Ser Arg Gly Arg145 150 155 160Val Phe Val His Glu Trp Ala His Leu Arg Trp Gly Val Phe Asp Glu 165 170 175Tyr Asn Asn Asp Lys Pro Phe Tyr Ile Asn Gly Gln Asn Gln Ile Lys 180 185 190Val Thr Arg Cys Ser Ser Asp Ile Thr Gly Ile Phe Val Cys Glu Lys 195 200 205Gly Pro Cys Pro Gln Glu Asn Cys Ile Ile Ser Lys Leu Phe Lys Glu 210 215 220Gly Cys Thr Phe Ile Tyr Asn Ser Thr Gln Asn Ala Thr Ala Ser Ile225 230 235 240Met Phe Met Gln Ser Leu Ser Ser Val Val Glu Phe Cys Asn Ala Ser 245 250 255Thr His Asn Gln Glu Ala Pro Asn Leu Gln Asn Gln Met Cys Ser Leu 260 265 270Arg Ser Ala Trp Asp Val Ile Thr Asp Ser Ala Asp Phe His His Ser 275 280 285Phe Pro Met Asn Gly Thr Glu Leu Pro Pro Pro Pro Thr Phe Ser Leu 290 295 300Val Glu Ala Gly Asp Lys Val Val Cys Leu Val Leu Asp Val Ser Ser305 310 315 320Lys Met Ala Glu Ala Asp Arg Leu Leu Gln Leu Gln Gln Ala Ala Glu 325 330 335Phe Tyr Leu Met Gln Ile Val Glu Ile His Thr Phe Val Gly Ile Ala 340 345 350Ser Phe Asp Ser Lys Gly Glu Ile Arg Ala Gln Leu His Gln Ile Asn 355 360 365Ser Asn Asp Asp Arg Lys Leu Leu Val Ser Tyr Leu Pro Thr Thr Val 370 375 380Ser Ala Lys Thr Asp Ile Ser Ile Cys Ser Gly Leu Lys Lys Gly Phe385 390 395 400Glu Val Val Glu Lys Leu Asn Gly Lys Ala Tyr Gly Ser Val Met Ile 405 410 415Leu Val Thr Ser Gly Asp Asp Lys Leu Leu Gly Asn Cys Leu Pro Thr 420 425 430Val Leu Ser Ser Gly Ser Thr Ile His Ser Ile Ala Leu Gly Ser Ser 435 440 445Ala Ala Pro Asn Leu Glu Glu Leu Ser Arg Leu Thr Gly Gly Leu Lys 450 455 460Phe Phe Val Pro Asp Ile Ser Asn Ser Asn Ser Met Ile Asp Ala Phe465 470 475 480Ser Arg Ile Ser Ser Gly Thr Gly Asp Ile Phe Gln Gln His Ile Gln 485 490 495Leu Glu Ser Thr Gly Glu Asn Val Lys Pro His His Gln Leu Lys Asn 500 505 510Thr Val Thr Val Asp Asn Thr Val Gly Asn Asp Thr Met Phe Leu Val 515 520 525Thr Trp Gln Ala Ser Gly Pro Pro Glu Ile Ile Leu Phe Asp Pro Asp 530 535 540Gly Arg Lys Tyr Tyr Thr Asn Asn Phe Ile Thr Asn Leu Thr Phe Arg545 550 555 560Thr Ala Ser Leu Trp Ile Pro Gly Thr Ala Lys Pro Gly His Trp Thr 565 570 575Tyr Thr Leu Met Cys Phe His His Ala Lys Leu Leu Thr Trp Lys Leu 580 585 590 170 791 PRT Homo sapien 170Met Thr Gln Arg Ser Ile Ala Gly Pro Ile Cys Asn Leu Lys Phe Val 1 5 10 15Thr Leu Leu Val Ala Leu Ser Ser Glu Leu Pro Phe Leu Gly Ala Gly 20 25 30Val Gln Leu Gln Asp Asn Gly Tyr Asn Gly Leu Leu Ile Ala Ile Asn 35 40 45Pro Gln Val Pro Glu Asn Gln Asn Leu Ile Ser Asn Ile Lys Glu Met 50 55 60Ile Thr Glu Ala Ser Phe Tyr Leu Phe Asn Ala Thr Lys Arg Arg Val65 70 75 80Phe Phe Arg Asn Ile Lys Ile Leu Ile Pro Ala Thr Trp Lys Ala Asn 85 90 95Asn Asn Ser Lys Ile Lys Gln Glu Ser Tyr Glu Lys Ala Asn Val Ile 100 105 110Val Thr Asp Trp Tyr Gly Ala His Gly Asp Asp Pro Tyr Thr Leu Gln 115 120 125Tyr Arg Gly Cys Gly Lys Glu Gly Lys Tyr Ile His Phe Thr Pro Asn 130 135 140Phe Leu Leu Asn Asp Asn Leu Thr Ala Gly Tyr Gly Ser Arg Gly Arg145 150 155 160Val Phe Val His Glu Trp Ala His Leu Arg Trp Gly Val Phe Asp Glu 165 170 175Tyr Asn Asn Asp Lys Pro Phe Tyr Ile Asn Gly Gln Asn Gln Ile Lys 180 185 190Val Thr Arg Cys Ser Ser Asp Ile Thr Gly Ile Phe Val Cys Glu Lys 195 200 205Gly Pro Cys Pro Gln Glu Asn Cys Ile Ile Ser Lys Leu Phe Lys Glu 210 215 220Gly Cys Thr Phe Ile Tyr Asn Ser Thr Gln Asn Ala Thr Ala Ser Ile225 230 235 240Met Phe Met Gln Ser Leu Ser Ser Val Val Glu Phe Cys Asn Ala Ser 245 250 255Thr His Asn Gln Glu Ala Pro Asn Leu Gln Asn Gln Met Cys Ser Leu 260 265 270Arg Ser Ala Trp Asp Val Ile Thr Asp Ser Ala Asp Phe His His Ser 275 280 285Phe Pro Met Asn Gly Thr Glu Leu Pro Pro Pro Pro Thr Phe Ser Leu 290 295 300Val Glu Ala Gly Asp Lys Val Val Cys Leu Val Leu Asp Val Ser Ser305 310 315 320Lys Met Ala Glu Ala Asp Arg Leu Leu Gln Leu Gln Gln Ala Ala Glu 325 330 335Phe Tyr Leu Met Gln Ile Val Glu Ile His Thr Phe Val Gly Ile Ala 340 345 350Ser Phe Asp Ser Lys Gly Glu Ile Arg Ala Gln Leu His Gln Ile Asn 355 360 365Ser Asn Asp Asp Arg Lys Leu Leu Val Ser Tyr Leu Pro Thr Thr Val 370 375 380Ser Ala Lys Thr Asp Ile Ser Ile Cys Ser Gly Leu Lys Lys Gly Phe385 390 395 400Glu Val Val Glu Lys Leu Asn Gly Lys Ala Tyr Gly Ser Val Met Ile 405 410 415Leu Val Thr Ser Gly Asp Asp Lys Leu Leu Gly Asn Cys Leu Pro Thr 420 425 430Val Leu Ser Ser Gly Ser Thr Ile His Ser Ile Ala Leu Gly Ser Ser 435 440 445Ala Ala Pro Asn Leu Glu Glu Leu Ser Arg Leu Thr Gly Gly Leu Lys 450 455 460Phe Phe Val Pro Asp Ile Ser Asn Ser Asn Ser Met Ile Asp Ala Phe465 470 475 480Ser Arg Ile Ser Ser Gly Thr Gly Asp Ile Phe Gln Gln His Ile Gln 485 490 495Leu Glu Ser Thr Gly Glu Asn Val Lys Pro His His Gln Leu Lys Asn 500 505 510Thr Val Thr Val Asp Asn Thr Val Gly Asn Asp Thr Met Phe Leu Val 515 520 525Thr Trp Gln Ala Ser Gly Pro Pro Glu Ile Ile Leu Phe Asp Pro Asp 530 535 540Gly Arg Lys Tyr Tyr Thr Asn Asn Phe Ile Thr Asn Leu Thr Phe Arg545 550 555 560Thr Ala Ser Leu Trp Ile Pro Gly Thr Ala Lys Pro Gly His Trp Thr 565 570 575Tyr Thr Leu Asn Asn Thr His His Ser Leu Gln Ala Leu Lys Val Thr 580 585 590Val Thr Ser Arg Ala Ser Asn Ser Ala Val Pro Pro Ala Thr Val Glu 595 600 605Ala Phe Val Glu Arg Asp Ser Leu His Phe Pro His Pro Val Met Ile 610 615 620Tyr Ala Asn Val Lys Gln Gly Phe Tyr Pro Ile Leu Asn Ala Thr Val625 630 635 640Thr Ala Thr Val Glu Pro Glu Thr Gly Asp Pro Val Thr Leu Arg Leu 645 650 655Leu Asp Asp Gly Ala Gly Ala Asp Val Ile Lys Asn Asp Gly Ile Tyr 660 665 670Ser Arg Tyr Phe Phe Ser Phe Ala Ala Asn Gly Arg Tyr Ser Leu Lys 675 680 685Val His Val Asn His Ser Pro Ser Ile Ser Thr Pro Ala His Ser Ile 690 695 700Pro Gly Ser His Ala Met Tyr Val Pro Gly Tyr Thr Ala Asn Gly Asn705 710 715 720Ile Gln Met Asn Ala Pro Arg Lys Ser Val Gly Arg Asn Glu Glu Glu 725 730 735Arg Lys Trp Gly Phe Ser Arg Val Ser Ser Gly Gly Ser Phe Ser Val 740 745 750Leu Gly Val Pro Ala Gly Pro His Pro Asp Val Phe Pro Pro Cys Lys 755 760 765Ile Ile Asp Leu Glu Ala Val Asn Arg Arg Gly Ile Asp Pro Ile Leu 770 775 780Asp Ser Thr Trp Arg Arg Leu785 790 171 1491 DNA Homo sapien 171cctcctgcca gccaagtgaa gacatgctta cttccccttc accttccttc atgatgtggg 60aagagtgctg caacccagcc ctagccaacg ccgcatgaga gggagtgtgc cgagggcttc 120tgagaaggtt tctctcacat ctagaaagaa gcgcttaaga tgtggcagcc cctcttcttc 180aagtggctct tgtcctgttg ccctgggagt tctcaaattg ctgcagcagc ctccacccag 240cctgaggatg acatcaatac acagaggaag aagagtcagg aaaagatgag agaagttaca 300gactctcctg ggcgaccccg agagcttacc attcctcaga cttcttcaca tggtgctaac 360agatttgttc ctaaaagtaa agctctagag gccgtcaaat tggcaataga agccgggttc 420caccatattg attctgcaca tgtttacaat aatgaggagc aggttggact ggccatccga 480agcaagattg cagatggcag tgtgaagaga gaagacatat tctacacttc aaagctttgg 540agcaattccc atcgaccaga gttggtccga ccagccttgg aaaggtcact gaaaaatctt 600caattggact atgttgacct ctatcttatt cattttccag tgtctgtaaa gccaggtgag 660gaagtgatcc caaaagatga aaatggaaaa atactatttg acacagtgga tctctgtgcc 720acatgggagg ccatggagaa gtgtaaagat gcaggattgg ccaagtccat cggggtgtcc 780aacttcaacc acaggctgct ggagatgatc ctcaacaagc cagggctcaa gtacaagcct 840gtctgcaacc aggtggaatg tcatccttac ttcaaccaga gaaaactgct ggatttctgc 900aagtcaaaag acattgttct ggttgcctat agtgctctgg gatcccatcg agaagaacca 960tgggtggacc cgaactcccc ggtgctcttg gaggacccag tcctttgtgc cttggcaaaa 1020aagcacaagc gaaccccagc cctgattgcc ctgcgctacc agctgcagcg tggggttgtg 1080gtcctggcca agagctacaa tgagcagcgc atcagacaga acgtgcaggt gtttgaattc 1140cagttgactt cagaggagat gaaagccata gatggcctaa acagaaatgt gcgatatttg 1200acccttgata tttttgctgg cccccctaat tatccatttt ctgatgaata ttaacatgga 1260gggcattgca tgaggtctgc cagaaggccc tgcgtgtgga tggtgacaca gaggatggct 1320ctatgctggt gactggacac atcgcctctg gttaaatctc tcctgcttgg cgacttcagt 1380aagctacagc taagcccatc ggccggaaaa gaaagacaat aattttgttt ttcattttga 1440aaaaattaaa tgctctctcc taaagattct tcacctaaaa aaaaaaaaaa a 1491 172 364 PRT Homo sapien 172Met Trp Gln Pro Leu Phe Phe Lys Trp Leu Leu Ser Cys Cys Pro Gly 1 5 10 15Ser Ser Gln Ile Ala Ala Ala Ala Ser Thr Gln Pro Glu Asp Asp Ile 20 25 30Asn Thr Gln Arg Lys Lys Ser Gln Glu Lys Met Arg Glu Val Thr Asp 35 40 45Ser Pro Gly Arg Pro Arg Glu Leu Thr Ile Pro Gln Thr Ser Ser His 50 55 60Gly Ala Asn Arg Phe Val Pro Lys Ser Lys Ala Leu Glu Ala Val Lys65 70 75 80Leu Ala Ile Glu Ala Gly Phe His His Ile Asp Ser Ala His Val Tyr 85 90 95Asn Asn Glu Glu Gln Val Gly Leu Ala Ile Arg Ser Lys Ile Ala Asp 100 105 110Gly Ser Val Lys Arg Glu Asp Ile Phe Tyr Thr Ser Lys Leu Trp Ser 115 120 125Asn Ser His Arg Pro Glu Leu Val Arg Pro Ala Leu Glu Arg Ser Leu 130 135 140Lys Asn Leu Gln Leu Asp Tyr Val Asp Leu Tyr Leu Ile His Phe Pro145 150 155 160Val Ser Val Lys Pro Gly Glu Glu Val Ile Pro Lys Asp Glu Asn Gly 165 170 175Lys Ile Leu Phe Asp Thr Val Asp Leu Cys Ala Thr Trp Glu Ala Met 180 185 190Glu Lys Cys Lys Asp Ala Gly Leu Ala Lys Ser Ile Gly Val Ser Asn 195 200 205Phe Asn His Arg Leu Leu Glu Met Ile Leu Asn Lys Pro Gly Leu Lys 210 215 220Tyr Lys Pro Val Cys Asn Gln Val Glu Cys His Pro Tyr Phe Asn Gln225 230 235 240Arg Lys Leu Leu Asp Phe Cys Lys Ser Lys Asp Ile Val Leu Val Ala 245 250 255Tyr Ser Ala Leu Gly Ser His Arg Glu Glu Pro Trp Val Asp Pro Asn 260 265 270Ser Pro Val Leu Leu Glu Asp Pro Val Leu Cys Ala Leu Ala Lys Lys 275 280 285His Lys Arg Thr Pro Ala Leu Ile Ala Leu Arg Tyr Gln Leu Gln Arg 290 295 300Gly Val Val Val Leu Ala Lys Ser Tyr Asn Glu Gln Arg Ile Arg Gln305 310 315 320Asn Val Gln Val Phe Glu Phe Gln Leu Thr Ser Glu Glu Met Lys Ala 325 330 335Ile Asp Gly Leu Asn Arg Asn Val Arg Tyr Leu Thr Leu Asp Ile Phe 340 345 350Ala Gly Pro Pro Asn Tyr Pro Phe Ser Asp Glu Tyr 355 360

Claims

1. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:155.

2. A composition comprising a polypeptide of claim 1 and a physiologically acceptable carrier.

3. A composition comprising a polypeptide of claim 1, and a non-specific immune response enhancer.

4. The composition of claim 3 wherein the non-specific immune response enhancer is an adjuvant.